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Hiel veul renners an de start 
Nog mier kenners langs de kant 
En inens dan giet ’t hard 
Trekt ’t circus dor ’t land 
 
De longe vol met frisse lucht 
En de oege zeen vol veur 
Elke bocht is heer berucht 
Hande trekke an ’t steur 
 
Na boave, nar boave 
Umhoeg, zo snel ’t giet 
Nar boave, nar boave 
’t moeiste oetzicht dat bestiet 
 
De veut vast op ’t pedaal 
En de spiere die stoan strak 
Elke berg het zien verhaal 
Genne meater din is vlak 
 
Nar boave, nar boave 
Dor de zomerwind umermd 
Heer boave, als enne oave 
Din te lang is veurverwermd 
 
Oaver afgeslete stien 
Doffe klappe op de maag 
Fietste met owelf alien 
De latste meaters van vandaag 
 
Nar boave, nar boave, nar boave 
 
Nar boave, nar boave 
An de kant, ik lig op stoem 
Nar boave, nar boave 
Onderweg nar miene droem 
Want doarboave loert de kans 
Winnaar van de Tour de France 
 
Nar boave, nar boave, nar boave 
’t podium dat keumt in zicht 
Nar boave, nar boave, nar boave 
Oet de schaduw van ‘t licht 
 
Nar boave, nar boave, nar boave 
In de allerlatste sprint 
Nar boave, nar boave 
Dreit ’t felgekleurde lint 
 
Nar boave, nar boave, nar boave 
Waterdruppels in de zon 
Nar boave, nar boave, nar boave 
De moeiste platst op ’t balkon 
 
Nar boave, nar boave, nar boave 
 
 
Jack Poels [2008] 
Nar Boave 
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A   Frequency factor 
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DMA   N,N-dimethylacetamide 
DP   Degree of polymerisation 
DSC   Differential scanning calorimetry 
EA   Activation energy 
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EtOH   Ethanol 
EtOx   2-ethyl-2-oxazoline 
FDA   U.S. Food and Drug Administration 
FTIR   Fourier transform infrared spectroscopy 
GC   Gas chromatography 
GRTs   Guanidinium-rich transporters 
HA   Hyaluronic acid 
HA-MA  Methacrylated hyaluronic acid 
HDI   Hexamethylene diisocyanate 
IEMA   2-Isocyanatoethyl methacrylate 
IPD   Isophorone diisocyanate 
iPropOx  2-isopropyl-2-oxazoline 
K3   Trilysine 
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LCSC   Lower critical solution concentration 
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MeOx   2-methyl-2-oxazoline 
MeOTs  methyl p-toluenesulfonate 
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MMA   Methyl methacrylate 
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MDI   Diphenyl methane diisocyanate 
MoTrs   Molecular transporters 
NHS   N-Hydroxysuccinimide 
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Chapter 1 
 
Introduction 
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C.M. van Hest, Richard Hoogenboom, The chemistry of tissue adhesive materials, Progress 
in Polymer Science, 2014, 39, 7, 1375-1405 
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1.1 The chemistry of tissue adhesive materials 
Each year millions of people suffer from wounds that do not heal spontaneously, but which 
require closure via a medical procedure. These wounds not only include skin wounds but are 
also caused by any surgical or traumatic disruption of solid and hollow organs, connective 
tissue, muscles, tendons and membranes. Suturing is the most common method to achieve 
tissue approximation and wound healing. For many purposes suturing has proven to be very 
suitable. Sutures can provide great tensile strength and show relatively low failure rate.
1
 
Suture materials can be grossly divided in biologic or synthetic and in absorbable or non-
absorbable materials. Nylon was the first synthetic suture applied and is still the most widely 
used non-absorbable suture. Disadvantages are the need to remove the suture, provoking high 
stress concentrations at the suture point and granuloma formation when it resides for 
prolonged periods of time in the body. Absorbable sutures are made of catgut, poly(lactic-co-
glycolic acid) (PLGA), poly(glycolic acid), polydioxanone or poly(trimethylene carbonate) 
(PTMC), and degrade between 7 to 120 days depending on the material, which is long after 
they have lost tensile strength.
2
 Absorbable sutures, however, frequently evoke inflammatory 
reactions and are relatively expensive. A common feature of suturing is the inevitable 
penetration of surrounding tissue, nerve damage and post-surgical adhesion which can occur, 
and ischemia and necrosis of entrapped tissue caused by damaged capillaries. Needle holes 
and necrotic spaces might provide a passage for fluids or air to leak out. Such compromised 
tissue anastomosis may result in severe complications depending on the leaking material (e.g. 
blood, bowel content, bile, cerebrospinal fluid or air). Gastro-intestinal anastomoses, for 
example, have a 3-15% risk of leakage which can cause intra-abdominal abscesses, fistula, 
peritonitis and mortality.
3, 4
 Other disadvantages of suturing are that it is time-consuming, not 
always technically possible, anaesthesia is needed and it induces undesirable scar formation.
5
 
 
Staples are a frequently used alternative to sutures. The application is faster compared to 
sutures and both absorbable and non-absorbable staples are available. Like sutures, however, 
staples tend to damage surrounding tissue, evoke an inflammatory response and cause scar 
tissue formation including intra-abdominal adhesions. Most importantly, the use of staples 
also harbours a significant failure rate.
1, 2
 
 
In the past decades, a wide variety of chemical and mechanical closure materials has been 
developed with the intention of providing more reliable, more practical and faster methods of 
tissue closure or connection without compromising tissue vascularisation. They can be 
categorised in haemostatic agents, sealants and adhesives. A haemostatic agent initiates the 
formation of a blood clot, resulting in fibrin networks binding or covering tissues. Sealants are 
used to provide a watertight (e.g. for cerebrospinal fluid (CSF)) or airtight (e.g. after lung 
surgery) seal. Tissue adhesives are glues or patches that bind various tissues together in order 
to allow for the natural healing process to occur. Tissue adhesives are applied to a variety of 
tissues, such as skin, muscle and intestine.
6, 7
 
 
Any material used as a haemostatic agent, sealant, adhesive or a combination of these should 
meet extensive requirements. Spotnitz and Burke in 2008
6
 listed five main requirements: 
safety, efficacy, usability, cost and approval from the US Food and Drug Administration 
(FDA) for use in the US and CE mark approval for use in the EU.
7
 Some more specific 
requirements are biocompatibility, biodegradability, mechanical compliance with underlying 
tissue, an acceptable swelling index and shelf stability. Depending on the desired application 
a requirement can also be water tightness, tuneable adhesion and even the ability to enhance 
the healing process by delivery of drugs or growth factors. 
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Biocompatibility means that the components and their degradation products should be non-
toxic and non-haemolytic and cause minimal inflammatory or immune reactions. Also, the 
risk of microbial transmission or contamination and the risk of carcinogenic activity should be 
negligible. The material or its adhesive reaction must not have irritating effects and should not 
jeopardise normal wound healing. Degradation should occur via hydrolysis or enzymatic 
breakdown and the time frame in which this occurs must be sufficiently long for the wound to 
heal, ideally degradation should start after 3 weeks and the tissue adhesive material should be 
completely degraded after 3 months. For complete clearance, all degradation products have to 
be metabolised by the body or excreted via the kidneys or liver. 
 
Regarding quality and functionality, tissue adhesives must not only have sufficient adhesive 
and cohesive strength, but also the flexibility to comply with underlying tissue and the ability 
to retain these properties in moist or wet conditions. The swelling index should be low to 
prevent compression of nerves and blood vessels. Ideally, the adhesive product is easy to 
produce, store and apply. 
 
This chapter will describe the state of the art of the different polymeric materials available in 
the surgical toolbox for wound closure and discuss their advantages and drawbacks. This 
includes both the materials already on the market and new adhesives reported in recent 
scientific literature. These materials will be addressed from a polymer chemistry viewpoint, 
with a focus on synthetic polymers and biomimetic tissue adhesives. Materials based on 
polysaccharides and proteins are not included in this chapter, more information can be found 
in recent review articles.
5-11
 Even though we try to compare the different materials as 
quantitatively as possible, the majority of papers unfortunately only provide qualitative data. 
Even when quantitative data are available it is hard to compare different studies, because the 
used tests and test conditions differ a lot, which has a major influence on the quantitative 
evaluation. In the second part of this chapter, poly(2-oxazoline)s are described as potentially 
interesting polymers for the preparation of tissue adhesive materials. 
 
1.1.2 Polycyanoacrylates 
In 1949 cyanoacrylates were first reported by Ardis,
12, 13
 although their relevance for adhesive 
purposes was only recognised by Coover et al. in 1959.
14
 Since then cyanoacrylates have 
found application as superglues in households, in the automotive and construction industries. 
In the 1960s the potential of cyanoacrylates for the use of wound closure was discovered.
15
 
Their popularity for this application can be ascribed to a variety of favourable properties. The 
liquid monomers show a high reactivity and polymerise in seconds at room temperature 
without addition of a catalyst, heat or pressure. Due to the electron-withdrawing nitrile group, 
the acrylate bond is polarised and therefore susceptible to nucleophilic attack by weak bases 
such as water or amines. After initiation by water the monomers rapidly react via anionic 
polymerisation. The reaction rate is inversely proportional to the length of the alkyl side 
chain. Adhesion between the glue and the tissue is accomplished via covalent bonds between 
the cyanoacrylate and functional groups in the tissue proteins, for example the primary amines 
of the lysine side chains. When applied on tissue, the monomers flow into the cracks and 
channels of the tissue surface, giving a strong bonding between the tissue and the glue. Also 
important for the strength is the mechanical interlocking of the polycyanoacrylates with the 
underlying tissue. 
 
Different cyanoacrylate monomers have been reported to be interesting as tissue adhesives 
(Figure 1).
16
 The strength of the adhesive is determined by the length of the alkyl chain, 
where shorter chains (butyl cyanoacrylates) give stronger polymerised networks than longer 
10 
 
chains (2-octyl cyanoacrylate); the longer alkyl chains on the other hand give more flexible 
bonds resulting in a higher breaking strength.
9, 17
 
 
Figure 1: Structures of cyanoacrylates used as tissue adhesives with A) methyl-cyanoacrylate, B) 
ethyl-cyanoacrylate, C) n-butyl cyanoacrylate and D) 2-octyl cyanoacrylate. 
 
The first cyanoacrylates applied in clinical settings were methyl-2-cyanoacrylate (Figure 1A) 
and ethyl-2-cyanoacrylate (Figure 1B) for wound closing purposes varying from abdominal to 
eye surgery. However, the fast degradation of the resulting polymers leads to accumulation of 
the degradation products in tissue and causes a histotoxic reaction, i.e. an inflammatory 
response. Degradation of the polymer occurs via hydrolysis leading to release of cyanoacetate 
and formaldehyde, a histotoxic component.
9, 18
 This is much less of a problem for polymers 
with longer alkyl chains, since they degrade more slowly, due to steric hindrance and higher 
hydrophobicity (Figure 1C-D).
9
 Due to the histotoxic reaction, the use of the short side chain, 
methyl- and ethyl-cyanoacrylates is nowadays mostly abandoned.
18-20
 Besides cytotoxic 
limitations, cyanoacrylates also have poor mechanical properties. After polymerisation the 
adhesives become brittle, especially for ethyl- and butyl-cyanoacrylates, so they can fracture 
when applied in long incisions or skin creases.
16
 Some cases are reported where a foreign 
body reaction occurs after the use of 2-octyl cyanoacrylate.
21
 
 
Despite these drawbacks, cyanoacrylate tissue adhesive have been available since the 1980s in 
Canada and Europe, and several products that are commercially available are summarised in 
Table 1. These are all medical cyanoacrylate formulations with longer alkyl chains, used for 
suture-less closure of wounds and surgical incisions. In 1998 the FDA approved the use of 2-
octyl cyanoacrylate from Dermabond® for the closure of topical skin incisions. Poly(2-octyl 
cyanoacrylate) degrades slowly, usually after 7 till 10 days the strip sloughs off the skin 
before the histotoxic degradation products are formed.
16
 Indermil® consisting of n-butyl-
cyanoacrylate, and Dermabond® also have an approved claim for usage as a barrier against 
microbial penetration.
9
 n-Butyl cyanoacrylates are found to be cytotoxic in undiluted form; 
however, when diluted ten times with culture medium the cytotoxicity is acceptable, because 
in vitro studies showed that L929 cells were quite unaffected by the glue with a viability score 
above 70%.
22
 Different studies have been performed comparing polycyanoacrylates with the 
use of sutures for wound closure, providing, however, no conclusive answer on which 
methodology is better regarding the cosmetic outcome, wound dehiscence (rupture along a 
suture) or prevention of infection.
16, 17, 23, 24
 Internal application of cyanoacrylate adhesives 
remains troublesome: inflammatory responses that inhibit collagen remodelling and thus 
wound healing, and even pancreatic tumour development have been reported.
9
 
 
  
11 
 
Table 1: Commercially available cyanoacrylate tissue adhesives 
Commercial 
product 
Manufacturer Approved indications Constituents 
Histoacryl® and 
Histoacryl® Blue
9
 
B. Braun Closure of topical skin 
incisions and trauma-
induced skin 
lacerations 
n-butyl-2-cyanoacrylate 
Dermabond®
9, 21
 Ethicon Closure of topical skin 
incisions and trauma-
induced skin 
lacerations 
Barrier to microbial 
penetrations 
2-octyl-2-cyanoacrylate 
Indermil®
9
 Henkel Closure of topical skin 
incisions and trauma-
induced skin 
lacerations 
Barrier to microbial 
penetrations 
n-butyl-2-cyanoacrylate 
Omnex®
9
 Ethicon blocking the passage of 
blood, body fluids or 
air 
n-octyl-2-cyanoacrylate / 
butyl lactoyl-2-cyano 
acrylate 
Glubran® and 
Glubran2®
22
 
GEM Italy synthetic surgical glue, 
CE certified for 
internal and external 
use, with haemostatic, 
adhesive, sealer and 
bacteriostatic 
properties 
n-butyl-2-cyanoacrylate / 
methacryloxysulpholane 
IFABond® IFA medical Class III implantable 
device designed to 
offer an alternative to 
staples and sutures 
(mesh) 
N-hexyl-2-cyanoacrylate 
 
1.1.3 Poly(ethylene glycol)-based tissue adhesives 
Another important class of tissue adhesives is based on poly(ethylene glycol) (PEG). PEG has 
properties favourable for the use in medical sciences: the polymer is water-soluble, 
biocompatible, and shows a stealth-like behaviour in vivo, i.e. it is not readily recognised by 
the immune system.
25-27
 Three major classes of PEG-based tissue adhesives can be 
distinguished: photopolymerisable adhesives (FocalSeal®, successor of AdvaSeal), PEG-
trilysine adhesives (DuraSeal™) and adhesives based on two differently functionalised PEG 
polymers (CoSeal®, SprayGel).
6, 9
 
 
The first photopolymerisable and biodegradable PEG-based adhesive dates back to 1993 and 
consists of a triblock copolymer with a PEG middle block and poly(dl-lactic acid) (PLA) or 
poly(glycolic acid) (PGA) outer blocks.
28
 These ABA-triblock copolymers are prepared by 
using PEG as bifunctional macroinitiator for the ring-opening polymerisation of lactide or 
glycolide, followed by end-functionalisation of the terminal hydroxyl groups with 
photopolymerisable acrylate moieties (Figure 2A). In an aqueous environment these triblock 
12 
 
copolymers form micellar gels in which the hydrophobic outer blocks aggregate and the PEG 
acts as hydrophilic linker between these hydrophobic domains. This self-assembly process 
enables fast polymerisation due to high local acrylate concentration in the hydrophobic 
micellar core. The acquired gel itself is non-adhesive to tissue after polymerisation, whereas 
direct polymerisation in contact with tissue gives an adhered complex, which is ascribed to 
the formation of an interpenetrating network with the extracellular proteins in the tissue.
28
 
 
Figure 2: Two different photopolymerisable block copolymer building blocks for hydrogel tissue 
adhesives with A) PLAm-PEGn-PLAm diacrylate and B) PTMCm-PEGn-PTMCm diacrylate. 
 
FocalSeal® is a sealant based on this self-assembly principle
29
 and is approved by the FDA 
since 2000 for sealing air leaks after lung surgery.
29
 To obtain a hydrogel with mechanical 
properties appropriate for the use as tissue adhesive, a second ABA triblock copolymer is 
added containing poly(trimethylene carbonate) (PTMC) instead of the PLA blocks (Figure 
2B). The PEG-PLA polymer is used as primer solution and is brushed onto the tissue and, due 
to its low viscosity, allowed to flow into the cracks to obtain good adhesion, after which the 
sealant solution of the PTMC-PEG polymer is added, providing better mechanical properties. 
After polymerisation using irradiation with light of 470-520 nm in the presence of a photo-
initiator, usually eosin Y, the hydrogel is formed due to formation of crosslinks between the 
acrylate groups of the polymers.
9, 29-31
 The resulting sealant consists for more than 80 wt% of 
water. Over time the sealant degrades by hydrolysis of the poly(ester) blocks, releasing 
biocompatible degradation products, namely lactic acid and PEG, that can be metabolised or 
cleared by the kidneys.
31
 Other photopolymerisable PEG sealants have also been reported, 
which work via the same principle. These triblock copolymers consist of PEG as middle 
block and poly(propylene fumarate)
32, 33
 or poly(succinic acid) as outer blocks.
34
 
 
Besides sealants for lung surgery, PEG photopolymerisable tissue adhesives have also been 
applied for repair of the ventricular wall.
35
 The use of these photopolymerisable tissue 
adhesives is, however, not widespread due to the limitation that irradiation is needed for the 
polymerisation reaction, which is not applicable to all places in the body. Furthermore, the 
generated free radicals during the polymerisation process may cause damage to healthy tissue. 
 
A second tissue adhesive based on PEG is known as DuraSeal™ Dural Sealant device. First 
reports of DuraSeal™ date from 200336 when this sealant was used in combination with 
sutures for dural closure (the outermost membrane around the brain) to prevent leakage of 
cerebrospinal fluid (CSF), which is one of the potentially dangerous complications of cranial 
surgery.
37
 DuraSeal is a two-component system, which spontaneously forms a crosslinked gel 
when the components are mixed. The first solution contains trilysine (Figure 3A), a tetra-
amine crosslinker, dissolved in sodium borate buffer (pH 10.2) and the second solution 
consists of an aqueous solution (sodium phosphate buffer, pH 4.0) of a four-armed star-PEG 
end-capped with N-hydroxysuccinimide-esters (NHS) (Figure 3B). The PEG mixture also 
contains a dye, FD&C Blue No. 1, for easy visualisation.
36, 38, 39
 This DuraSeal tissue adhesive 
can be applied by simultaneously spraying the two components onto the tissue, whereby the 
amines of trilysine react with the NHS-esters, resulting in the formation of amide bonds, 
13 
 
giving a crosslinked network in seconds (Figure 4). Furthermore, upon application on the 
tissue the aqueous solution will fill the cavities of the tissue surface and the amine and thiol 
groups of proteins present in the tissue also react with the NHS-functionalised polymer gel 
providing covalent adhesion to the tissue.
36, 40
 
 
Figure 3: Structures of A) trilysine and B) pentaerythritol poly(ethylene glycol) ether tetrasuccinimidyl 
glutarate. 
 
The resulting crosslinked gel is a seal giving close to 100% efficacy in watertight closure after 
brain surgery in human patients.
37, 40
 Hydrolysis of this tissue adhesive starts to take place 
after 4-8 weeks, mostly by hydrolysis of the ester linkages and enzymatic degradation of the 
lysine units, giving degradation products that are readily cleared from the body by renal 
clearance.
41
 A possible downside of the DuraSeal™ is the uptake of water and, therefore, the 
swelling of the hydrogel (about 50%) after application. This limits the use of DuraSeal™ in, 
e.g., bone structures due to the possible oppression of nerves.
6, 42, 43
 A modified two 
compound adhesive DuraSeal™ Xact Adhesion Barrier and Sealant System (DSX) claims to 
suppress this swelling by introducing more crosslinks between the PEG linker and trilysine. 
Therefore, this sealant can possibly be used in other applications.
39, 44, 45
 Since the chemical 
composition of the components and the resulting hydrogel are identical to DuraSeal™,39 it is 
most likely that lower swelling is achieved by changing the ratio of PEG versus trilysine to 
get a higher crosslinking density. A final drawback of DuraSeal is the two-component design 
that can lead to clogging of the syringes, during mixing of the components in the syringe, 
when not used completely or if the adhesive is not applied quickly enough. 
14 
 
 
Figure 4: A schematic overview of the process of applying DuraSeal™ using a two component system 
with a solution of PEG and a solution of trilysine41 Copyright© 2013 Covidien. All rights reserved. 
Used with Permission of Covidien. 
 
The third important class of PEG-based tissue adhesives are the so called PEG-PEG 
adhesives, like CoSeal® Surgical Sealant. This two-component tissue sealant contains a 20% 
(w/v) solution of a four-armed star-PEG polymer of 10 kDa molecular weight end-capped 
with thiol end groups (Figure 5) in a sodium phosphate/sodium carbonate buffer (pH 9.6) and 
a second component comprising a 20% (w/v) solution of a 10 kDa four-armed star-PEG end-
functionalised with NHS-ester groups, the same as in the DuraSeal Sealant (Figure 3B), in 
sodium phosphate buffer (pH 6.0).
46, 47
 Upon mixing these functional PEG solutions, the thiol 
reacts with the NHS-ester resulting in the formation of a thioester linkage between the two 
PEG polymers, giving a crosslinked network within 3 seconds. A small amount of disulfide 
bridges is also formed. Covalent bonding to the tissue takes place via an amidation reaction 
between amines present in the tissue and the thioesters in the PEG network.
9, 46, 47
 However, 
even when CoSeal® is applied on non-reactive surfaces, like poly(tetrafluorethene), adhesion 
to the material is observed, indicating mechanical bonding when the liquid solution flows into 
the cracks of the material. Hydrolysis of the thioesters and the glutarate esters (present in the 
star-PEG with NHS groups) leads to degradation of the hydrogel within several weeks.
46
 This 
faster degradation compared to DuraSeal results from the lower stability of the thioester 
groups in comparison to the amide bonds in DuraSeal. 
 
The main disadvantage of this PEG-PEG hydrogel is its high degree of swelling after 
application (about 4 times its original size). Furthermore, adhesion to the surrounding tissue is 
relatively weak.
6, 9, 48
 The mechanical strength of DuraSeal™ was compared with CoSeal® In 
a 2005 study, revealing a higher mechanical strength of the DuraSeal
TM
 adhesive.
49
 
 
Figure 5: Structure of pentaerythritol poly(ethylene glycol) ether tetra thiol, used in CoSeal®. 
15 
 
 
Another example of a PEG-PEG sealant is the SprayGel adhesion barrier system, which 
consists of two reactive PEG solutions. One solution contains NHS-functionalised star-PEG 
and the other amine-functionalised star-PEG and methylene blue for visualisation. Upon 
mixing an adhesive hydrogel is formed, which remains intact for 5 to 7 days after which the 
degradation products are excreted by renal clearance.
50
 The system was reported to prevent 
adhesion after genealogical and colorectal surgery. 
50-53
  Although early preliminary clinical 
trials showed the effectiveness of this PEG-PEG sealant, a larger-scale study was stopped 
owing to a lack of efficacy.
54
 
 
The synthetic hydrogels described above, typically based on PEG, are commonly applied as a 
surgical tissue tape. They offer the benefit of not containing any human/animal material, are 
safe and well tolerated, bind strongly and covalently to wet tissue surfaces (adhesion), have a 
good elasticity and ductility, and are biodegradable. They do have some weaknesses as well, 
preventing more widespread applications. First of all, they are relatively difficult to handle. 
The hydrogel is produced in situ out of two components, which are individually stored as 
freeze-dried products. Before use, they have to be dissolved, and are then applied through a 
dual syringe spray. Once applied, the hydrogel shows a fast crosslinking, resulting in a short 
handling time. Moreover, as the hydrogels have a rather weak cohesion (internal strength), 
they behave more like a gel than a film. This is related to the poor mechanical properties of 
PEG, due to its low glass transition temperature (Tg < -40 °C)
55
 and the tendency to crystallise 
in a brittle material. The crosslink density of the hydrogel is furthermore relatively low, since 
it is limited by the number of end-groups in PEG. The large swelling of these hydrogels is 
another important downside. Therefore, these PEG-based adhesives are regarded as a valuable 
add-on to sutures, but are inappropriate to function as a strong tissue adhesive that can fully 
replace them. Apart from this, these PEG-based hydrogel tissue adhesives are rather costly, 
albeit this has not limited its use in the clinic so far.  
 
Table 2 provides an overview of the polymer-based tissue adhesive products that are currently 
on the market. 
 
Table 2: Overview of commercially available tissue adhesive materials based on synthetic polymers 
Commercial product Approved indications Constituents 
FocalSeal-L (Focal Inc.), 
replaced AdvaSeal 
28, 29
 
Sealing lung air leaks 
 
Photopolymerisable PEG-co-
poly(lactic 
acid)/poly(trimethylene 
carbonate) 
DuraSeal (Covidien), 
DuraSeal Xact 
37-39, 44
 
Adjunct to sutures for dural 
repair 
Anti-adhesion (SprayShield) 
Retina reattachment 
Nerve sciatic anastomosis 
Vascular closure 
Tetra-NHS-derivatised PEG 
and trilysine 
CoSeal (Cohesion 
Technologies)
46, 47
 
Adjunct haemostasis in vascular 
surgery; inhibiting suture line 
bleeding 
Tetra-NHS-derivatised PEG 
and tetra-thiol-derivatised 
PEG 
SprayGel (Covidien)
50-52
 Adhesion barrier in 
gynaecological and colorectal 
procedures 
Tetra-NHS-derivatised PEG 
and tetra-amine-derivatised 
PEG 
TissuGlu®
56-58
 Prevention of seroma formation Lysine di/tri isocyanate-PEG 
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under skin flaps prepolymers 
TissuePatch 
(TissueMed)
59-63
 
Air leakage in thoracic surgery 
Sealing and reinforcing soft 
tissues adjunct to sutures 
Dural repair in cranial surgery, 
adjunct to sutures 
poly-((N-
vinylpyrrolidone)50-co-
(acrylic acid)25-co- (acrylic 
acid N-hydroxysuccinimide 
ester)25) 
OcuSeal (Hyperbranch 
Medical Technology)
64-
68
 
dressing for corneal lacerations 
and bandage for corneal 
transplants 
poly(glycerol succinic acid) 
and PEG-aldehyde 
Adherus 
(Hyperbranch)
69, 70
 
Surgical sealant for dural repair, 
hernia mesh fixation, spinal and 
cardiovascular applications 
Activated PEG and branched 
poly(ethylene imine) 
 
1.1.4 Polyurethanes 
A wide variety of polyurethanes is used for different tissue adhesive or sealant purposes, 
because of the excellent thermal stability at physiological temperature and absence of 
haemolytic behaviour of this class of synthetic polymers.
71
 The most prominent commercial 
example is TissuGlu® Surgical Adhesive, which is used for abdominal tissue bonding. 
 
A frequently observed side effect after abdominal or breast surgery is fluid accumulation 
under the skin, resulting in a so-called seroma. This leads to discomfort by patients and 
regularly requires drainage to remove the fluid. After surgery, the abdominal skin tissue has to 
reconnect to the underlying layers of the abdominal wall. However, imperfect connections 
lead to a void between the skin and the underlying tissue. Fluid accumulation after surgery 
might be due to the occurrence of this void. Therefore, this tissue adhesive TissuGlu® 
Surgical Adhesive has been developed to reduce the dead space by forming a bond between 
the tissue layers.
56
 
 
TissuGlu® is a polyurethane-based adhesive of Cohera Medical Inc. and it is a one-
component glue consisting of a hyperbranched polymer with isocyanate end groups 
containing about 50 wt% of lysine. 
56, 57
 This polyurethane prepolymer is made by reacting a 
combination of lysine diisocyanate and lysine triisocyanate with diols and polyols such as 
PEG and glycerol.
58
 When this pre-polymer comes in contact with the water present in tissue 
it further crosslinks to form a solid network by hydrolysis of some of the isocyanate groups 
into amines, which react with the remaining isocyanate groups to form the network via urea 
linkages. Crosslinking takes place within 25 minutes, which gives surgeons enough time to 
close the abdominal skin. 
56, 57
 The obtained adhesive is biodegradable due to hydrolysis and 
enzymatic degradation of the lysine-based linkages, giving a variety of water-soluble 
degradation products like polyols (e.g. glycerol), lysine (57%), ethanol and carbon dioxide 
(7%), which can all be readily cleared from the body.
56, 57
 Results of TissuGlu® after 
abdominoplasty surgery in dogs showed little evidence of fluid accumulation after five days, 
whereas the control group, not treated with the adhesive, revealed significant fluid 
accumulation. 
56
 Trials with human patients show that TissuGlu® is safe to use and, indeed, 
may decrease the extent of fluid accumulation.
72
 A CE Mark approval in 2011 has led to 
commercialisation of TissuGlu® in Europe.
5
 
 
Cohera Medical Inc. also developed a single component Sylys® Surgical Sealant, which is 
based on the combination of triethoxysilane chemistry and the same urethane chemistry as 
TissueGlu®. The alkoxysilane in the mixture also reacts with diols and polyols, thereby 
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providing enhanced crosslinking density. This tissue adhesive can be used to provide support 
after anastomosis in combination with prevention of leakage.
58, 73
 
 
Polyurethanes are also being used for bone fixation, haemostasis and sealing of vascular 
grafts in several surgery procedures.
74-76
 Vascular grafts are slightly permeable for blood, 
causing leakage of blood into the body. Therefore sealants are needed to water-tighten these 
grafts and polyurethanes can be used for this purpose. A suitable polyurethane has been 
synthesised via the reaction of 4,4-diphenylmethane diisocyanate (MDI) with a 
poly(tetramethylene ether glycol) (PTMEG) of 1000 Da; subsequently 2,2-
bis(hydroxymethyl)-propionic acid (DHMPA) was added to this pre-polymer giving the final 
poly(urethane) (Figure 6).
5, 75
 Besides water-tightening the artificial blood vessel, the sealant 
must also be able to bind proteins present in the bloodstream, which is important for the 
blood/biomaterial interaction. For this purpose DHMPA is introduced as this leads to the 
functionalisation of the product with carboxylic acid groups to which proteins can be bound 
using EDC chemistry (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide). 
5, 75
 No in vivo 
studies are yet reported. It should be noted that the rather hydrophobic and stable character of 
PTMEG might cause problems due to accumulation. 
 
Figure 6: A polyurethane consisting of MDI (black), PTMEG (blue) and DHMPA (red) where the 
carboxyl groups can covalently bind to tissue. 
 
1.1.5 Polyesters 
Aliphatic polyesters such as poly(ε-caprolactone) (PCL) and poly(lactic-co-glycolic acid) 
(PLGA), which have been widely used in biomedical applications, have also been applied as 
tissue adhesives. Ferreira et al
77
 end-functionalised PCL (Figure 7A) with different isocyanate 
groups, namely isophorone diisocyanate (IPD, Figure 7B) and hexamethylene diisocyanate 
(HDI, Figure 7C), to obtain tissue-reactive polymers. This tissue-reactive isocyanate group 
and its crosslinking mechanism are already explained in section 1.1.4 The adhesive properties 
were tested by placing the polymers between two pieces of gelatin, followed by pulling apart 
the gelatin sheets. IPD-modified PCL was able to efficiently bind the gelatin parts together, 
since mechanical failure occurred in the gelatin matrix without compromising the glued 
section. The HDI-modified PCL on the other hand was less effective, as pulling led to 
separation of the two pieces, probably due to a lower NCO concentration in this polymer.
77
 A 
potential limitation of these systems is the absence of crosslinks, i.e. the system fully relies on 
chain entanglements of linear chains. 
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Figure 7: Chemical structures of A) poly(ε-caprolactone) (PCL), B)isophorone diisocyanate (IPD) and 
C) hexamethylene diisocyanate (HDI). 
 
Instead of using amines present in tissue to react with the isocyanates in the polymer material 
also faster curing radical crosslinking systems can be applied. Therefore, the biodegradable 
PCL was modified with 2-isocyanatoethylmethacrylate (IEMA) to form a macromonomer 
(Figure 8A). Photoinitiator Irgacure 2959 (Figure 8B) was used to start the radical 
polymerisation of PCL-IEMA and a crosslinked network was formed within 60 seconds and 
showed a low swelling ratio up to 3%. The crosslinked polymers are biodegradable by 
hydrolysis of the ester bonds in PCL and after 6 weeks about 10 weight % loss was found. 
The adhesive strength of this material was tested in the same manner as described above. The 
polymer and photoinitiator were placed between two pieces of gelatin followed by 60 seconds 
of irradiation to start the polymerisation. The resulting PCL network was able to hold the 
gelatin pieces together, similar to the IPD-modified PCL, which is based on interpenetration 
of the polymer network and the tissue.
78
 No in vivo studies are reported yet.  
 
Figure 8: A) Photocrosslinkable poly(ester) consisting of PCL and IEMA and B) photoinitiator 
Irgacure 2959. 
 
A recently commercialised example of a tissue adhesive based on PLGA is TissuePatch™. 
This tissue adhesive and sealant is used in the prevention of air leakage after lung surgery or 
prevention of fluid leakage after surgery on soft tissue.
59
 A related sealant is 
TissuePatchDural™, which is used for watertight closure of the dura to prevent leakage of 
CSF in patients after brain surgery.
61, 62
 Both adhesives are patches based on multiple layers 
consisting of two different polymers, namely PLGA (Figure 9B) accounting for 23% of the 
mass of the TissuePatch™ and poly((N-vinylpyrrolidone)50-co-(acrylic acid)25-co- (acrylic 
acid NHS-ester)25) (Figure 9A). TissuePatch™ is composed of four layers (Figure 9C), where 
layers 2 and 3 represent the adhesive NHS-functionalised polymer and layers 1 and 4 consist 
of PLGA interspersed with the NHS-functionalised polymer.
63
 For easy visualisation 
methylene blue is added.
60
 When the patch is applied on tissue it covalently binds to the 
amine groups present in proteins on the tissue surface that attack the NHS-moieties of the 
TissuePatch™ creating amide bonds between the patch and the tissue.59 Adhesion to the 
tissue occurs within a minute. The tape degrades due to hydrolysis of the amide bonds and the 
PLGA in the body within 50 days.
79
 The major advantage of the tape in comparison to the 
previously discussed sprays is that it is ready to use, so no costly and cumbersome preparation 
time in the operating theatre is needed. 
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Figure 9: The two polymers present in TissuePatch™: A) poly((N-vinylpyrrolidone)50-co-(acrylic 
acid)25-co- (acrylic acid N-hydroxysuccinimide ester)25) B) poly(lactic-co-glycolic acid), C) a 
schematic overview of the patch where blue layers 1 and 3 represent the NHS-polymer, yellow layers 
2 and 4 represent the PLGA layers with openings where the NHS-polymer is present (5 and 6). 
 
1.1.6 Dendrimers and hyperbranched polymers 
Dendrimers are perfectly branched polymers grown from a central core. The addition of a 
branching layer, or generation [Gn], leads to an exponential increase in the number of 
peripheral groups. Due to their large number of functional groups at their periphery, 
dendrimers are attractive crosslinkable building blocks for tissue adhesives.
80
 In 2002 the use 
of dendritic tissue adhesives for ophthalmology was reported.
81
 These dendritic structures 
were copolymers consisting of a linear polymer PEG and a dendrimer of poly(glycerol 
succinic acid) (PGLSA). Different dendrimer generations were made and functionalised with 
methyl methacrylate (MMA) end groups, giving a series of ([Gn]-PGLSA-MMA)2-PEG 
dendrimers (Figure 10). An aqueous solution of this dendrimer and photoinitiator, namely 
ethyl eosin, was added to an animal eye in which a laceration was made and the solution was 
radically polymerised to form a hydrogel. Binding to the tissue was ascribed to the formation 
of an interpenetrating network between the crosslinked polymer and the tissue,
81
 in which the 
polymers and tissue were intertwined but not covalently bound.
82
 The hydrogels with 
different dendritic generations were compared in terms of polymerisation time, gel formation 
and water solubility of the initial components. It turned out that the first generation dendrimer 
[G1]-PGLSA-MMA)2-PEGn (Figure 10) was the optimal hydrogel for this application.
81
 
 
Figure 10: The structure of ([G1]-PGLSA-MMA)2-PEGn with PEG in pink, the succinic acid moieties 
in black, glycerol in blue and the methacrylate groups in red. 
 
Dendrimers containing different PEG building blocks with a molecular weight of either 3.4, 
10 or 20 kDa were also compared and concentrations of the polymers were varied between 
10% w/v, 20% w/v and 40% w/v. Tissue adhesives are generally tested by making an incision 
in tissue and gluing this together with the tissue adhesive. The space under the laceration is 
filled with liquid until leakage is observed. The pressure at which this happens is the leaking 
pressure. Leaking pressures of a 4.1 mm laceration on the eye were measured using the [G1]-
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PGLSA-MMA)2-PEGn adhesive, showing that the 10% [G1]-PGLSA-MMA)2-PEG220 
hydrogel best withstood pressure.
83
 No in vivo degradation time or mechanism were reported 
in literature, although the ester bonds should be susceptible to hydrolysis. 
 
These dendritic tissue adhesives are as effective as traditional sutures in closing a corneal 
incision in in vitro studies. Both methods have however their downsides. Sutures inflict 
trauma on the tissue, bring unnecessary strain on the cornea and may give an inflammation 
reaction. The major downside of using these photocrosslinkable dendrimers is the need of an 
argon laser to start the polymerisation as well as the radical polymerisation process itself. 
Therefore, research is focused on finding spontaneous dendritic crosslinking adhesives.
67, 84
 
 
A spontaneous crosslinking system was developed based on the reaction between a lysine-
based dendrimer with cysteine end groups ([G2]-(Lys)3-(Cys)4 ) (Figure 11A) and a range of 
linear PEG75 chains end-functionalised with aldehydes (Figure 11B-D). The 1,2-thiolamine 
moiety present in cysteine readily reacts with aldehydes, forming a thiazolidine linkage 
(Figure 11E). Crosslinking between the two components occurred within three minutes at 
room temperature and pH 3-9, and was successfully used to seal a corneal incision in vitro.
64
 
The ester aldehyde PEG-2-oxoethyl succinate (Figure 11D) furthermore showed a 
rearrangement reaction of the thiazolidine linkage into a pseudoproline, which is more stable 
(Figure 11F ).
65
 Due to hydrolysis of the thiazolidine or the pseudoproline linker the 
hydrogels degraded into biocompatible compounds. The degradation time of the gels with 
either PEG75-propionic aldehyde, PEG75-butyric aldehyde or PEG75-ester aldehyde were 3h, 
1.5 weeks or 24 weeks respectively due to the formation of more stable pseudoproline 
linkages. The short degradation time of the PEG75-propionic aldehyde makes it unsuitable as 
tissue adhesive. The polymers showed no cytotoxicity in rabbit eyes
66
 and this sealant is 
expected to soon become commercially available as OcuSeal and CE mark trials have been 
started.
68
 
 
Figure 11: Different components of a hydrogel based on a peptide dendrimer and a PEG-aldehyde 
with a) [G2]-(Lys)3-Cys4, b) PEG75-propionic aldehyde, c) PEG75-butyric aldehyde, d) PEG75-ester 
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aldehyde and the reaction between the peptide dendrimer and the PEG-aldehyde to form a e) 
thiazolidine linkage or f) a thiazolidine linkage that rearranges to a pseudoproline. 
 
PEG lysine-based dendrons bearing four terminal thiols (Figure 12) can be crosslinked with 
poly(ethylene glycol) disuccinimidyl valerate to obtain a biocompatible adhesive hydrogel, 
which is formed within seconds by the formation of thioester bonds. This hydrogel can seal a 
2.5 mm hole in a vein surface and withstands 250 mmHg pressure. The gel can be 
disassembled by addition of an excess thiol-containing solution leading to thiol-thiolester 
exchange and disruption of the crosslinks. By addition of an amine-containing solution, the 
gel is not degraded. In contrast, a hydrogel of PEG lysine dendron bearing amine groups 
cannot be degraded by addition of thiols.
85
 This recently reported hydrogel is the first 
example of a tissue adhesive, which can be degraded on demand. This specific feature might 
be very useful to temporarily close a wound, allowing easy opening for definitive surgical 
care. 
 
Figure 12: PEG lysine dendron bearing four terminal thiol groups 
 
Hyperbranch Medical Technology Inc. developed sealants (Adherus) based on hyperbranched 
poly(ethylene imine) (PEI) and an NHS-activated poly(ethylene glycol).
69, 70
 PEI (Figure 13) 
is mostly investigated as non-viral vector system for gene delivery. One of the main concerns 
of this polymer is its cytotoxicity due to strong electrostatic interactions with the extracellular 
matrix and cell membranes. Chemical modifications can however reduce the cytotoxicity. 
Linear PEI (l-PEI) (Figure 13A) only contains secondary amines and also has lower toxicity 
than hyperbranched PEI (Figure 13B) that contains primary, secondary and tertiary amines.
86
 
The Adherus Sealant consists of a dual syringe where one syringe contains the NHS-activated 
PEG solution and the other the PEI solution. The reaction mechanism is the same as for other 
NHS containing tissue adhesive materials as described in section 1.1.3 and 1.1.5. Upon 
mixing, a crosslinked hydrogel was quickly formed.
70
 The maximum swelling was 25% and 
the hydrogel was fully resorbed in 90 days.
69
 
 
Figure 13: Structures of a) linear and b) hyperbranched poly(ethylene imine). 
 
l-PEI can be prepared by acidic hydrolysis of poly(2-methyl-2-oxazoline) or poly(2-ethyl-2-
oxazoline),
86
 which are biocompatible and show similar stealth behaviour as PEG (see also 
section 1.2).
26, 87
 Therefore, partial hydrolysis of poly(2-oxazoline)s leading to a copolymer of 
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poly(2-oxazoline) and l-PEI yields a material with lower toxicity than pure l-PEI (Figure 
14).
88
 Furthermore, the secondary amino groups present in such a copolymer can be 
crosslinked with diglycidyl ether to form a hydrogel.
89
 Even though the reported hydrogel was 
not shown to exhibit adhesive properties, this methodology has the potential to be used for 
tissue adhesive materials as the utilised diglycidyl ether crosslinker can also react with the 
amines present in tissue. 
 
Figure 14: Partial hydrolysis of poly(2-oxazolline) to poly(2-oxazoline-co-ethylene imine). 
 
1.1.7 Mussel adhesive protein-based polymers 
A relatively recent development are tissue adhesives inspired by naturally occurring adhesive 
proteins. One of the main classes investigated are the protein glues produced by mussels. 
Mussels strongly adhere to natural or man-made underwater structures. They are 
mechanically robust and operate under saline conditions. These properties have inspired 
materials scientists to investigate how synthetic mimics of these protein glues can be made 
and applied in a biomedical setting. The mussel proteins responsible for the adhesive 
behaviour are well adapted for metal complexation, π-π or π–cation interactions, coulombic 
interactions and hydrogen bonding. They contain as key elements the amino acids lysine and 
tyrosine, of which the latter is post-translationally modified to L-3,4-dihydroxyphenylalanine 
(DOPA). Subsequent oxidation of DOPA leads to quinone formation (Figure 15).
90-93
 
Although the exact mechanism of crosslinking is still unclear, it is demonstrated that 
oxidation of DOPA by metal ions or enzymes is necessary to adhere to surfaces or tissue. It is 
therefore proposed that during maturation of the adhesive plaque of the mussel, the quinone 
moieties crosslink with other quinones (radical mechanism), amines and/or thiols (Michael 
addition).
92-94
 In addition, crosslinking by metal complexation of three catechol groups to an 
iron(III) ion might play a role in crosslinking.
95, 96
 
 
Figure 15: Tyrosine residues are post-translationally modified by the enzyme tyrosinase giving DOPA 
in mussel adhesive proteins. 
 
Adhesive proteins were extracted and tested for adhesive strengths, which were comparable to 
fibrin glue. Application was limited for patient use because long curing times, 12-24 h, were 
needed.
97
 Adding oxidizing agents resulted in adhesive strengths which were greater than 
octyl and butyl cyanoacrylate after only one hour of curing time.
98
 Because protein 
extraction
97, 98
 and genetically engineered proteins
92
 resulted in low yields
99
, biomimetic 
synthetic polymers have been developed comprising DOPA moieties. To obtain adhesive 
material with tuneable properties 3,4-dihydroxystyrene, which mimics the catechol side chain 
of DOPA, was copolymerised with styrene yielding a variety of poly[(3,4-dihydroxystyrene)x-
co-styreney] copolymers (Figure 16).
93, 100
 The copolymer was crosslinked using various 
crosslinking agents. Dichromate (Cr2O7
2-
) showed the fastest crosslinking, while Fe(III) and 
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periodate (IO4
-
) promoted hardening to the largest extent.
100
 The hydrogel with optimal 
adhesive properties was composed of poly[(3,4-dihydroxystyrene)33%-co-styrene67%]. When 
increasing the catechol content, too much crosslinking was obtained, biasing the system 
toward extra cohesion and thus lowering surface attachment, a copolymer containing 5% 
catechol groups already showed increased adhesive properties. The adhesion strength of the 
polymer on aluminium plates was compared with other adhesive glues such as ethyl 
cyanoacrylate and showed similar results. The polymer has improved adhesion properties 
compared to mussel adhesive protein obtained via an extraction process. However, the curing 
time for these biomimetic polymers still amounted to 1h and no adhesive studies on tissues 
are reported yet.
93
 
 
 
Figure 16: The structure of a poly[(3,4-dihydroxystyrene)x-co-styreney] a biomimetic of the mussel 
adhesive protein. 
 
DOPA-functionalised poly(ethylene glycol) was first reported in 2002.
101
 The triblock 
copolymer of PEG-poly(propylene oxide) (PPO)-PEG (PEG-PPO-PEG, Pluronics) was 
functionalised with DOPA and DOPA methyl ester. 
101
 Pluronics show temperature dependant 
sol-gel transition behavior at a lower critical solution temperature (LCST), primarily due to 
micelle formation.
102
 The DOPA modified PEG-PPO-PEG demonstrated higher micellisation 
transition temperatures and were more muco-adhesive than the unmodified Pluronics.
101
 
In follow-up research PEG-DOPA hydrogels were published.
94
 Linear and branched PEG 
were modified with DOPA endgroups (Figure 17). When the polymer contained two or more 
catechol units, upon oxidative crosslinking a hydrogel was formed within 1 minute, whereby 
the gelation time could be controlled by the type and concentration of polymer and oxidising 
agent. 
94
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Figure 17: Chemical structures of DOPA-PEG 
 
The four-armed star-PEG functionalised with four DOPA molecules (Figure 17A and B) was 
mixed with thermally responsive NaIO4-filled liposomes. The liposomes are stable at room 
temperature and disassemble upon heating, thereby releasing the NaIO4. When the two 
solutions were mixed and brought to 37 ˚C NaIO4 was released from the liposomes and used 
to oxidise the catechol groups, resulting in rapid hydrogel formation. The strength of the 
hydrogel was tested on porcine skin and showed better mechanical properties than fibrin glue. 
The hydrogel was allowed to cure for 24h in this study before the mechanical properties were 
tested. A disadvantage of this glue is the need for NaIO4, which is toxic.
103
 Nonetheless, this 
adhesive was tested in mice to immobilise transplanted islets at external liver surfaces and an 
epididymal fat pad. The tissue showed minimal acute or chronic inflammatory response. The 
hydrogel maintained an intact interface with the tissue for up to one year.
104
 This adhesive 
was compared with other sealants, namely Dermabond (2-octyl cyanoacrylate), Histoacryl (n-
butyl-2-cyanoacrylate), SprayGel (4 arm PEG-NHS and 4 arm PEG-NH2), photopolymerised 
PEG sealant and fibrin glue, for sealing foetal membranes in vitro. Only the PEG-DOPA 
sealant met the requirements of membrane bonding and non-toxicity.
105
 To overcome the 
problem of long degradation times, a dipeptide of alanine-alanine was incorporated between 
the PEG polymer and the DOPA moiety. Even though this dipeptide is susceptible to 
enzymatic degradation, in vitro studies showed no degradation and only slow degradation was 
found in vivo.
106
  
 
Murphy et al
107
 developed PEG-polycaprolactone (PCL) copolymers with DOPA end-groups. 
This tissue adhesive was solvent cast onto surgical meshes used for hernia repair to provide 
adhesive coated meshes. The films were cured by addition of sodium periodate and up to 30 
wt% of PCL-triol. These constructs had significantly higher adhesive strengths than fibrin 
glue. The degradation, mechanical and physical properties were tuned by varying polymer 
composition, PCL-triol content, coating density and oxidant concentration. This adhesive can 
eliminate the need for mechanical fixation of meshes and probably be used as reinforcement 
for soft tissue and surgical repair.
107
 The PEG-PCL-DOPA polymer was tested for tendon 
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repair. Its adhesive strength was significantly higher compared to Tisseel fibrin glue and 
reached 60% of the Dermabond strength. The adhesive was coated onto a biological scaffold 
and this was placed over a transected tendon improving the biomechanical properties 
compared to suture repair.
108
 
 
Citric acid, PEG and dopamine have also been combined to form catechol-containing 
prepolymers (Figure 18). This adhesive was applied in a dual syringe system with the 
prepolymer in one syringe and a sodium periodate (initiator) solution in the other, resulting in 
an injectable citrate-based mussel-inspired bioadhesive (iCMBA). After mixing, gel times 
varied from 18 seconds to just over 5 minutes, depending on the structure of the prepolymer, 
the amount of initiator and the amount of dopamine present. In vivo studies in rats showed 
only minor acute inflammation. Bleeding wounds in these rats were closed with the iCMBA 
within 2 minutes, without the use of sutures. iCMBAs showed 2.5 to 8 times greater strength 
than fibrin glue. Due to the ester linkages, the tissue adhesive formulation is biodegradable.
109
 
 
 
Figure 18: Schematic representation of iCMBA pre-polymer synthesis. 
 
Another possible wound dressing hydrogel consists of thiol-functionalised poly(ethylene 
glycol)-poly(propylene oxide)-poly(ethylene glycol) (PEG-PPO-PEG) (Plu-SH, Figure 19B) 
and catechol-functionalised hyaluronic acid (HA) (Figure 19A). The crosslinking between the 
thiol and quinone groups, obtained by oxidation of the catechol groups, led to the formation 
of a hydrogel upon mixing (Figure 20) whereas reaction with amine groups present in the 
tissue proteins gave adhesion to the tissue. This mixture is thermosensitive; at room 
temperature the two polymers were barely crosslinked, leading to a low viscous reaction 
mixture. However, at the body temperature of 37 °C, above the LCST of Plu-SH, the mixture 
became highly crosslinked giving a robust hydrogel. For in vivo studies a premixed solution 
of 16 wt% was injected subcutaneously into mice where the hydrogel was allowed to form. 
After 21 days 78 wt% of the hydrogel was still present, showing slow degradation. The 
hydrogel was adhered to the surrounding tissue, although both HA and Plu by themselves are 
normally used as anti-adhesive materials in surgery. The adhesion was therefore due to the 
reaction between the lysine residues in tissue with the remaining catechol moieties.
110
 Instead 
of hyaluronic acid, chitosan can also be functionalised with DOPA groups resulting in a 
hydrogel with similar properties. After 25 days in vivo, this gel maintained 97% of its original 
weight, so it degrades even slower.
111
 Since chitosan shows haemostatic behavior, a possible 
additional use of the latter gel could be to stop excessive bleeding. 
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Figure 19: Structures of A) catechol-functionalized hyaluronic acid and B) thiol-functionalized 
poly(ethylene glycol)-poly(propylene oxide)-poly(ethylene glycol) (Plu-SH). 
 
 
Figure 20: A schematic representation of HA/Pluronic hydrogels. Slightly cross-linked 3-D network 
formation of HA/Pluronic hydrogels and their sol–gel transition behavior. Reproduced from ref110 with 
permission of The Royal Society of Chemistry 
 
Swelling is one of the main issues of PEG-based materials leading to adhesion failure of the 
gel and, therefore, polymeric branched gels based on PPO-PEG were developed. The 4 arm 
PPO-PEG block copolymer (tetronic polymer) is end-functionalised with DOPA moieties and 
exhibits LCST behavior based on collapse of the PPO block. When crosslinking is performed 
at room temperature a hydrogel is formed that contracts upon heating to physiological 
temperatures due to collapse of the PPO. By varying the gel formation temperature and 
polymer concentration, swelling can be controlled between 0 and -25%. The tissue adhesion 
of this PPO-PEG material was better than PEG based adhesives.
112
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Catechol oxidation requires cytotoxic oxidising agents or high pH values (>8). To avoid these 
conditions, a water-soluble biocatalyst was developed. This catalyst consists of hematin, an 
iron-containing heme group which has been studied as an oxidative catalyst, grafted onto 
chitosan to improve solubility. However, hydrogen peroxide is needed for the oxidation of the 
catechols, which raises concerns about cytotoxicity of the formulation, even though 
cytotoxicity studies showed 95% cell viability. Hydrogels were prepared using this catalyst 
and these showed enhanced tissue adhesion compared to hydrogels formed by a pH trigger.
113
 
If hydrogen peroxide can be produced in situ, the cytotoxicity concerns will be avoided. 
 
The main concerns of using mussel adhesive protein mimics are the long degradation times 
and the use of toxic oxidising agents like periodate and iron (III). Since most of these systems 
are PEG based, all previously mentioned drawbacks (section 1.1.3) associated with the use of 
this polymer also account here. Nonetheless, DOPA-functionalised polymers show high 
potential as tissue adhesives, although no clinical studies have been performed to date. 
 
1.1.8 General discussion on polymer-based tissue adhesives 
The use of sutures or staples for closure of incisions has certain drawbacks, especially when 
delicate and vulnerable tissues, prone to leakage of fluids or gas, have to be closed or 
connected. Tissue adhesives seem a good alternative for these purposes. Additionally, tissue 
adhesives can be used in combination with sutures to yield a water tight seal. Many different 
synthetic polymers, polysaccharide- and protein-based adhesives have already entered the 
market.
8
 They, however, have several drawbacks as well. When comparing these three types 
of adhesives, general problems arise for each of the different classes. 
 
A main class of synthetic adhesives are the cyanoacrylates, which are suitable for closure of 
skin incisions. However, due to their toxic degradation products (formaldehyde) other 
applications are difficult to realize. PEG-based hydrogels don't have this problem, but 
significantly swell in vivo and thereby limit applications close to nerves. The PEG gels often 
also lack good mechanical strength, which greatly limits their applicability. The general 
challenge regarding synthetic adhesives is to find polymers which are non-toxic and which 
display good gel strength. The variety of polymers used at the moment is therefore small and 
most adhesives are based on either PEG, polyurethanes or PLGA. Clearly there is a need for 
new synthetic polymers which satisfy better the criteria for an optimal tissue adhesive. 
Biomimetic adhesives are a rapidly expanding research field. Especially the introduction of 
the dihydroxyphenyl moiety (DOPA), responsible for the adhesive behavior of mussel 
adhesive proteins, into synthetic polymers, such as polystyrene or PEG, is being explored. 
This research area shows a lot of perspective in adhesion strength, but long degradation times 
and the use of toxic oxidizing agents are major concerns. The long degradation problems can 
be solved by using biodegradable polymers or by introducing dipeptides which are susceptible 
to enzymatic degradation.  
 
A limited number of reactive groups are frequently used for tissue adhesive materials. The 
most popular functional moieties are methacrylates for photopolymerisation and NHS-esters 
or aldehydes for spontaneous crosslinking with amines. The large downside of using 
methacrylate functionalisation is the absence of a direct linkage to tissue and the use of 
external irradiation to start the polymerization. NHS-ester chemistry is very popular in the 
search for new adhesives due to its reactivity towards amines which are widely present in 
tissue. It is used in various synthetic polymer-based adhesives and in chondroitin sulphate 
adhesives.
8
 It also does not have the problems associated with toxicity as is the case with 
glutaraldehyde or formaldehyde-based crosslinkers. Functional groups which are less 
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frequently used are isocyanates and DOPA. Isocyanates can react with all sorts of 
nucleophiles, including water, which as a side reaction diminishes the possibility of the 
isocyanates to bind to tissue. DOPA is already discussed before. 
 
The list of functional moieties used in tissue adhesives is much more extended when the 
patent literature is taken into account.
8
 It will however be difficult to promote one of these 
alternative chemistries into real applications, as the abovementioned existing coupling routes 
are at the moment still sufficient and reliable. 
 
Looking at the general direction that the research on adhesives is taking and the demands of 
the market, a future tissue adhesive should ideally fulfil all following requirements: 
 The adhesive and its metabolites are biocompatible, biodegradable and non-toxic, 
giving no allergic or histotoxic reaction; 
 Tuneable adhesion time for different applications; 
 Cohesion strength matches the application 
 Short or no preparation time, be readily usable for surgeons;  
 Swelling index is acceptable; 
 The tissue adhesive is shelf-stable; 
 Tuneable degradation time; 
 Coloured for easy visualization; 
 No device or extra reagents are needed for application. 
 
Despite the large amount of research on tissue adhesives, there is no product on the market 
that complies with all of these requirements, leaving opportunity for further improvement in 
the (near) future. However, when trying to bring a new tissue adhesive to the market, the 
largest challenge will probably be to find a unique quality that stands out from the rest, by 
incorporating special properties (anti-microbial activity or haemostatic behavior for example) 
or to significantly outperform all current products. It is to be expected that more advanced 
adhesives will soon enter the market, especially those that are easier applicable for surgeons, 
have better adhesive and mechanical properties, as well as more switchable adhesives 
allowing on demand removal. One class of polymers that is regarded to be potentially very 
interesting for biomedical applications are the poly(2-oxazoline)s which are described in the 
second part of this chapter. 
 
1.2 Poly(2-oxazoline)s 
Poly(2-alkyl/aryl-2-oxazoline)s (PAOx) are an interesting class of polymers because of their 
tuneable properties, biocompatibility, stealth behavior and thermosensitivity.
87, 114-116
 The 
living cationic ring opening polymerisation (CROP) of 2-oxazoline monomers (Figure 21) 
was first reported by four independent research groups in the 1960s,
117-120
 which provides 
easy access to well-defined polymers with controlled end group functionalities, incorporated 
by the use of functional initiating and terminating agents. 
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Figure 21: Polymerisation mechanism of 2-oxazoline monomers to yield poly(2-alkyl/aryl-2-
oxazoline)s 
 
1.2.1 Monomer synthesis 
2-Oxazoline monomers can be prepared via different routes, of which the Witte-Seeliger 
synthesis, modified Wenker method and the α-deprotonation route are mostly used.114, 121, 122 
 
The Witte-Seeliger synthesis
123
 is the most commonly used method to synthesize a 2-
oxazoline monomer. In a one-step synthesis a nitrile and 2-aminoalcohol are reacted in the 
presence of a Lewis acid catalyst, e.g. zinc acetate, to activate the nitrile function (Figure 22). 
During this synthesis ammonia is released, which is the biggest drawback of this synthesis 
because it can act as terminating agent preventing the polymerisation. This reaction is 
performed at high temperatures, typically 130 °C, which limits the choice of reagents; 
furthermore, the release of ammonia can cause problems when functional groups are 
incorporated. 
 
Figure 22: The Witte-Seeliger procedure for the preparation of 2-oxazolines 
 
The modified Wenker method
122, 124-126
 provides milder reaction conditions. In this multistep 
process (Figure 23) an activated carboxylic acid, usually an acid chloride commercially 
available or home-made, is reacted with 2-chloroethylamine hydrochloride to form a 
secondary amide. This intermediate compound is subsequently ring-closed under basic 
conditions to yield the monomer. 
 
Figure 23: Modified Wenker synthesis of oxazoline monomers 
 
A more recent route for monomer synthesis is the α-deprotonation of 2-methyl-2-oxazoline 
(MeOx),
127, 128
 followed by a nucleophilic substitution with an alkylbromide (Figure 24). The 
deprotonation is performed with n-butyllithium/tetramethylethylenediamine (n-
BuLi/TMEDA) or lithium diisopropyl amide (LDA). 
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Figure 24: α-deprotonation of MeOx followed by nucleophilic substitution with an alkylbromide. 
 
1.2.2 Polymerisation mechanism 
During initiation the nitrogen of the first monomer attacks the electrophilic initiator, such as 
tosylates, triflates, methyl iodides or alkyl halides, resulting in the formation of an 
oxazolinium cation. A fast initiation is needed to avoid slow or incomplete initiation which 
will lead to a deviation of the desired first order kinetics yielding broader molecular mass 
distributions and higher dispersities.
114, 115
 The nucleophilicity of the counterion influences 
the equilibrium between the cyclic ionic active species and the covalent species.
114, 115, 129, 130
 
Functional initiators can be used to introduce groups which can be used for later post 
polymerisation modification, to e.g. alkyne,
131, 132
 anthracene
122, 133, 134
 methacrylate
135
 or 
other unsaturated substituents.
122, 136, 137
 
 
Figure 25: Imitation mechanism of CROP of 2-oxazolines and the equilibrium between covalent and 
ionic species 
 
The next monomer subsequently attacks this cation, leading to the formation of the ring-
opened poly(2-oxazoline) which still has the active propagating cationic chain end. The 
addition of the first monomer to the cation formed during initiation (kp,1) is the rate-
determining step. After this the propagation rate (kp) dramatically increases due to the 
interaction of the carbonyl of the penultimate unit with the oxazolinium ring, (Figure 26) 
resulting in the stabilisation of the transition state and shift towards the more reactive 
species.
129, 130
 Also during polymerisation covalent or ionic species can be present depending 
on the counterion and the nucleophilicity of the monomer, the more oxazolinium species 
present the faster the polymerisation proceeds. Chloride counterions result in covalent 
propagating species while tosylate and triflate counterions yield ionic oxazolinium species.
115, 
122, 129, 130
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Figure 26: Propagation mechanism of CROP of 2-oxazolines 
 
A living polymerisation is characterised by fast initiation and the absence of undesired 
transfer and termination reactions and the overall rate will thus follow first-order kinetics: 
−
𝑑[𝑀]
𝑑𝑡
= 𝑘𝑝[𝑃
+][𝑀] 
where [M] is the monomer concentration, t is the reaction time and [P
+
] is the concentration of 
growing chains. Because the polymerisation is living, [P
+
] is constant and equal to the 
initiator concentration [I0], so the equation can be rewritten and integrated: 
𝑙𝑛 (
[𝑀]0
[𝑀]𝑡
) = 𝑘𝑝[𝐼]0𝑡 
The propagation rate constant (kp) can be determined by measuring monomer concentrations 
at different time intervals and subsequently calculated from the linear first order kinetic plot. 
True living polymerisations also have a linear correlation between conversion and number 
averaged molecular weights because all polymers grow at the same time. 
 
The kp of 2-oxazolines is dependent on temperature and monomer structure. Conditions for 
polymerisation were optimised revealing a reaction temperature of 140 °C in a microwave 
reactor as ideal conditions due to the minimum side reactions. Because the boiling point of 
acetonitrile, the most common solvent for oxazoline polymerisation, is 82 °C, an overpressure 
is created in a closed reaction vessel. Similar kinetics were obtained by microwave synthesis 
and conventional heating in pressure tubes, demonstrating that no specific microwave effect 
occurs.
138
 The polymerisation can be performed over a wide range of temperatures without 
the occurrence of significant chain-transfer reactions.
114, 115
 
 
Side chain functionalisation can be obtain by (co)polymerisation of a functional monomer. 
Nucleophilic groups which can interfere with the polymerisation should be protected. The 
simplest monomers bear linear alkyl side chains varying in length (Figure 27 1-4),
139
 more 
complex monomers bear chains which contain protected carboxylic acids
126, 140, 141
 (Figure 27 
5), protected alcohols
140
 (Figure 27 6), alkynes
142
 for performing copper(I)-catalysed azide-
alkyne cycloaddition (CuAAC) click chemistry (Figure 27 7), azides
143, 144
 for CuAAC 
(Figure 27 8), protected amines
145
 (Figure 27 9), protected aldehydes,
127
 branched or cyclic 
alkyl chains,
120, 128, 146
 inert perfluorinated chains,
120, 147
 aromatic chains,
120, 148-150
 fatty 
acids
151, 152
 or terminal alkyl chains for thiol-ene or thiol-yne chemistry.
125, 142
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Figure 27: Different monomer structures. From left to right 1: 2-methyl-2-oxazoline (MeOx), 2: 2-
ethyl-2-oxazoline (EtOx), 3: 2-n-propyl-2-oxazoline (nPropOx), 4: 2-n-butyl-2-oxazoline, 5: protected 
acid oxazoline, 6: protected alcohol oxazoline, 7: alkyne functionalized oxazoline, 8: azide 
functionalized oxazoline, 9: protected amine oxazoline 
 
After the polymerisation is finished a terminating agent can be added; in literature 
piperidine
136, 153
 or a methanolic sodium or potassium hydroxide
122, 154
 are mostly used.
114, 136
 
The latter one results in a hydroxyl terminus which can be functionalised. All nucleophilic 
reagents can be used as terminating agent. Some bear functional groups for post modification, 
e.g. azide,
133, 155
 piperazine
142, 156, 157
 or polymerisable groups.
158-160
 
 
The synthetic versatility of poly(2-oxazoline)s allows the copolymerisation of different 
monomers to tune properties, gives easy access to a wide diversity of polymer structures, like 
block copolymers and non-linear architectures.
87, 114, 115, 121, 122, 161, 162
 
 
1.2.3 Polymer properties 
The poly(2-oxazoline) polymer properties can be tuned by variation of the side chain of the 
oxazoline monomer and copolymerisation of monomers with diverse properties.
87, 114, 115, 163
 
In this section the solution and thermal properties and biocompatibility are discussed.  
 
1.2.3.1 Aqueous solution behaviour 
Poly(2-methyl-2-oxazoline) (PMeOx) is water soluble in the entire temperature range under 
atmospheric pressure. Poly(2-ethyl-2-oxazoline) (PEtOx) and poly(2-propyl-2-oxazoline) 
(PPropOx) show lower critical solution temperature (LCST) behaviour. At low temperatures 
the polymer is completely water soluble, but upon heating it undergoes an entropy-driven 
dehydration which results in the collapse of the polymer chain (Figure 28). This phase 
separation of high polymer concentration droplets results in a turbid or cloudy solution, which 
occurs at the cloud point temperature (TCP). The incorporation of more hydrophilic monomers 
will favour the water solubility, so the hydrophobic-hydrophilic balance in the polymer will 
determine the TCP. The LCST is defined as the temperature minimum of the phase diagram 
(Figure 29), the corresponding concentration is the lower critical solution concentration 
(LCSC).
163, 164
 
 
Figure 28: Schematic representation of phase transition of polymers in aqueous solution. 
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Figure 29: Temperature composition phase diagram for polymers exhibiting LCST behaviour 
 
PEtOx has an LCST of 60 °C, but depending on molecular weight, concentration and end 
groups, soluble polymers up to 100 °C can be obtained.
87, 114, 163, 165
 Increasing the side chain 
with one carbon atom to obtain PPropOx leads to a dramatic decrease of the LCST. Poly(2-n-
propyl-2-oxazoline) (PnPropOx) has a transition temperature of 25 °C, poly(2-cyclopropyl-2-
oxazoline) (PcPropOx) of 30 °C and poly(2-isopropyl-2-oxazoline) (PiPropOx) of 35 °C, 
while side chains with four or more carbon atoms are fully water insoluble. 
114, 166, 167
  
 
TCPs can be tuned from 9 °C to 100 °C by varying the molecular weight and composition of 
the polymer by incorporation of more hydrophobic or hydrophilic monomeric units, either by 
copolymerisation or post-modification.
153, 154, 163, 168-171
 The addition of salts to the polymer 
solutions can also influence the cloud points. Sodium chloride will lead to salting out, 
decreasing the TCP, while tetrabutylammonium bromide causes salting in, increasing the 
TCP.
172, 173
 
 
1.2.3.2 Thermal properties 
PAOx is a highly thermally stable polymer which only starts to degrade above 300 °C.
88, 114
 
PMeOx and PEtOx are amorphous polymers with glass transition temperatures (Tg) of 80 and 
60 °C respectively. Nonetheless, melting transitions have been reported: PMeOx fibres are 
semicrystalline with a melting transition of 200 °C,
120
 and PEtOx can crystallize when 
isothermally heated above its LCST, resulting in a melting temperature (Tm) of 201 °C.
174
 
PnPropOx is an amorphous polymer, while PiPropOx can be crystallised upon isothermal 
heating above LCST.
175, 176
 Polymers with longer side chains show lower Tgs, correlated 
inversely with chain length, poly(2-hexyl-2-oxazoline) has a Tg of -10 °C. Polymers with 
longer side chains only exhibit melting temperatures.
152
 Tgs of aromatic PAOx polymers are 
higher compared to poly(2-alkyl-2-oxazolines) due to the higher rigidity.
177
 The thermal 
properties can also be tuned by copolymerisation.
120, 170, 178
 
 
1.2.3.3 Biocompatibility and stealth behaviour 
PEG is regarded as the gold standard biocompatible polymer for biomedical applications,
55
 
but still has some drawbacks like oxidative degradation and, upon prolonged exposure in the 
human body, the occurrence of an immune response as indicated by the presence of PEG 
antibodies. 
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The biocompatibility of PMeOx was already proven in 1989; by injection of 
125
I-labeled 
polymers into mice, no accumulation was found in organs. However, a small, probably high 
molecular weight fraction was found in the muscles and skin.
179
 More recent work showed 
that well-defined PMeOx and PEtOx do not accumulate in tissue and show rapid blood 
clearance.
180
 Stealth behaviour was proven by coating of liposomes with PMeOx or PEtOx, 
resulting in enhanced circulation times in rats and mice. PMeOx and PEG-decorated 
liposomes had similar circulation times, while PEtOx was cleared slightly faster.
181, 182
 Rathna 
showed that PEtOx improved the biocompatibility of hydrogels.
183
 
 
Polymer-drug/protein conjugation is a well-known method to improve circulation time, 
solubility and immunogenicity.
87, 116
 Many proteins, e.g. catalase, trypsin, BSA, insulin, have 
been coupled with PMeOx or PEtOx showing similar performances as PEG conjugates.
116, 184, 
185
 Only a few PAOx-drug conjugates are known in literature.
116
 Serina Therapeutics 
developed the most promising one; a ritigotine-PAOx conjugate which provides an increased 
circulation time of this drug, enabling once-a-week injection of the conjugate to Parkinson’s 
disease patients.
186
 
 
PAOx-based micellar or aggregated drug systems are more studied than the conjugates, these 
systems can be formed by the self-assembly of amphiphilic block copolymers. Multiple drugs 
can be loaded at the same time into the micelle/polymersome, enhancing solubility of 
hydrophobic drugs in the hydrophobic core and circulation times and reducing side effects.
187
 
Aggregates based on poly(2-phenyl-2-oxazoline) (PPhOx)-PMeOx gradient or block 
copolymers and di- and triblock copolymers of poly(2-n-butyl-2-oxazoline) (PnBuOx) have 
been used for drug loading.
188-190
 Assemblies of other ABA triblock copolymers, consisting of 
PMeOx-PDMS-PMeOx (PDMS=polydimethylsiloxane), have been loaded with various 
proteins or DNA.
191-194
 
 
1.3 Outline of thesis 
Today a wide variety of tissue adhesive materials are available on the market, but 
unfortunately none of them fulfils all requirements needed for an optimal material. New 
polymeric materials are needed for this application; poly(2-oxazoline)s might be an 
interesting class of materials, based on their biocompatibility, stealth behaviour and tuneable 
properties. In particular, poly(2-oxazoline)s have the advantage compared to PEG that side-
chain functionalities can be introduced, which increases the density of reactive groups 
considerably. In order to be useful for tissue tape applications, the reactive moieties are 
preferably NHS esters, which can be used for crosslinking with multi-amine compounds and 
which can adhere to tissue. In this thesis a new series of poly(2-oxazoline)s is described 
which can be used for the development of a tissue tape. The first chapters focus on the 
synthesis and physical properties of poly(2-oxazoline) copolymers, which can be modified 
into the desired NHS ester- functional polymers. In the final chapter application of the 
obtained polymers in the development of a tissue tape is reported.  
Chapter 2 describes the preparation of methyl ester functionalised poly(2-oxazoline)s. 
Synthetic strategies for the synthesis of two monomers with different chain lengths (ethyl or 
propyl spacer between the oxazoline and ester moiety) were optimised and homo- and 
copolymerisation kinetics studies were performed. In this way the distribution of these 
functional monomers along the polymer chain was determined, which is important for 
functionalisation later on. 
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In chapter 3 four series of methyl ester-containing copolymers were prepared by 
copolymerisation of the two methyl ester monomers in different ratios with either EtOx or 
nPropOx. Also the homopolymers of the two methyl ester-containing monomer were 
synthesised. The physical properties of these side chain functionalised polymers, such as 
cloud point temperatures, glass transition temperatures and thermal stability were determined 
in relation to their composition. 
 
In chapter 4 the amidation of a methyl ester oxazoline homopolymer with a series of primary 
and secondary amines was investigated in order to introduce new properties. In particular 
cloud point- and glass transition temperatures and thermal stability were determined. 
 
In chapter 5 the side-chain functionalisation of poly(2-oxazoline) copolymers was used to 
synthesise polymeric mimics of cell penetrating peptides. Therefore copolymers with methyl 
ester and ethyl side chains were modified in an efficient three-step process into guanidines. 
Polymers of different degree of functionalisation and with a random or blocky structure were 
prepared. These guanidine-functionalised polymers were tested for toxicity and cell uptake as 
a function of their composition.  
 
In chapter 6 a first approach to a poly-(2-oxazoline) based tissue tape was developed. Methyl 
ester functional poly(2-oxazoline)s were modified into either NHS esters or amines. The NHS 
polymers were combined with the amine-functional polymers in ratios that ensured sufficient 
crosslinking, while leaving NHS groups available for conjugation with tissue. NHS:NH2 
ratios ranging from 1:1 to 10:1 were tested. The crosslinked films were placed on a 
biodegradable backing material to improve the mechanical stability of the adhesive tape. The 
adhesion on tissue and cohesion of the tapes was finally tested, demonstrating the feasibility 
of the approach. 
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Abstract 
Poly(2-oxazoline)s with methyl ester-functionalised side chains are interesting as they can 
undergo a direct amidation reaction or can be hydrolysed to the carboxylic acid, making them 
versatile functional polymers for conjugation. Here we present detailed studies on the homo- 
and copolymerisation kinetics of two methyl ester-functionalised  2-oxazoline monomers with 
2-methyl-2-oxazoline, 2-ethyl-2-oxazoline and 2-n-propyl-2-oxazoline. The 
homopolymerisation of the methyl ester-functionalised monomers is found to be faster 
compared with the alkyl monomers, while copolymerisation unexpectedly reveals that the 
order of monomer incorporation is reversed. The methyl ester-containing monomers are found 
to significantly accelerate the polymerisation of all present monomers due to extra 
stabilisation of the oxazolinium cation by the carbonyl of the methyl ester side chain. 
 
Introduction 
The living cationic ring-opening polymerisation (CROP) of 2-oxazoline monomers (Scheme 
1) was first reported in the 1960s,
1-4
 providing easy access to a wide variety of well-defined 
poly(2-alkyl/aryl-2-oxazoline)s (PAOx) with controlled end-group functionality during 
initiation and termination.
5-9
 PAOx are an interesting class of polymers because of their 
highly tuneable and diverse properties.
6, 10-12
 Poly(2-methyl-2-oxazoline) (PMeOx) and 
poly(2-ethyl-2-oxazoline) (PEtOx) are of special interest for biomedical applications because 
of their water solubility, biocompatibility and stealth behaviour, similar to poly(ethylene 
glycol) (PEG).
6, 10, 11, 13
 PEtOx and poly(2- propyl-2-oxazoline) (PPropOx) show lower critical 
solution (LCST) behaviour with better reversibility compared to the gold standard poly(N-
isopropylacrylamide).
14-16
 The properties of PAOx can be easily tuned by variation of the side 
chain substituents, also enabling the incorporation of (protected) side-chain functionalities.
17-
29
 
Scheme 1: Cationic ring-opening polymerisation of 2-oxazolines with methyl p-toluenesulfonate as 
initiator and piperidine as terminating agent. 
 
PAOx with methyl ester-functionalised side chains are especially interesting as the methyl 
ester can be hydrolysed to the carboxylic acid, a versatile functionality for conjugation of 
peptides and proteins, as well as the introduction of pH-responsive behaviour. Moreover, 
PAOx with side chain methyl ester groups can undergo direct amidation with a variety of 
functional amines to easily introduce functional moieties, such as amine, alcohol or hydrazide 
units.
30, 31
 Even though the synthesis and polymerisation of 2-methoxycarbonyl-ethyl-2-
oxazoline, a methyl ester-containing oxazoline monomer (MestOx; Scheme 2), was already 
first reported by Levy and Litt in 1968
17
 and this monomer has also been used more recently 
by the groups of Nuyken and Voit,
17-20, 22, 23
 the (co)polymerisation kinetics of MestOx are yet 
unknown. 
 
Scheme 2: Monomer structures of MestOx (1), C3MestOx (2), MeOx (3), EtOx (4), and nPropOx (5). 
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In this chapter we describe an improved synthesis for MestOx (1) and the synthesis of a new 
methyl ester-containing monomer with a C3-spacer between the oxazoline ring and the 
methyl ester, namely 2-methoxycarboxypropyl-2-oxazoline (C3MestOx, 2). Detailed studies 
on the homo- and copolymerisation kinetics of these two methyl ester-functionalised 2-
oxazoline monomers, MestOx and C3MestOx, with MeOx (3), EtOx (4) and 2-n-propyl-2-
oxazoline (nPropOx, 5) are reported. To better understand the observed copolymerisation rate 
constants, the Arrhenius parameters of the MestOx and C3MestOx homopolymerisations as 
well as the MestOx-MeOx copolymerisation were also determined by studying the 
(co)polymerisation at different temperatures. 
 
Results and discussion 
Monomer synthesis 
The 2-methyl ester-functionalised-2-oxazoline monomers, MestOx and C3MestOx, were 
prepared from commercially available acid chlorides 1a and 2a through a reaction with 2-
chloroethylamine hydrochloride in the presence of triethylamine yielding intermediate 
compounds 1b and 2b. The monomers (1 and 2) were obtained by ring-closure of these 
intermediate compounds with a strong non-nucleophilic base (sodium carbonate) to avoid 
saponification of the ester. This latter reaction was performed on a rotary evaporator under 
reduced pressure to allow good mixing of the precursor oil and the solid base and to ease the 
release of carbon dioxide. The monomers were obtained pure after distilling them twice over 
barium oxide. It should be noted that the synthesis of C3MestOx was easier due to the lower 
viscosity of the amide precursor 2b in comparison to 1b. As a result, the ring-closing reaction 
that involves release of CO2 proceeded significantly faster. 
 
Scheme 3: Synthesis of methyl ester-containing 2-oxazoline monomers 
 
Homopolymerisation kinetics 
All monomers (MestOx, C3MestOx, MeOx, EtOx and nPropOx) were polymerised with 
methyl p-toluenesulfonate (MeOTs) as initiator,
32
 acetonitrile as solvent under microwave 
irradiation at both 80 and 140 °C and 3 M monomer concentration with a [M]/[I] ratio of 
100.
33
 The corresponding first order kinetic plots obtained at 140 °C are shown in Figure 30A 
revealing linear first order kinetics for all monomers, indicating a constant concentration of 
propagating species in time and, thus, the absence of termination reactions. Each data point 
represents a separate polymerisation and, thus, the linearity proves the good reproducibility. 
The livingness of these homopolymerisations was confirmed by a linear increase of the 
number average molecular weight (Mn) with conversion as well as the low dispersities of the 
resulting polymers (Ð < 1.17, Figure 30B). Similar results were obtained at 80 °C, also 
revealing living polymerisation of all monomers (Figure 30 C and D). 
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Figure 30: A) First order kinetic plot for homopolymerisation of MeOx, EtOx, nPropOx, MestOx and 
C3MestOx at 140 °C and B) corresponding number average molecular weight (Mn) and dispersity (Ð) 
plotted against conversion, C) First order kinetic plot for homopolymerisation of MeOx, EtOx, 
nPropOx, MestOx and C3MestOx at 80 °C and D) corresponding number average molecular weight 
(Mn) and dispersity (Ð) plotted against conversion. 
 
The polymerisation rate constants (kp) were calculated from the slope of the kinetic plots in 
Figure 30 and Figure 32, which are summarized in Table 3. The rates obtained for MeOx and 
EtOx were in good agreement with previously reported values,
34
 but the kp of nPropOx at 140 
°C was slightly higher, possibly due to a small overshoot in temperature to 150 °C during the 
heating of the reaction mixture. 
 
(C3)MestOx, however, revealed a significantly faster polymerisation with kps of 0.171 and 
0.193 L mol
−1
 s
−1
 for 1 and 2 respectively. This fast propagation might be related to the 
activation of the chain ends and/or stabilization of the transition state by nearby MestOx 
residues. This mechanism is also indirectly supported by literature
35
 as it has been shown that 
the first monomer addition to the oxazolinium cation formed during initiation (kp,1) is the rate 
determining step. After this, the propagation rate (kp) dramatically increases proposedly due 
to the interaction of the carbonyl of the penultimate unit with the oxazolinium ring, resulting 
in the stabilization of the transition state and shift towards the more reactive species. The 
(C3)MestOx monomers have an additional carbonyl group that could enhance this effect 
(Figure 31), leading to stabilization of the transition state and higher electrophilicity of the 5 
position and thus enhancing the reactivity of the living chain end.
36, 37
 A similar 
intramolecular activation occurs between the amide carbonyl of the last monomer before the 
oxazolinium chain leading to a higher kp compared to kp,1 for the first monomer addition 
during CROP.
35
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Figure 31: Proposed stabilisation mechanism of the oxazolinium transition state by the side chain ester 
group 
 
Table 3:Homopolymerisation rate constants 
Monomer 1 T 
(°C) 
kp (10
-3
 L 
mol
-1
s
-1
) 
T 
(°C) 
kp (10
-3
 L 
mol
-1
s
-1
) 
T 
(°C) 
kp (10
-3
 L 
mol
-1
s
-1
) 
T 
(°C) 
kp (10
-3
 L 
mol
-1
s
-1
) 
MeOx 140 133 ± 4     80 4.1 ± 0.2 
EtOx 140 99 ± 3     80 3.0 ± 0.1 
nPropOx 140 133 ± 3     80 3.9 ± 0.3 
MestOx 140 171 ± 4 120 59 ± 2 100 28 ± 2 80 6.9 ± 0.3 
C3MestOx 140 193 ± 4 120 49 ± 1 100 17 ± 1 80 5.3 ± 0.4 
 
At 140 °C MestOx polymerised faster than C3MestOx, while at 80 °C the order was reversed, 
but both of them were still faster than MeOx, EtOx and nPropOx (Table 3). Similar results 
were obtained for the intermediate temperatures 120 and 100 °C, also revealing linear living 
polymerisation kinetics (Figure 32). At these intermediate temperatures MestOx also 
polymerised faster than C3MestOx. The livingness of these homopolymerisations was 
confirmed by a linear increase of the number average molecular weight (Mn) with conversion 
as well as the low dispersities of the resulting polymers (Ð < 1.17, Figure S 1). 
 
Figure 32:First order kinetic plots for homopolymerisation of A) MestOx and B) C3MestOx at 
different temperatures 
 
The logarithms of the kps of MestOx and C3MestOx showed a linear relationship with the 
inverse temperature as expected based on the Arrhenius equation (eq 1). 
𝑘𝑝 = 𝐴𝑒
−𝐸𝐴
𝑅𝑇    (1) 
 
The Arrhenius plots for the MestOx and C3MestOx homopolymerisations are shown in 
Figure 33. From these plots the activation energy (EA, MestOx= 63.0 ± 4.3 kJ mol
-1
, EA,C3MestOx = 
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71.7 ± 4.9 kJ mol
-1
) and the frequency factor (AMestOx = 1.54 ± 0.13 * 10
7
 L mol
-1
 s
-1
, 
AC3MestOx = 1.92 ± 0.15 *10
8
 L mol
-1
 s
-1
) were calculated. These activation energies are lower 
than for MeOx (EA = 75.4 ± 0.5 kJ mol
-1
)
38
 and EtOx (EA = 73.4 ± 0.5 kJ mol
-1
),
39
 thereby 
indicating that the methyl ester groups indeed lower the activation barrier for monomer 
addition, especially for MestOx. 
 
 
Figure 33: Arrhenius plot of MestOx and C3MestOx. The data from literature of MeOx
38
 and EtOx
39
 
are included for comparison. 
 
Copolymerisations 
To further examine this intriguing polymerisation behaviour of (C3)MestOx, 
copolymerisations were studied with MeOx, EtOx and nPropOx, with a monomer to 
monomer ratio of 50:50 using the same conditions as for the homopolymerisations. For 
MeOx-C3MestOx copolymerisations at 140 °C, the monomer ratios of 75:25 and 25:75 were 
also included, but not further discussed. Commonly, the copolymerisation of different 2-
oxazoline monomers follows the same relative order of monomer incorporation as the 
corresponding homopolymerisations of the individual monomers,
40-43
 the only reported 
exception being the copolymerisation of 2-butyl-4-ethyl-2-oxazoline with 2-phenyl-2-
oxazoline ascribed to steric constraints.
44
 Remarkably, here the first order kinetic plots 
revealed that MeOx, EtOx and nPropOx were incorporated faster than MestOx and 
C3MestOx, which is the reversed order compared to the homopolymerisations (Figure 34, 
Figure 35 and Figure S 4).  
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Figure 34: First order kinetic plots for copolymerisation of MestOx with A) MeOx at 140 °C, B) EtOx 
at 140 °C, C) nPropOx at 140 °C, D) MeOx at 80 °C, E) EtOx at 80°C and F) nPropOx at 80°C. 
 
Figure 35: First order kinetic plots for copolymerisation of C3MestOx with A) MeOx at 140 °C, B) 
EtOx at 140 °C, C) nPropOx at 140 °C, D) MeOx at 80 °C, E) EtOx at 80°C and F) nPropOx at 80°C. 
 
All first order kinetic plots furthermore revealed a linear increase, indicating a constant 
concentration of propagating species in time and, thus, the absence of termination reactions. 
Each data point represents a separate polymerisation and the linearity, thus, also proves the 
good reproducibility. The livingness of the polymerisation was confirmed by the linearly 
increasing Mn with conversion as well as low Ð values (Ð<1.17, Figure S 2 - Figure S 4). 
 
The kps were calculated from the slope of the kinetic plots and are summarized in Table 4. 
Compared to the kps of the homopolymerisations, the incorporation of 2-alkyl-2-oxazoline 
monomers was accelerated while the incorporation of MestOx and C3MestOx was slowed 
50 
 
down. This can be explained by the activation of the alkyl monomer by the interaction of the 
incoming alkyl monomer with the methyl ester side chain of the growing polymer chain. This 
theory is supported by modelling experiments.
36, 37
 
 
By dividing both kps the apparent reactivity ratios (r
app
) for both monomers were calculated 
(Table 4).
45
 For copolymerisations of MestOx and C3MestOx with EtOx and nPropOx, the 
different reaction temperatures (140 and 80 °C) did not influence the apparent reactivity ratios 
and thus the monomer distribution of the resulting polymer is independent of the temperature. 
In fact, for these copolymerisations r1
app
 is smaller than 1.9 while r2
app
 is larger than 0.5, so 
there is only a minor deviation from an ideal random monomer distribution. This was indeed 
confirmed by a visualisation of the average monomer distributions along the polymer chain 
using a calculation based on the first order kinetic plots (Figure 36B and Figure 37). 
 
Table 4: Copolymerisation rates and apparent reactivity ratios 
Monomer 1 Monomer 2 T (°C) kp,1 (10
-3
 L 
mol
-1
s
-1
) 
kp,2(10
-3
 L 
mol
-1
s
-1
) 
r1
app
 (k1/k2) r2
app
 (k2/k1) 
MeOx MestOx 140 244 ± 6 89 ± 3 2.74 0.37 
EtOx MestOx 140 162 ± 4 97 ± 3 1.67 0.60 
nPropOx MestOx 140 212 ± 6 114 ± 3 1.86 0.54 
MeOx C3MestOx 140 184 ± 12 93 ± 8 1.98 0.50 
EtOx C3MestOx 140 144 ± 3 113 ± 3 1.26 0.79 
nPropOx C3MestOx 140 157 ± 7 109 ± 6 1.44 0.70 
MeOx MestOx 120 73 ± 6 27 ± 2 2.71 0.37 
MeOx MestOx 100 29 ± 1 8.9 ± 0.4 3.29 0.30 
MeOx MestOx 80 5.1 ± 0.1 1.3 ± 0.1 3.79 0.26 
EtOx MestOx 80 4.5 ± 0.3 2.7 ± 0.2 1.68 0.60 
nPropOx MestOx 80 4.7± 0.1 2.5 ± 0.2 1.90 0.53 
MeOx C3MestOx 80 7.9 ± 0.6 3.4 ± 0.03 2.36 0.42 
EtOx C3MestOx 80 5.8 ± 0.3 4.1 ± 0.1 1.41 0.71 
nPropOx C3MestOx 80 7.4 ±0.4 5.3 ± 0.2 1.40 0.72 
MeOx(75 
mol%) 
C3MestOx(25 
mol%) 
140 181 ± 3 92 ± 5 1.96 0.51 
MeOx(25 
mol%) 
C3MestOx(75 
mol%) 
140 278 ± 8 120 ± 8 2.32 0.43 
 
Figure 36: Monomer distribution of A) MeOx (black, open) and MestOx (blue) after 80 °C and B) 
EtOx (red, open) and C3MestOx (pink) after copolymerisation at 140 °C copolymerisation along the 
polymer chain, calculated from kinetics plots 
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Figure 37: Gradient plots of the instantaneous copolymer composition along the polymer chains for A) 
MestOx copolymers at 140 °C, B) C3MestOx copolymers at 140 °C, C)MestOx copolymers at 80 °C 
and D)C3MestOx copolymers at 80 °C. On the y-axis 0 refers to no MestOx, 1 refers to fully MestOx 
and 0.5 to an equimolar mixture of both monomers, the average composition of 5 consecutive 
monomers is plotted. 
 
The copolymerisations of the more reactive MeOx with MestOx and C3MestOx exhibited an 
r1
app
 which was larger than 1.9 and an r2
app
 which was smaller than 0.5, so the monomer 
distribution significantly deviated from an ideal random distribution, and consequently, a 
gradient copolymer was formed. The strength of the gradient was determined by 
polymerisation temperature, with a lower temperature leading to a more pronounced gradient, 
and type of monomer, with MestOx resulting in a stronger gradient than C3MestOx. 
 
In Figure 36A the most extreme gradient is shown, obtained from MeOx and MestOx 
copolymerized at 80 °C An overview of all the different gradients is plotted in Figure 37; a 
(C3)MestOx monomeric unit was given a value of 1 and an alkyl monomer a value of 0, the 
average per 5 units was calculated and plotted. 
 
As the MeOx-MestOx copolymerisation showed the strongest gradient formation as well as a 
temperature dependence of r
app
, MeOx-MestOx kinetic studies were also performed at two 
intermediate temperatures (100 and 120 °C). Both temperatures also revealed linear first order 
kinetics (Figure 38), indicating a constant concentration of propagating species in time and, 
thus, absence of termination reactions. The livingness was again confirmed by a linear 
increase of the Mn with conversion as well as low dispersities of the resulting polymer (Ð < 
1.13, Figure S 5). The kps and r
app
 values are listed in Table 4. The r
app
 values are plotted 
versus temperature in Figure 39A; upon raising temperature up to 120 °C the difference in 
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reaction rates became smaller, while there was no further decrease noticeable when the 
temperature was further increased to 140 °C. The gradient plots of MeOx-MestOx 
copolymerisations at different temperatures are depicted in Figure 39B, showing slightly 
stronger gradient formation at lower temperatures. 
 
 
Figure 38: First order kinetic plots of copolymerisation of MeOx and MestOx at A) 120 °C and B) 100 
°C 
 
 
Figure 39: A) Temperature dependence of the apparent reactivity ratios of MeOx-MestOx 
copolymerisation and B) Gradient plots of MeOx-MestOx copolymerisation at different temperatures. 
 
Because the kps were determined at different temperatures an Arrhenius plot could be made 
(Figure 40) and from this the activation energy (EA, MeOx= 76.1 ± 5.8 kJ mol
-1
, EA,MestOx = 83.4 
± 5.6 kJ mol
-1
) and the frequency factor (AMeOx = 1.04 ± 0.09* 10
7
 L mol
-1
 s
-1
, AMestOx = 3.27 
± 0.27 *10
9
 L mol
-1
 s
-1
) were calculated. The activation energy of MeOx in the 
copolymerization is comparable to the activation energy of MeOx in homopolymerisation 
(EA,MeOx = 75.4 kJ mol
-1
), while the activation energy of MestOx was raised in comparison 
with homopolymerisation (EA, MestOx= 63.0 ± 4.3 kJ mol
-1
), because the MestOx itself is 
probably less nucleophilic towards MeOx-oxazolinium chain ends. 
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Figure 40: Arrhenius plot of MeOx-MestOx copolymerisation 
 
Conclusions 
The methyl ester-containing 2-oxazoline monomers, MestOx and C3MestOx were 
successfully synthesized via the reaction of an acid chloride with 2-chloroethylamine and 
subsequent ring closure with powderous sodium carbonate. Homopolymerisation kinetic 
studies revealed a faster propagation of MestOx and C3MestOx compared to the alkyl 
monomers, MeOx, EtOx and nPropOx, while in copolymerisation a reversal of monomer 
incorporation rate was found. In case of EtOx and nPropOx copolymerisations this led to a 
minor deviation from ideal random monomer distribution, whereas copolymerisation of 
MeOx with either MestOx or C3MestOx led to gradient polymers. The large difference in 
reaction rates between homo- and copolymerisation of MeOx with the ester-containing 
oxazolines was further corroborated by the determination of the activation energy of MeOx 
during copolymerisation, which was comparable to homopolymerisation, while the activation 
energy of MestOx was increased. 
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Experimental section 
Materials 2-Chloroethylamine hydrochloride, methyl p-toluenesulfonate (MeOTs) and 
sodium carbonate powder were purchased from Acros Organics. All other reagents were 
purchased from Sigma Aldrich and used as received, except 2-methyl-2-oxazoline (MeOx), 2-
ethyl-2-oxazoline (EtOx) and methyl p-toluenesulfonate (MeOTs). These were purified by 
distillation over barium oxide and stored under argon. Dry solvents were obtained from a 
solvent purification system from J.C. Meyer, with aluminium oxide drying system and a 
nitrogen flow. 
 
Instrumentation Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 
DMC300 (300 MHz for 
1
H, 75 MHz for 13C) or a Bruker DMX 500 (500 MHz for 
1
H, 125 
MHz for 13C). 
54 
 
 
Electro spray ionisation mass (ESI MS) spectra were recorded on a Thermo Finnigan LCQ 
Advantage Max. 
 
Polymerisation reaction mixtures were prepared in a VIGOR Sci-Lab SG 1200/750 Glovebox 
system, with less than 1 ppm of O2 and H2O. 
 
Polymerisations were carried out in a Biotage Initiator Microwave System with Robot Sixty 
utilizing capped reaction vials. These vials were heated to 120 °C overnight, allowed to cool 
to room temperature and filled with nitrogen prior to use. All microwave polymerisations 
were performed with temperature control (IR sensor). 
 
Size exclusion chromatography (SEC) was performed on an Agilent 1260 - series HPLC 
system equipped with a 1260 online degasser, a 1260 ISO-pump, a 1260 automatic liquid 
sampler, a thermostatted column compartment, a 1260 diode array detector (DAD) and a 1260 
refractive index detector (RID). Analyses were performed on a PSS Gram30 column in series 
with a PSS Gram1000 column at 50 °C. N,N-dimethylacetamide (DMA), containing 50 mM 
of LiCl, was used as an eluent, at a flow rate of 0.593 ml min
-1
. The SEC traces were analysed 
using the Agilent Chemstation software with the GPC add on. Number average molecular 
weights (Mn) and dispersity (Ð) values were calculated against polymethylmethacrylate 
(PMMA) standards. 
 
Gas chromatography (GC) was performed on a 7890A from Agilent Technologies with an 
Agilent J&W Advanced Capillary GC column (30 m, 0.320 mm, and 0.25 μm). Injections 
were performed with an Agilent Technologies 7693 auto sampler. Detection was done with a 
Flame ionization detector (FID) detector. Injector and detector temperatures were kept 
constant at 250 and 280 °C, respectively. The column was initially set at 50 °C, followed by 
two heating stages: from 50 °C to 100 °C with a rate of 20 °C /min and from 100 °C to 300 °C 
with a rate of 40 °C /min, and then held at this temperature for 0.5 minutes. Conversion was 
determined based on the integration of monomer peaks using acetonitrile (CH3CN) as an 
internal standard. 
 
Monomer synthesis 
Synthesis of methyl 4-(2-chloroethyl)amino-4-oxobutanoate (1b, MestOx-precursor) 
Methyl succinyl chloride (1a, 50 g, 332.1 mmol, 40.88 mL) and 2-chloroethylamine 
hydrochloride (38.52 g, 332.1 mmol) were suspended in dry dichloromethane (375 mL) under 
an argon atmosphere. The reaction mixture was cooled continuously to 0°C while 
triethylamine (TEA) (72.25 g, 714 mmol, 99.2 mL) was added dropwise within 2 hours. The 
reaction was allowed to warm to room temperature overnight, after full addition of the TEA. 
The mixture was washed with water (2x50 mL) and brine (1x 50 mL). The organic phase was 
dried over Na2SO4 and the solvent was removed under reduced pressure. The resulting 
product was purified by filtration column chromatography (neutral Al2O3, DCM:MeOH 99:1) 
yielding product 1b as a yellow oil (107 g, 664.2 mmol, 83%). 
 
1
H NMR (CDCl3 ,500 MHz): δ 6.1 (br, 1H, NH), 3.68 (t, 2.1 Hz, 2H, CH2Cl), 3.61 (m, 5H, 
OCH3 & CH2CH2Cl), 2.68 (t, 7.0 Hz, 2 H, NC=OCH2), 2.52 (t, 7.0 Hz, 2H, CH2COOCH3) 
13
C NMR (75 MHz, CDCl3): δ 172.9 (C=ONH), 171.1 (C=OOCH3), 51.4 (OCH3), 43.5 
(CH2CH2Cl), 40.8 (CH2Cl), 30.5 (CH3C=OCH2), 28.8 (CH3C=OCH2CH2) 
ESI MS: m/z: calculated 193.05, found 194.1&196.1 [M+H
+
], 216.1&218.1 [M+Na
+
] 
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Synthesis of 2-methoxycarbonylethyl-2-oxazoline (1, MestOx) The precursor (1b, 107 g, 
552.6 mmol) and anhydrous sodium carbonate (52.7 g, 497.3 mmol) were mixed. The 
reaction was performed for 48 hours by mounting the flask on a rotary evaporator (40 °C, 50 
mbar) to allow good mixing of the salt in the viscous mixture and providing a larger surface 
area for evaporation of the released CO2. Subsequently dichloromethane (DCM) was added, 
the reaction mixture was filtered and the solvent was removed under reduced pressure. The oil 
was distilled twice over barium oxide, under reduced pressure yielding a colourless liquid that 
crystallized in time into a white solid (60 g, 381.8 mmol, 69%). 
 
1
H NMR (CDCl3, 500 MHz,): δ 4.3 (t, 2H, 9.4 Hz, CH2O), 3. 8 (t, 9.4 Hz, 2H, CH2N=), 3.7 
(s, 3H, COOCH3), 2.7 (t, 2H, 7.3 Hz, CH2COO), 2.6 (t, 2H, 7.3 Hz, CH2C(=N)O) 
13
C NMR (CDCl3, 75 MHz): δ 172.9 (COOCH3), 169.2 (C(=N)O), 67.6 (CH2O), 54.3 
(CH2N), 51.9 (OCH3), 30.2 (CH2COO), 23.2 (CH2N)  
ESI MS: m/z: calculated 157.07, found 158.1 [M+H
+
] 
 
Synthesis of methyl 5-((2-chloroethyl)amino)-5-oxopentanoate (2b, C3MestOx 
precursor) Glutaric acid monomethyl ester chloride (2a, 50 g, 303.8 mmol, 41.98 mL) and 2-
chloroethylamine hydrochloride (35.24 g, 303.8 mmol) were suspended in dry 
dichloromethane (375 mL) under an argon atmosphere. The reaction mixture was cooled 
continuously to 0°C while triethylamine (TEA) (66.09 g, 653 mmol, 90.8 mL) was added 
dropwise within 2 hours. The reaction was allowed to warm to room temperature overnight, 
after full addition of the TEA. The mixture was washed with water (2x50 mL) and brine (1x 
50 mL). The organic phase was dried over Na2SO4 and the solvent was removed under 
reduced pressure. A yellow liquid (60 g, 289 mmol, 95%) was obtained. 
 
1H NMR (CDCl3, 300 MHz): δ 6.0 (br, 1H, NH), 3.67 (s, 3H, OCH3), 3.61 (m, 4H, CH2Cl & 
CH2CH2Cl), 2.39 (t, 7.3 Hz, 2 H, NHC=OCH2), 2.27 (t, 7.3 Hz, 2H, CH2COOCH3), 1.97 (qt, 
7.3 Hz, 2H, CH2CH2CH2) 
13C NMR (CDCl3, 125 MHz): δ 173.4 (C=ONH), 172.4 (C=OOCH3), 51.8 (OCH3), 44.2 
(CH2Cl), 41.3 (NHCH2), 35.5 (NHC=OCH2), 33.1 (CH3C=OCH2), 20.9 (CH2CH2CH2) 
ESI MS: m/z: calculated 207.07, found 208.0&210.0 [M+H
+
] 
 
Synthesis of 2-methoxycarbonylpropyl-2-oxazoline (2, C3MestOx) The precursor (2b, 60 
g, 289 mmol) and anhydrous sodium carbonate (27.6 g, 260 mmol) were mixed. The reaction 
was performed overnight by mounting the flask on the rotary evaporator (40 °C, 50 mbar) to 
allow good mixing of the salt in the viscous mixture and providing a larger surface area for 
evaporation of the released CO2. Subsequently, DCM was added, the reaction mixture was 
filtered and the solvent was removed under reduced pressure. The oil was distilled twice over 
barium oxide, under reduced pressure, yielding a colourless liquid (24.8 g, 145 mmol, 50%). 
 
1
H NMR (CDCl3, 500 MHz): δ 4.3 (t, 2H, 9.5 Hz, CH2O), 3. 8 (t, 9.5 Hz, 2H, CH2N=), 3.7 (s, 
3H, COOCH3), 2.7 (t, 2H, 7.3 Hz, CH2COO), 2.6 (t, 2H, 7.3 Hz, CH2C(=N)O) ), 1.97 (quint, 
7.3 Hz, 2H, CH2CH2CH2) 
13
C NMR (CDCl3, 75 MHz): δ 173.6 (COOCH3), 167.8 (C(=N)O), 67.3 (CH2O), 54.5 
(CH2N), 51.7 (OCH3), 32.9 (CH2COOCH3), 27.2 (CH2C(=N)O), 21.3 (CH2CH2CH2) 
ESI MS: m/z: calculated 171.09, found 172.1[M+H
+
] 
 
Synthesis of 2-n-propyl-2-oxazoline (5, nPropOx) nPropOx was synthesized according to 
literature.
34
 In brief, butyronitrile (32.78 mL, 26.02 g, 377 mmol)), amino ethanol (25 mL, 
25.30 g, 414 mmol) and zinc acetate dihydrate (1.382 g, 7.53 mmol) were refluxed at 130 °C 
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overnight. The reaction mixture was cooled to room temperature, and dichloromethane was 
added. The organic phase was washed 3 times with water and once with brine. The combined 
organic phases were dried over sodium sulphate. After removing the dichloromethane under 
reduced pressure, the monomer was purified by fractional distillation over barium oxide. 
 
1
H NMR (CDCl3, 500 MHz): δ 4.2 (t, 2H, 9.5 Hz, CH2O), 3. 8 (t, 9.5 Hz, 2H, CH2N=), 2.2 (t, 
2H, 7.3 Hz, CH2C(=N)O), 1.7 (quint, 2H, 7.3 Hz, CH2CH2CH2), 1.0 (t, 7.3 Hz, 2H, CH2CH2 
CH3). 
 
Polymerisation kinetics Stock solutions (7 mL) for polymerisation kinetics were prepared in 
the glovebox. Total monomer concentration [Mtot] = [M1] + [M2] = 3 M, monomer (M1 + 
M2):initiator ratio 
(𝑀]
[𝐼]
= 100, MeOTs was used as an initiator, acetonitrile (CH3CN) was used 
as solvent. For most copolymerisations the ratio of both monomers was 50:50, only for 
MeOx-C3MestOx copolymerisation at 140 °C ratios of 75:25 and 25:75 were used. The stock 
solution was divided in 0.7 mL portions in separate 0.5-2 mL Biotage reaction vials. The 
polymerisation times used are listed in Table 5. After heating, 0.1 mL polymerisation mixture 
was diluted with 0.9 mL of chloroform for GC measurement. Conversion was determined 
based on the integral of monomer peaks using acetonitrile as an internal standard. A second 
sample of 0.1 mL was diluted with 0.9 mL of DMA containing 50 mM of LiCl for SEC 
measurement to determine Mn and Ð. 
 
Table 5: Overview of different reaction times at different temperatures 
Sample 140 °C 120 °C 100 °C 80 °C, MestOx 
homo 
80 °C, 
MestOx co 
80 °C, 
C3MestOx 
1 1 s 1 s 7 min 30 s 30 min 20 min 35 min 
2 2 min 7 min  30 
s 
15 min 1 h 40 min 1 h 10 min 
3 4 min 15 min 30 min 2 h 1 h 1 h 45 min 
4 6 min 22 min 
30 s 
45 min 3 h 1h 20 min 2 h 20 min 
5 8 min 30 min 1 h 4 h 1 h 40 min 2 h 55 min 
6 10 min 37 min 
30 s 
1 h 15 min 5 h 2 h 3 h 30 min 
7 12 min 45 min 1 h 30 min 6 h  4 h 05 min 
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Supporting information 
 
Figure S 1: Mn against conversion plot, including Ð of A) PMestOx100 and B) PC3MestOx100, 
polymerisation at different temperatures. The discrepancies with the theoretical Mn values are caused 
by the PMMA standards used for the SEC calibration. 
 
 
Figure S 2: Mn against conversion plot, including Ð of A) P(MeOx50-MestOx50) copolymer, 
polymerisation at 140 °C, B) P(EtOx50-MestOx50) copolymer, polymerisation at 140 °C,.C) 
P(nPropOx50-MestOx50) copolymer, polymerisation at 140 °C, D) P(MeOx50-MestOx50) copolymer, 
polymerisation at 80 °C, E) P(EtOx50-MestOx50) copolymer, polymerisation at 80 °C, F) P(nPropOx50-
MestOx50) copolymer, polymerisation at 80 °C. The discrepancy with the theoretical Mn values is 
caused by the PMMA standards used for the SEC calibration. 
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Figure S 3: Mn against conversion plot, including Ð of A) P(MeOx50-C3MestOx50) copolymer, 
polymerisation at 140 °C, B) P(EtOx50-C3MestOx50) copolymer, polymerisation at 140 °C, C) 
P(nPropOx50-C3MestOx50) copolymer, polymerisation at 140 °C, D) P(MeOx50-C3MestOx50) 
copolymer, polymerisation at 80 °C, E) P(EtOx50-C3MestOx50) copolymer, polymerisation at 80 °C, 
F) P(nPropOx50-C3MestOx50) copolymer, polymerisation at 80 °C. The discrepancy with the 
theoretical Mn values is caused by the PMMA standards used for the SEC calibration. 
 
Figure S 4: A) First order kinetic plots for copolymerisation of C3MestOx (25 mol%) with MeOx (75 
mol%) at 140 °C, B) Mn against conversion plot, including Ð of P(MeO75-C3MestOx25) copolymer, 
polymerisation at 140 °C, C) First order kinetic plots for copolymerisation of C3MestOx (75 mol%) 
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with MeOx (25 mol%) at 140 °C, B) Mn against conversion plot, including Ð of P(MeO25-
C3MestOx75) copolymer, polymerisation at 140 °C. 
 
 
Figure S 5: Mn against conversion plot, including Ð of A) P(MeOx50-MestOx50) copolymer, 
polymerisation at 120 °C and B) P(MeOx50-MestOx50) copolymer, polymerisation at 100 °C. The 
discrepancy with the theoretical Mn values is caused by the PMMA standards used for the SEC 
calibration. 
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Abstract 
This chapter describes the synthesis and thermal properties in solution and bulk of poly(2-
alkyl-oxazoline)s (PAOx) containing a methyl ester side chain. Homopolymers of 2-
methoxycarbonylethyl-2-oxazoline (MestOx) and 2-methoxycarbonylpropyl-2-oxazoline 
(C3MestOx) as well as copolymers with 2-ethyl-2-oxazoline (EtOx) and 2-n-propyl-2-
oxazoline (nPropOx) were prepared with systematic variations in composition. Investigation 
of the solution properties of these polymers revealed that the cloud point temperatures (TCPs) 
could be tuned between 24 and 108 °C depending on the PAOx composition. To the best of 
our knowledge, the TCPs of PMestOx and PC3MestOx are reported for the first time and they 
closely resemble the TCPs of PEtOx and PnPropOx, respectively, indicating similar 
hydrophilicity of the methyl ester and alkyl side chains. Furthermore, the thermal transitions 
and thermal stability of these polymers were investigated by DSC and TGA measurements, 
respectively, revealing amorphous polymers with glass transition temperatures between -2 °C 
and 54 °C that are thermally stable up to > 300 °C. 
 
Introduction 
Smart polymeric materials can change their physical properties in response to external 
stimuli, such as temperature, ionic strength, pH, chemical and biological stimuli, light or 
electromagnetic radiation.
1-3
 Thermoresponsive polymeric behaviour has most extensively 
been studied, in particular how polymer solubility is affected by temperature changes. One of 
the best characterized thermoresponsive polymers is poly(N-isopropyl acrylamide) 
(PNIPAAm), which displays a lower critical solution temperature (LCST) of 32 °C, just 
below body temperature.
2-5
 Other classes of thermoresponsive polymers that have emerged in 
recent years are for example poly(oligo ethylene glycol acrylate)s,
2, 6
 polyisocyanopeptides 
grafted with oligo(ethylene glycol) side chains,
7-9
 poly(2-oxazine)s
10
 and poly(2-oxazoline)s.
3, 
5, 11-17
 These types of polymers can be applied in temperature sensors,
18
 protein 
chromatography
19
 and various biomedical applications such as drug delivery and tissue 
engineering.
1
 For these latter applications thermoresponsive polymers are needed that are 
biocompatible and that can be conveniently functionalized. 
 
A polymer class which fulfils these requirements is the class of poly(2-alkyl/aryl-2-
oxazoline)s (PAOx) as they are biocompatible, thermoresponsive and have tuneable 
properties.
15, 20, 21
 Poly(2-methyl-2-oxazoline) (PMeOx) and poly(2-ethyl-2-oxazoline) 
(PEtOx) are interesting for biomedical applications because they show stealth behaviour 
similar to poly(ethylene glycol) (PEG).
15, 20-24
 Furthermore, PEtOx and poly(2-propyl-2-
oxazoline)s (PPropOx) show thermoresponsive properties. PEtOx has an LCST of 60 °C, 
poly(2-n-propyl-2-oxazoline) (PnPropOx) of 25 °C, poly(2-cyclopropyl-2-oxazoline) 
(PcPropOx) of 30 °C and poly(2-isopropyl-2-oxazoline) (PiPropOx) of 38 °C.
3, 5, 15, 25
 Cloud 
points can be tuned from 9 °C to 100 °C by varying the molecular weight and composition of 
the polymer by incorporation of more hydrophobic or hydrophilic monomeric units, either by 
copolymerisation or post-polymerisation modification.
5, 11-13, 26, 27
 
 
Functional groups, often protected, can be introduced into PAOx by making use of a 
functional monomer or initiator during the living cationic ring opening polymerisation 
(CROP, Scheme 1) of 2-oxazoline monomers or by using a functional terminating agent, 
yielding well-defined PAOx with control over number and type of functionalities.
15, 28-37
 
Methyl esters are especially interesting, because they can undergo a direct amidation with a 
variety of amines to easily introduce other functional groups such as alcohols, hydrazide and 
amines.
38-41
 Moreover, the ester  can be hydrolysed to the corresponding carboxylic acid 
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providing a versatile handle for conjugation as well as a means to introduce pH 
responsiveness. Although the potential of side-chain methyl ester-containing PAOx 
copolymers is well established, there is remarkably little known about their thermal features 
and thermoresponsive behaviour.
32, 42-46
 
 
Scheme 4: A) Cationic ring-opening polymerisation of 2-oxazolines with methyl p-toluenesulfonate as 
initiator and piperidine as terminating agent and B) Monomer structures of EtOx (1), nPropOx (2), 
MestOx (3) and C3MestOx (4) 
 
In this chapter we describe the synthesis and thermal properties of methyl ester-containing 
PAOx. Homopolymers and copolymers of 2-ethyl-2-oxazoline (EtOx, 1) and 2-n-propyl-2-
oxazoline (nPropOx, 2) with 2-methoxycarbonylethyl-2-oxazoline (MestOx, 3) and 2-
methoxycarbonylpropyl-2-oxazoline (C3MestOx, 4) were prepared with 10, 20, 30, 50 and 70 
mol% methyl ester content. The thermal solution and bulk properties of these polymers were 
determined by turbidimetry, differential scanning calorimetry (DSC) and thermal gravimetric 
analysis (TGA), respectively. 
 
Results and discussion 
Series of homopolymers and copolymers of EtOx and nPropOx with MestOx and C3MestOx 
were prepared
36, 37
 with varying feed ratio of 10, 20, 30 50 and 70 mol% MestOx or 
C3MestOx and a constant monomer to initiator ratio of [M]/[I] = 100, yielding four sets of 
copolymers. Also random and block copolymers of 2-methyl-2-oxazoline and C3MestOx 
were prepared with feed ratios of 50:50 and 25:75. All polymers were terminated with 
piperidine instead of the widely used methanolic sodium hydroxide to avoid saponification of 
the methyl ester. All polymers were characterised by 
1
H NMR spectroscopy and SEC and 
were obtained with the desired composition and a narrow dispersity (Ð < 1.21, Table 6). 
  
65 
 
Table 6: Overview of synthesis and characterisation data of studied (co)polymers 
Monomer 1 Monomer 2 Feed ratio 
(M1:M2) 
Composition
a 
(M1:M2) 
 SEC
b
  TCP (°C)
c
  Tg
d 
(°C) 
 TGA (°C)
e
 
Mn (kDa) Ð  Heating Cooling  5 % 50% 
MestOx - 100:0 100:0  19.4 1.10  101 102  39  258 353 
C3MestOx - 100:0 100:0  24.1 1.12  26 26  -1  325 360 
EtOx* - 100:0 100:0  14.0* 1.19*  91* 91*  54*    
nPropOx - 100:0 100:0  16.6 1.10  27 23  35  312 406 
               
EtOx MestOx 90:10 91:9  18.9 1.14  93 96  53  322 403 
EtOx MestOx 80:20 82:18  16.9 1.14  99 102  45  293 389 
EtOx MestOx 70:30 70:30  17.4 1.13  103 106  44  310 376 
EtOx MestOx 50:50 49:51  19.3 1.14  # #  39  306 365 
EtOx MestOx 30:70 29:71  22.8 1.16  102 104  38  296 359 
               
nPropOx MestOx 90:10 90:10  21.0 1.12  25 24  30  327 393 
nPropOx MestOx 80:20 79:21  15.5 1.12  27 30  30  306 385 
nPropOx MestOx 70:30 68:32  16.3 1.13  32 36  30  303 377 
66 
 
nPropOx MestOx 50:50 48:52  20.6 1.15  40 40  32  310 367 
nPropOx MestOx 30:70 27:73  29.3 1.19  55 54  35.0  309 367 
               
EtOx C3MestOx 90:10 90:10  21.1 1.13  89 89  43  334 399 
EtOx C3MestOx 80:20 82:18  21.8 1.14  78 79  39  313 382 
EtOx C3MestOx 70:30 70:30  21.6 1.14  71 78  27  316 377 
EtOx C3MestOx 50:50 50:50  22.7 1.14  56 56  17  322 369 
EtOx C3MestOx 30:70 30:70  24.1 1.14  42 43  -2  320 363 
               
nPropOx C3MestOx 90:10 90:10  19.2 1.21  24 25  28  321 399 
nPropOx C3MestOx 80:20 79:21  20.7 1.15  25 32  18  328 385 
nPropOx C3MestOx 70:30 68:32  21.0 1.15  25 301  15  332 379 
nPropOx C3MestOx 50:50 48:52  16.7 1.21  26 27  12  311 368 
nPropOx C3MestOx 30:70 28:72  18.8 1.16  25 30  5  304 361 
* Literature values 
26
 
# no cloud point temperature observed up to 110 °C 
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a. determined by 1H NMR spectroscopy 
b. determined by SEC against PMMA standards 
c. determined by turbidimetry measurements 
d. determined by DSC measurements 
e. 5%: loss of 5 wt% after loss of solvents; for some polymers it was difficult to 
determine the point where all solvents were removed and for these the start of the 
flatter area was used for calculation of the 5% weight loss temperature. 50%: loss of 
50 w% from the total mass 
 
Cloud point temperatures (TCPs) of the homo- and copolymers were determined by 
turbidimetry of 5 mg mL
-1
 aqueous solutions. All polymers, except EtOx49-MestOx51, showed 
reversible LCST behaviour covering a broad temperature range (24-108 °C, Table 6) 
depending on the polymer composition with nearly no hysteresis between heating and cooling 
cycles (Figure 41 and Figure S 6-Figure S 11). In some cases the TCP in the cooling cycles 
was slightly higher than in the heating cycles; this can be possibly explained by the fact that 
redissolution of these polymers was a rather slow process, leading to lower concentrations in 
solution during cooling and thus an increase of TCP. However, the precipitates were fully 
dissolved when the solution cooled down completely. 
 
Interestingly, the homopolymers of MestOx (PMestOx) and C3MestOx (PC3MestOx) also 
showed thermo-responsive properties. PMestOx displayed a shallow transition with a TCP of 
101 °C similar to PEtOx with a degree of polymerization of 100 (Figure 41A), whereas 
PC3MestOx exhibited a sharp transition at 26 °C (Figure 41B) comparable to PnPropOx. 
When the polymers were heated above 100 °C during turbidimetry measurements, the TCP 
slightly increased during every run (Figure 41, Figure 43 and Figure S 6-Figure S 12), which 
is ascribed to partial hydrolysis of the methyl ester groups resulting in the corresponding 
carboxylic acid, as was confirmed by 
1
H NMR spectroscopy (Figure S 14 and Figure S 14). 
The determined average TCP of all heating and cooling cycles are reported in Table 6, except 
for the polymers that were heated above 100 °C for which the TCP in the first heating and 
cooling runs are listed. 
 
Figure 41: Turbidity measurements for A) PMestOx and B) PC3MestOx 
 
The TCP’s of the different copolymers (Table 6) are plotted as a function of the copolymer 
composition (Figure 42). The relationship between the TCPs and EtOx content of the EtOx-
C3MestOx copolymers is linear (Figure 42A), and thus with this monomer combination the 
TCP can straightforwardly be tuned between the TCPs of the corresponding homopolymers by 
varying the polymer composition. A linear relationship between copolymer composition and 
TCP was previously also described for P(iPropOx-nPropOx), P(iPropOx-EtOx) and 
P(cPropOx-EtOx) copolymers.
13, 14, 26
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Figure 42: Cloud point temperatures (TCP) as function of polymer composition of A) P(EtOx-
C3MestOx), B) P(nPropOx-C3MestOx), C) P(nPropOx-MestOx and D) P(EtOx-MestOx), lines are 
added to guide the eye. 
 
All TCPs of nPropOx-C3MestOx copolymers were in between 24 and 26.5 °C (Figure 42B), 
revealing that varying the polymer composition hardly changed the thermo-responsive 
behaviour. This behaviour was expected as the hydrophobicity of both monomers and the 
TCP’s of the homopolymers are comparable. 
In the nPropOx-MestOx copolymer series, the TCPs exponentially increased with increasing 
MestOx content (Figure 42C). A similar trend was also reported for EtOx-nPropOx 
copolymers.
14, 27
 The hydrophobic nPropOx monomer seems to be more dominant in 
determining the overall polymer hydrophilicity and TCP than the hydrophilic MestOx 
monomer. 
Copolymers of EtOx and MestOx displayed TCPs in between 93 °C and 103 °C at EtOx-
MestOx comonomer ratios of 90-10, 80-20, 70-30 and 30-70 (Figure 42D, Table 6), whereas 
surprisingly the copolymer with a 50-50 comonomer ratio did not show a transition up to 110 
°C. This observation indicates more efficient polymer hydration and/or decreased polymer-
polymer interactions, which both may be related to near random placement of the smaller 
ethyl and larger methoxycarbonylethyl side chains. 
 
Copolymers of MeOx and C3MestOx only showed thermoresponsive behaviour for the 25:75 
feed ratio (Figure 43). Both 50:50 polymers did not show a transition up to 110 °C (Figure S 
12). P(MeOx-C3MestOx 25-75) showed a similar transition as the EtOx and nPropOx 
copolymers described above (Figure 43A). The block copolymer, P(MeOx-b-C3MestOx 25-
75), showed a different transmittance curve (Figure 43B). The transmittance goes down a bit 
with increasing temperature and subsequently goes back to 100%, this minimum indicates the 
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formation of particles and is already described in literature for PEtOx-block-(P(EtOx-stat-
PropOx) polymers.
47
 The increase in transmittance after the minimum is explained as 
fragmentation into smaller micelle like structures. Upon further heating all the present 
particles aggregate leading to a decrease of the transmittance. 
 
 
Figure 43: Turbidity measurements for A) P(MeOx-C3MestOx 25-75) and B) P(MeOx-b-C3MestOx 
25-75). 
 
The thermal bulk properties of the homo- and copolymers were investigated by differential 
scanning calorimetry (DSC) and thermogravimetric analysis (TGA). All polymers showed a 
clear glass transition (Figure 44, Figure S 15, Table 6), indicating that they are amorphous. 
The Tgs of the homopolymers PMestOx (Tg = 39 °C) and PnPropOx (Tg = 35 °C) are 
comparable, while PC3MestOx has a Tg of -1 °C and PEtOx has a Tg of 54°C. The rather low 
Tg of PC3MestOx indicates high chain mobility induced by the side chain. 
 
 
Figure 44: DSC traces of second heating run (10 K min-1) of PMestOx, PC3MestOx and PnPropOx 
homopolymers 
 
The Tgs of the copolymers are plotted in Figure 45. In the P(EtOx-MestOx) copolymer series, 
the Tgs did not change much up to 40 wt% EtOx (Figure 45A) and from this point on it 
increased linearly towards the Tg of PEtOx. The Tg of the MestOx homopolymer is slightly 
higher than the Tg of P(EtOx-MestOx 30-70), indicating that the packing between the polymer 
chains is better, i.e. not distorted by other monomeric units, so there is more interaction 
between the polyamide backbones in the homopolymers. A very similar trend in Tg was 
observed for P(EtOx-C3MestOx) copolymers (Figure 45B), with the exception that after 
already 20 wt% incorporation of EtOx the glass transition temperature started to increase 
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linearly with increasing amount of EtOx, possibly due to the larger difference in Tg of the 
homopolymers. 
 
Figure 45: Glass transition temperatures as function of polymer composition of A) P(EtOx-MestOx), 
B) P(EtOx-C3MestOx), C) P(nPropOx-MestOx) and D) P(nPropOx-C3MestOx). Lines are added to 
guide the eye and empirical formulas are given to describe the correlation of Tg with the wt% of 
comonomer. 
 
For the P(nPropOx-MestOx) copolymers all measured Tgs were lower than those of the 
homopolymers (Figure 45C) and the Tgs only vary 5 °C within the composition range. A 
similar trend was recently reported for copolymers of 2-cyclopropyl-2-oxazoline (cPropOx) 
and EtOx,
26
 and this can be ascribed to suppression of interchain interactions. The Tg of 
nPropOx-C3MestOx copolymers increased linearly with increasing nPropOx content (Figure 
45D), so with this combination of monomers the glass transition can be accurately tuned 
between the Tgs of the corresponding homopolymers by varying the monomer ratios. 
 
TGA analysis revealed that the PMestOx homopolymer was thermally stable up to 250 °C 
(Figure 46A), while all other homo- and copolymers were stable at least up to 300 °C (Figure 
46 and Figure S 16). The lower stability of PMestOx is rather surprising, especially compared 
to PC3MestOx and may indicate that the close proximity of the secondary amide to the ester 
group decreases the stability of the latter. In Table 6 the temperature for 5 % and 50% weight 
loss are listed, whereby the 5 wt% loss was determined after loss of solvents. However, not all 
polymers show a plateau after loss of solvent and for these the start of the flatter area was 
used for calculation of the 5% weight loss temperature. The 50% loss is reported as the 50% 
loss of the total weight. In general, when more (C3)MestOx was incorporated into the 
copolymers, the thermal stability slightly decreased, because the P(C3)MestOx 
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homopolymers are less stable than PEtOx or PnPropOx homopolymers, most likely due to 
decomposition of the methyl ester units. 
 
Figure 46: Thermogravimetric analysis of A) PMestOx, PC3MestOx and PnPropOx homopolymers 
and B) P(EtOx-C3MestOx) copolymers 
 
Conclusions 
Homo- and copolymers of MestOx and C3MestOx with EtOx and nPropOx were successfully 
synthesized. All polymers, except P(EtOx49-MestOx51), showed TCPs that varied in between 
24 °C and 108 °C depending on the composition, at a concentration of 5 mg/mL in water. 
Interestingly, PC3MestOx has a low TCP of 26 °C making it interesting for biomedical 
applications. DSC measurements revealed that all polymers are amorphous with Tg’s between 
-2 °C and 54 °C. For P(EtOx-MestOx), P(EtOx-C3MestOx) and P(nPropOx-C3MestOx) 
copolymers the glass transition temperature can be tuned in between the Tgs of the 
homopolymers. However, for P(nPropOx-MestOx) copolymers, the Tgs of all copolymers are 
lower than the ones of both homopolymers, indicating suppression of interchain interactions. 
All homo- and copolymers are thermally stable up to at least 250 °C, whereby copolymers 
with more (C3)MestOx were found to be less stable. Nonetheless, the stabilities will allow 
thermal processing, e.g. hot-melt extrusion, at temperatures well above room temperature. 
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Experimental section 
Materials 
2-Chloroethylamine hydrochloride, methyl p-toluenesulfonate (MeOTs) and sodium 
carbonate were purchased from Acros Organics. EtOx was kindly donated by Polymer 
Chemistry Innovations. All other reagents were purchased from Sigma Aldrich and used as 
received. EtOx and methyl p-toluenesulfonate (MeOTs) were purified by distillation over 
barium oxide and stored under argon. Dry solvents were obtained from a solvent purification 
system from J.C. Meyer, with aluminium oxide drying system and a nitrogen flow. MestOx,
36
 
C3MestOx
37
 and nPropOx
48
 were prepared according to literature procedures. 
 
Instrumentation 
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Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker DMC300 (300 MHz 
for 
1
H, 75 MHz for 
13
C). 
Polymerisation reaction mixtures were prepared in a VIGOR Sci-Lab SG 1200/750 Glovebox 
system, with purity levels of less than 1 ppm for O2 and H2O.  
Polymerisations were carried out in a Biotage Initiator Microwave System with Robot Sixty 
utilizing capped reaction vials. These vials were heated to 120 °C overnight, allowed to cool 
to room temperature and filled with nitrogen prior to use. All microwave polymerisations 
were performed with temperature control (IR sensor). 
Size exclusion chromatography (SEC) was performed on an Agilent 1260 - series HPLC 
system equipped with a 1260 online degasser, a 1260 ISO-pump, a 1260 automatic liquid 
sampler, a thermostatted column compartment, a 1260 diode array detector (DAD) and a 1260 
refractive index detector (RID). Analyses were performed on a PSS Gram30 column in series 
with a PSS Gram1000 column at 50 °C. N,N-dimethylacetamide (DMA), containing 50 mM 
of LiCl, was used as an eluent, at a flow rate of 0.593 ml min
-1
. The SEC traces were analysed 
using the Agilent Chemstation software with the GPC add on. Number average molecular 
weights (Mn) and dispersity (Ð) values were calculated against poly(methyl methacrylate) 
PMMA standards. 
Turbidity measurements were performed on an Avantium Crystal 16 platform. Solutions of 
the polymers were prepared in MilliQ water at 5 mg mL
-1
 and were stirred at room 
temperature until all polymer was dissolved. Three heating cycles were applied with a 
heating/cooling rate of 1 °C min
-1
, temperature ranges of 5-45, 20-60, 20-75, 60-105 or 70-
110 °C were used depending on the polymer, and with hold steps of 5 min at the extreme low 
temperatures, no hold time was applied when the samples were heated above 100 °C; all 
measurements were performed with a stirring rate of 700 rpm. The cloud points are given as 
the 50% transmittance point during heating. GC vials with open caps and septa were used for 
these measurements allowing heating until 110 °C with minor pressure build-up as noticed by 
slight expansion of the septum. 
Differential scanning calorimetry (DSC) traces were recorded under nitrogen with a Mettler-
Toledo DSC1 module. Glass transition temperatures were obtained from the second heating 
run with heating/cooling rates of 10 K min
-1
. Indium was used as a standard for temperature 
and enthalpy calibrations. 
Thermogravimetric analysis (TGA) was performed with a Mettler Toledo TGA/SDTA851e 
instrument under nitrogen atmosphere at a heating rate of 10 ° C min
-1 
between 25 °C and 800 
°C. 
 
Polymer Synthesis 
 
Scheme 5: Reaction conditions for the cationic ring opening copolymerisation of 2-oxazolines 
 
Polymerisation mixtures with a total monomer concentration of 4 M in acetonitrile, an overall 
[M]/[I] ratio of 100 and MeOTs as initiator, were prepared in the glovebox under argon and 
the reactor vials were crimped air-tight inside the glovebox. Polymerisations were carried out 
under microwave irradiation at 140 °C for 20 minutes aiming for full conversion.
36, 37
 After 
cooling to room temperature, the polymerisations were quenched by the addition of 
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piperidine. After removal of the solvents under reduced pressure, the polymers were 
redissolved in dichloromethane and precipitated in cold diethyl ether twice. The polymers 
were dried in the vacuum oven at 50 °C before further analysis. 
1
H NMR data of the polymers synthesized  
 
PMestOx 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 297 H), 3.46 (br, NCH2CH2N, 396 H), 
3.14 (br, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (br, COCH2CH2CO, 396 H), 
1.78 (s, CH2CH2CH2 piperidine, 6 H) 
 
PC3MestOx 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 267 H), 3.46 (br, NCH2CH2N, 356 H), 
3.14 (br, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (br, COCH2CH2CH2CO, 356 
H), 1.90 (br, COCH2CH2CH2CO, 178 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H) 
 
PnPropOx 
1
H NMR (CDCl3, 300 MHz): δ 3.46 (br, NCH2CH2N, 380 H), 3.14 (b, CH2NCH2 piperidine, 
4 H), 2.96 (s, NCH3, 3 H), 2.27 (b, COCH2, 190 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 
1.63 (b, COCH2CH2, 190 H), 0.95 (br, CH2CH3, 285 H) 
 
P(EtOx-MestOx 90-10) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 24 H), 3.46 (br, NCH2CH2N, 380 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 32 H), 2.27 (b, 
COCH2, 174 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 261 H) 
 
P(EtOx-MestOx 80-20) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 388 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 76 H), 2.27 (b, 
COCH2, 156 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 234 H) 
 
P(EtOx-MestOx 70-30) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 87 H), 3.46 (br, NCH2CH2N, 388 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 116 H), 2.27 (b, 
COCH2, 136 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 204 H) 
 
P(EtOx-MestOx 50-50) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 147 H), 3.46 (br, NCH2CH2N, 384 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 196 H), 
2.27 (b, COCH2, 96 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 144 H) 
 
P(EtOx-MestOx 30-70) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 207 H), 3.46 (br, NCH2CH2N, 388 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 276 H), 
2.27 (b, COCH2, 56 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 84 H) 
 
P(EtOx-C3MestOx 90-10) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 30 H), 3.46 (br, NCH2CH2N, 392 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 40 H), 2.27 
(b, COCH2, 174 H), 1.90 (br, COCH2CH2CH2CO, 20 H), 1.78 (s, CH2CH2CH2 piperidine, 6 
H), 1.12 (br, CH2CH3, 261 H) 
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P(EtOx-C3MestOx 80-20) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 392 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 76 H), 2.27 
(b, COCH2, 158 H), 1.90 (br, COCH2CH2CH2CO, 38 H), 1.78 (s, CH2CH2CH2 piperidine, 6 
H), 1.12 (br, CH2CH3, 237 H) 
 
P(EtOx-C3MestOx 70-30) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 388 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 116 H), 
2.27 (b, COCH2, 136 H), 1.90 (br, COCH2CH2CH2CO, 58 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H), 1.12 (br, CH2CH3, 204 H) 
 
P(EtOx-C3MestOx 50-50) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 147 H), 3.46 (br, NCH2CH2N, 388 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 196 
H), 2.27 (b, COCH2, 96 H), 1.90 (br, COCH2CH2CH2CO, 98 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H), 1.12 (br, CH2CH3, 144 H) 
 
P(EtOx-C3MestOx 30-70) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 204 H), 3.46 (br, NCH2CH2N, 384 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 204 
H), 2.27 (b, COCH2, 56 H), 1.90 (br, COCH2CH2CH2CO, 136 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H), 1.12 (br, CH2CH3, 84 H) 
 
P(nPropOx-MestOx 90-10) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 30 H), 3.46 (br, NCH2CH2N, 376 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 40 H), 2.27 (b, 
COCH2, 168 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 168 H), 0.95 
(br, CH2CH3, 252 H) 
 
P(nPropOx-MestOx 80-20) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 396 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 76 H), 2.27 (b, 
COCH2, 160 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 160 H), 0.95 
(br, CH2CH3, 240 H) 
 
P(nPropOx-MestOx 70-30) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 87 H), 3.46 (br, NCH2CH2N, 368 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 116 H), 2.27 (b, 
COCH2, 126 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 126 H), 0.95 
(br, CH2CH3, 189 H) 
 
P(nPropOx-MestOx 50-50) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 150 H), 3.46 (br, NCH2CH2N, 380 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 200 H), 
2.27 (b, COCH2, 90 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 90 H), 
0.95 (br, CH2CH3, 135 H) 
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P(nPropOx-MestOx 30-70) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 231 H), 3.46 (br, NCH2CH2N, 420 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 308 H), 
2.27 (b, COCH2, 56 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 56 H), 
0.95 (br, CH2CH3, 118 H) 
 
P(nPropOx-C3MestOx 90-10) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 30 H), 3.46 (br, NCH2CH2N, 416 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 40 H), 2.27 
(b, COCH2, 188 H), 1.90 (br, COCH2CH2CH2CO, 20 H), 1.78 (s, CH2CH2CH2 piperidine, 6 
H), 1.63 (b, COCH2CH2, 188 H), 0.95 (br, CH2CH3, 282 H) 
 
P(nPropOx-C3MestOx 80-20) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 368 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 76 H), 2.27 
(b, COCH2, 146 H), 1.90 (br, COCH2CH2CH2CO, 38 H), 1.78 (s, CH2CH2CH2 piperidine, 6 
H), 1.63 (b, COCH2CH2, 146 H), 0.95 (br, CH2CH3, 292 H) 
 
P(nPropOx-C3MestOx 70-30) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 87 H), 3.46 (br, NCH2CH2N, 372 H), 3.14 
(b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 116 H), 
2.27 (b, COCH2, 168 H), 1.90 (br, COCH2CH2CH2CO, 58 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H), 1.63 (b, COCH2CH2, 168 H), 0.95 (br, CH2CH3, 192 H) 
 
P(nPropOx-C3MestOx 50-50) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 147 H), 3.46 (br, NCH2CH2N, 376 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 196 
H), 2.27 (b, COCH2, 90 H), 1.90 (br, COCH2CH2CH2CO, 98 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H), 1.63 (b, COCH2CH2, 90 H), 0.95 (br, CH2CH3, 175 H) 
 
P(nPropOx-C3MestOx 30-70) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 204 H), 3.46 (br, NCH2CH2N, 380 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 272 
H), 2.27 (b, COCH2, 54 H), 1.90 (br, COCH2CH2CH2CO, 136 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H), 1.63 (b, COCH2CH2, 54 H), 0.95 (br, CH2CH3, 81 H) 
 
P(MeOx-C3MestOx 25-75) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 222 H), 3.46 (br, NCH2CH2N, 400 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 304 
H), 2.14 (b, COCH3, 78 H), 1.90 (br, COCH2CH2CH2CO, 148 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H) 
 
P(MeOx-C3MestOx 25-b-75) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 234 H), 3.46 (br, NCH2CH2N, 412 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 312 
H), 2.14 (b, COCH3, 75 H), 1.90 (br, COCH2CH2CH2CO, 156 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H) 
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P(MeOx-C3MestOx 50-50) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 153 H), 3.46 (br, NCH2CH2N, 392 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 200 
H), 2.14 (b, COCH3, 144 H), 1.90 (br, COCH2CH2CH2CO, 100 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H) 
 
P(MeOx-C3MestOx 25-b-75) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 138 H), 3.46 (br, NCH2CH2N, 388 H), 
3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 184 
H), 2.14 (b, COCH3, 153 H), 1.90 (br, COCH2CH2CH2CO, 92 H), 1.78 (s, CH2CH2CH2 
piperidine, 6 H) 
 
Supplementary information 
 
Figure S 6: Turbidity curves during heating and cooling of P(nPropOx) aqueous solutions (5 mg/mL) 
with a heating/cooling rate of 1 °C min
-1
. 
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Figure S 7: Turbidity curves during heating and cooling of aqueous solutions (5 mg/mL) with a 
heating/cooling rate of 1 °C min
-1
 of A) P(EtOx-MestOx 90-10), B) P(EtOx-MestOx 80-20), C) 
P(EtOx-MestOx 70-30) and D) P(EtOx-MestOx 50-50) 
 
Figure S 8: Turbidity curves during heating and cooling of aqueous solutions (5 mg/mL) with a 
heating/cooling rate of 1 °C min
-1
 of A) P(EtOx-MestOx 30-70), B) P(EtOx-C3MestOx 90-10), C) 
P(EtOx-C3MestOx 80-20) and D) P(EtOx-C3MestOx 70-30) 
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Figure S 9: Turbidity curves during heating and cooling of aqueous solutions (5 mg/mL) with a 
heating/cooling rate of 1 °C min
-1
 of E) P(EtOx-C3MestOx 50-50), B) P(EtOx-C3MestOx 30-70), C) 
P(nPropOx-MestOx 90-10) and D) P(nPropOx-MestOx 80-20). 
 
Figure S 10: Turbidity curves during heating and cooling of aqueous solutions (5 mg/mL) with a 
heating/cooling rate of 1 °C min
-1
 of A) P(nPropOx-MestOx 70-30), B) P(nPropOx-MestOx 50-50), 
C) P(nPropOx-MestOx 30-70) and D) P(nPropOx-C3MestOx 90-10) 
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Figure S 11: Turbidity curves during heating and cooling of aqueous solutions (5 mg/mL) with a 
heating/cooling rate of 1 °C min
-1
 of A) P(nPropOx-C3MestOx 80-20), B) P(nPropOx-C3MestOx 70-
30), C) P(nPropOx-C3MestOx 50-50) and D) P(nPropOx-C3MestOx 30-70). 
 
 
Figure S 12: Turbidity curves during heating and cooling of aqueous solutions (5 mg/mL) with a 
heating/cooling rate of 1 °C min
-1
 of A) P(MeOx-C3MestOx 49-51) and B) P(MeOx-b-C3MestOx 53-
47) 
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Figure S 13: 
1
H NMR spectrum of P(EtOx-MestOx 30-70) before TCP measurements in CDCl3 
The decrease of the methyl esters is determined by the integration of all side CH2 protons of 
the sidechains (peaks of CH2 next to methyl ester and carboxylic acid are overlapping, δ 2.17 
- 2.90 ppm) of which the value is  compared to the overlapping peaks of the backbone and the 
methyl ester (δ 3.37 - 3.80 ppm). 
 
Figure S 14: 
1
H NMR spectrum of P(EtOx-MestOx 30-70) after TCP measurements 
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Figure S 15: DSC traces of second heating run (10 K min
-1
) of A) P(EtOx-MestOx), B) P(EtOx-
C3MestOx), C) P(nPropOx-MestOx) and D) P(nPropOx-C3MestOx) 
 
Figure S 16: Thermogravimetric analysis under nitrogen atmosphere at a heating rate of 10 ° C min-1 
of A) P(EtOx-MestOx) copolymers, B) P(nPropOx-MestOx) copolymers and C) P(nPropOx-
C3MestOx) copolymers  
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Chapter 4 
 
Poly(2-oxazoline)s 
with tuneable 
properties: amidation 
of methyl ester side 
chains 
  
86 
 
Abstract 
Methyl ester side chain functionalised poly(2-oxazoline)s are an interesting platform for post 
polymerisation modification to introduce new properties. Here we present the modification of 
a homopolymer of 2-methoxycarbonylethyl-2-oxazoline (MestOx) with different primary and 
secondary amines. Solution and thermal bulk properties are determined with turbidimetry, 
DSC and TGA measurements. PMestOx has a cloud point temperature of 101 °C, whereas 
polymers modified with n-propylamine, pyrrolidine or piperidine showed cloud point 
temperatures between 28 and 64 °C, whereas n-butylamine modified PMestOx was not 
watersoluble at all. DSC measurements revealed an increase of glass transition temperature 
for all eight different modifications ranging from 53-89 °C compared to 39 °C of the starting 
material.  
 
Introduction 
In the 1960s four independent research groups reported the living cationic ring opening 
polymerisation (CROP) of 2-oxazoline monomers (Scheme 6).
1-4
 The resulting poly(2-
alkyl/aryl-2-oxazoline)s (PAOx) are a versatile class of polymers with tuneable properties, 
biocompatibility, stealth and thermoresponsive behaviour.
5-7
 Functional groups, often 
protected, can be introduced during CROP by the use of a functional monomer, initiating or 
terminating agent, yielding well-defined polymers with control over type and number of 
functionalities and polymer architecture.
8-17
 Poly(2-methyl-2-oxazoline) (PMeOx) and poly(2-
ethyl-2-oxazoline) (PEtOx) are interesting candidates for biomedical applications because of 
their biocompatibility and stealth behaviour similar to poly(ethylene glycol) (PEG).
5-7, 18, 19
 
PEtOx and PPropOx show thermoresponsive properties. PEtOx has an LCST of ~60 °C, 
poly(2-n-propyl-2-oxazoline) (PnPropOx) of ~25 °C, poly(2-cyclopropyl-2-oxazoline) 
(PcPropOx) of ~30 °C and poly(2-isopropyl-2-oxazoline) (PiPropOx) of ~38 °C.
5, 20-22
 
Copolymerisation provides direct access to polymers with tuneable cloud point temperatures 
(Tcps) from 9 °C to 100 °C.
20-27
  
 
Scheme 6: Cationic ring-opening polymerisation of 2-oxazolines with methyl p-toluenesulfonate as 
initiator and piperidine as terminating agent. 
 
The incorporation of functional groups into polymer side chains as  handles for post-
polymerisation modifications, enables the synthesis of a set of polymers with tuneable 
properties from a single precursor without the need of preparing different monomers. Many 
different groups and thus types of reactions have been reported for post-polymerisation 
modifications with a variety of polymers; thiol-ene and thiol-yne reactions, Michael additions 
(e.g. maleimide coupling), Diels-Alder Cycloaddition, thiol-disulfide exchange, reactions with 
epoxides, anhydrides, oxazolines and isocyanides, imine formation of aldehydes and ketones 
with amines, coupling to carboxylic acids and azide-alkyne cycloadditions.
28-32
 Substitution 
reactions, especially of activated esters with amines or alcohols, are the most important class 
of post-polymerisation modification reactions. The most widely used active ester is N-
hydroxysuccinimide (NHS) allowing quantitative functionalisation, however polymers 
modified with NHS are in some cases poorly water soluble.
28, 33
 Pentafluorophenyl (PFP) 
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esters often show a better hydrolytic stability, are soluble in a wide range of solvents and have 
a higher reactivity than NHS-esters. 
28, 32-35
 
 
Poly(2-oxazoline)s can very effectively be functionalized by post-polymerisation 
modification, for example with thiol-ene
36, 37
 and thiol-yne
37
 chemistry and copper(I)-
catalysed azide-alkyne cycloaddition (CuAAC).
15, 29, 37, 38
 CROP does not allow the use of 
monomers which contain active esters. These reactive groups have to be installed in a post-
polymerisation modification synthetic route via the corresponding carboxylic acid, which can 
be obtained via deprotection of a methyl ester. Carboxylic ester functionalised oxazolines 
have previously already been used for post-polymerisation functionalisation. The groups of 
Weberskirch and Weck, for example, used coupling agents to introduce via a carbodiimide 
amidation reaction a pyrrolidine derivative and a salen ligand respectively.
39, 40
 
 
In chapter 3 we described in detail the synthesis and (thermal) properties of two methyl ester 
functionalised PAOx polymers, namely PMestOx (1) and PC3MestOx (2) (Scheme 7). The 
PMestOx and PC3MestOx homopolymers showed TCPs at 5 mg/mL of 101 °C and 26 °C 
respectively.
41
 Methyl esters are of special interest because they can be easily hydrolysed to 
their corresponding carboxylic acids providing an easy handle for bioconjugation strategies. 
Moreover PAOx with methyl ester side chains were recently found to undergo direct, non-
catalysed amidation reactions to introduce other functional groups such as alcohols, hydrazide 
and amines.
42-45
 For these amidation reactions no further activation was required, proposedly 
due to the high concentration of amine reagents employed, and the neighbouring group effect 
in which the nitrogen groups of the backbone of PAOx participate in the reaction mechanism 
by stabilisation of the transition state.
43
 Although the amidation of MestOx containing 
polymers with mostly primary amines and one secondary amine (dimethyl amine) was 
recently described as prior art,
43
 this report only proved that amidation reactions are working 
on homopolymers with one example, PMestOx with 20 repeating units was reacted with 1-
aminopropane. The scope of this direct modification reaction and the effect on the polymer 
properties of PMestOx homopolymers is yet unexplored. 
 
Scheme 7: Structures of A) PMestOx and B) PC3MestOx. 
 
In this chapter the amidation of PMestOx with a series of primary and secondary amines 
(Scheme 8) was investigated in order to introduce new properties and to exploit the scope of 
this very straightforward modification reaction. The thermal solution and bulk properties of 
the resulting polymers were determined by turbidimetry, differential scanning calorimetry 
(DSC) and thermal gravimetric analysis (TGA), respectively. 
 
 
Scheme 8: Amidation of PMestOx with primary and secondary amines yielding PMestOx-amide 
polymers. 
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Results and discussion 
Homopolymers of MestOx (PMestOx) were prepared as described in chapter 3. Two different 
batches with a dispersity (Ð) of 1.10 and 1.18 and number average molecular weights (Mn) of 
19.4 and 16.1 kDa were used for the amidation reactions. 
 
Amidation reactions with primary amines 
The direct amidation reactions were performed according to the method recently reported in 
literature.
43
 PMestOx was dissolved in methylamine (33 wt% solution in absolute ethanol), 
ethylamine (70% solution in water), n-propylamine or n-butylamine and stirred overnight at 
room temperature instead of 70 °C as reported, directly yielding PMestOx-NH-methyl (3), 
PMestOx-NH-ethyl (4), PMestOx-NH-propyl (5) and PMestOx-NH-butyl (6) respectively 
(Scheme 9). After workup 
1
H NMR analysis revealed the disappearance of the methyl ester 
peak at 3.64 ppm and the appearance of peaks corresponding to the amines with the expected 
integrals indicating near quantitative conversion. Importantly, these amidation reactions were 
found to be compatible with water which is important for potential future use for 
bioconjugation. The polymers were also studied with FTIR spectroscopy, also showing the 
disappearance of the methyl ester band at 1729 cm
-1
 and the appearance of an NH band 
around 3300 cm
-1
. SEC analysis showed an increase in molecular weight after amidation, but 
more importantly Ð remained constant, indicating absence of interchain coupling (Table 7). 
 
Scheme 9: Polymeric structures after amidation of A) PMestOx-NHmethyl, B) PMestOx-NHethyl, C) 
PMestOx-NHpropyl and D) PMestOx-NHbutyl. 
 
Amidation with secondary amines 
First the amidation reaction was tried with diethyl amine, dipropylamine, diisopropylamine 
with the same method as described above. Unfortunately, the PMestOx polymer did not 
dissolve in these amines and the reaction did not proceed. Also the addition of solvent 
(dichloromethane and methanol were added to dissolve the polymer and/or heat did not yield 
any product. These secondary amines are probably not reactive enough to perform the 
amidation without the addition of catalyst. 
 
In literature the air-stable AlMe3 adduct of 1,4-diazobicyclo[2.2.2]octane (DABAL-Me3), a 
Lewis acid, (Scheme 10) has been reported for amide formation with secondary amines from 
low molecular weight methyl esters in THF.
46, 47
 Under reflux conditions 18 hours of reaction 
time were needed for the reaction to go to completion, while under microwave irradiation at 
130 °C the reaction was finished in minutes. Therefore the polymer was dissolved in THF and 
the secondary amines and DABAL-Me3 were added. After microwave heating to 130 °C, the 
solution turned into an intractable tar, which was also reported in literature,
47
 but no product 
could be recovered. Two other methods with potassium tert-butoxide
48
 or sodium methoxide
49
 
resulted in either no reaction or only hydrolysed methyl esters. 
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Scheme 10: Structure of AlMe3 adduct of 1,4-diazobicyclo[2.2.2]octane (DABAL-Me3). 
 
Another paper reported the use of triethylamine as catalyst for such amidation reactions.
50
 For 
the secondary amines reported above this method did also not work with PMestOx. Therefore 
we switched to the cyclic amines pyrrolidine, piperidine, morpholine and 1-acetylpiperazine 
to test the effect of the arrangement of the carbon atoms in the amine compound on the 
amidation reaction. The triethylamine method did work for these amines, yielding PMestOx-
pyrrolidine, PMestOx-piperidine, PMestOx-morpholine and PMestOx-1-acetylpiperazine 
respectively (Scheme 11). The triethylamine route was chosen here because it worked for 
isopropylamine which did not react in the previously described routes, probably due to steric 
hindrance. This compound was not tested for its properties, because only a test reaction was 
performed. The amidations with the cyclic amines without the addition triethylamine should 
be tried. The reactions with these secondary amines did possibly work because of the higher 
reactivity of the cyclic amines compared to the linear ones due to steric hindrance. After 
workup 
1
H NMR analysis revealed the disappearance of the methyl ester peak at 3.64 ppm 
and the appearance of peaks corresponding to the amines. The polymers were also studied 
with FTIR spectroscopy, also showing the disappearance of the methyl ester band at 1729 cm
-
1
. SEC analysis showed an increase in molecular weight after amidation, but more importantly 
Ð only slightly increased. 
 
Scheme 11: Polymeric structures of PMestOx after amidation with A) pyrrolidine, B) piperidine, C) 
morpholine and D) 1-acetylpiperazine. 
 
Table 7: Overview of polymer properties after amidation 
Amine SEC
a
 before SEC
a
 after TCP (°C)
b
 Tg 
(°C)
c
 
TGA 
(°C)
d
 Mn 
(kDa) 
Ð Mn 
(kDa) 
Ð Heating cooling 
Methylamine 19.4 1.10 25.1 1.13 # # 82 300 
Ethylamine 19.4 1.10 25.6 1.13 # # 74 305 
n-propylamine 19.4 1.10 22.6 1.10 28 * 64 339 
n-butylamine 19.4 1.10 22.8 1.09 § § 53 335 
Pyrrolidine 16.1 1.18 13.8 1.25 64 65 70 313 
Piperidine 16.1 1.18 ¥ ¥ 23 20 69 293 
Morpholine 16.1 1.18 19.1 1.23 # # 89 343 
1-acetylpiperazine 16.1 1.18 18.4 1.32 # # 70 225 
# no cloudpoint temperature (TCP) observed up to 100 °C at 5 mg/mL. 
* Due to sticking of the precipitated polymers TCP could not be determined. 
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§ Polymer was not watersoluble 
¥ No peak visible in SEC, probably due to low concentration 
a. Determined by SEC against PMMA standards 
b. Determined by turbidimetry measurements 
c. Determined by DSC measurements 
d. Onset values of degradation are reported 
 
Solution properties 
The modification of PMestOx will change the polymer properties, because of the replacement 
of the ester moiety by an amide and the introduction of extra carbon atoms into the polymer. 
TCPs of the modified polymers were determined by turbidimetry of 5 mg mL
-1
 aqueous 
solutions. All polymers were water-soluble except the n-butylamine modified polymer. The 
polymers PMestOx-NHpropyl, PMestOx-pyrrolidine and PMestOx-piperidine did show 
reversible LCST behaviour between 23 and 64 °C (Figure 47 and Table 7) while the other 
four polymers did not show a cloud point up to 100 °C (Figure S 17). The absence of a 
cloudpoint for the other four polymer was due to a shift in the hydrophilic/hydrophobic 
balance to the hydrophilic part, because of the ability to form extra hydrogen bonds with the 
solvent. However the introduction of extra methylene units resulted in a more hydrophobic 
polymer, leading to a lower TCP. PMestOx was reported a shallow turbidity transition and a 
TCP of 101 °C,
41
 whereas the polymers mentioned above show a sharp transition. PMestOx-
NHpropyl had a TCP of 28 °C which is comparable to PnPropOx with a TCP for a DP 100 
polymer at 5 mg/mL of 27 °C.
41
 Although PMestOx-NHpropyl had a longer side chain, the 
amide that was also introduced restored the hydrophilic/hydrophobic balance. The TCP upon 
cooling for PMestOx-NHpropyl could not be determined due to coagulation of the 
precipitated polymer onto the stirring bar and vial, which led to an increased transmittance 
(Figure 47A). PMestOx-morpholine and PMestOx-1-acetylpiperazine also showed shallow 
transitions, but they do not reach a transmission of 50%, so no TCP could be determined.  
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Figure 47: Turbidity measurements for A)PMestOx-NHpropyl, B) PMestOx-pyrrolidine and C) 
PMestOx-piperidine. 
 
These data show that TCPs can be changed upon post polymerisation modification of the 
methyl ester groups. The introduction of methylamine or ethylamine lead to the disappearance 
of LCST behaviour, while propylamine resulted in a TCP of 28 °C and butyl amine resulted in 
a water-insoluble polymer, clearly showing the influence of the number of carbon atoms in 
the polymeric chain. Interestingly PMestOx-pyrrolidine contained the same number of carbon 
atoms as PMestOx-NHbutyl and is highly watersoluble with a TCP of 64 °C. So also the way 
the carbons are organised is important; cyclic structure are more compact than their linear 
equivalents and are therefore less exposed to the solvent and have a higher TCP. Increasing the 
ring with one atom, going from pyrrolidine to piperidine leads to a lower TCP. The 
introduction of an extra heteroatom in six membered ring leads to the disappearance of TCP 
and a fully water-soluble polymer up to 100 °C, because more hydrogen bridges can be 
formed between water and the polymer. 
 
Thermal bulk properties 
The thermal bulk properties of the modified PMestOx polymers were further investigated by 
differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA). All polymers 
showed a clear glass transition and no melting transition (Figure 48 and Table 7), indicating 
that they are amorphous. All modifications led to an increase of Tg compared to PMestOx (Tg 
= 39 °C), indicating reduced chain mobility, i.e. better packing between polymer chains as 
may be expected by the hydrogen bonding ability of the secondary amide groups. The Tgs of 
7-10 were plotted against the number of carbon atoms introduced by the amidation reaction 
(Figure 48C). A linear decrease of Tg was observed with an increasing number of carbon 
atoms, because polymer packing becomes worse when the side chains are longer. This trend 
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has also been reported for poly(2-oxazoline)s with alkyl side chains,
51-53
 although the decrease 
of Tg of poly(2-alkyl-2-oxazoline)s is stronger. This can be explained by the better packing of 
the polymer chains due to the hydrogen bonding ability of the secondary amide groups in the 
amidated polymers. A second small transition is visible, this is probably an artefact. 
 
Figure 48: DSC traces of second heating run (10 K min
-1
) of PMestOx modified with A) primary 
linear amines yielding polymers 3-6 and B) secondary cyclic amines yielding polymers 7-10 and C) Tg 
of polymers 3-6 (black) and poly(2-alkyl-2-oxazoline)s (red) versus number of carbon atoms. 
 
TGA analysis revealed that all polymers, except PMestOx-1-acetylpiperazine, are stable up to 
300 °C (Figure 49), which is comparable to copolymers of (C3)MestOx with EtOx and 
nPropOx.
41
 The thermal stability increased compared to PMestOx, which was stable up to 250 
°C, because the methyl ester was replaced by a more stable amide group. The decreased 
stability of PMestOx-1-actylpiperazine is mostly likely due to the decomposition of the acetyl 
group. 
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Figure 49: Thermogravimetric analysis of PMestOx modified with A) primary linear amines and B) 
secondary cyclic amines 
 
Conclusions 
We successfully modified PMestOx with different linear primary and cyclic secondary 
amines. PMestOx has a cloudpoint of 101 °C, the polymers modified with n-propylamine, 
pyrrolidine or piperidine showed a lower TCP, and n-butylamine modified PMestOx was not 
water soluble at all. So the LCST behaviour could be varied over a broad range of 
temperatures by reaction with different amines. DSC measurements revealed an increase of Tg 
ranging from 53-89 °C compared to 39 °C of the starting material. When linear primary 
amines are used, the relation between Tg and number of carbon atoms is linear, similar to the 
reported trend for poly(2-alkyl-2-oxazoline)s. TCPs and Tgs of PMestOx can be changed by 
performing an amidation reaction onto the methyl ester, enabling a wide variety of properties 
from the same PMestOx scaffold. More amidation reactions have to be performed with 
different amines and also combinations of amines to allow more fine tuning of solution and 
bulk properties. 
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Experimental section 
Materials 
2-Chloroethylamine hydrochloride, methyl p-toluenesulfonate (MeOTs), sodium carbonate 
and ethyl amine (70% solution in water) were purchased from Acros Organics. All other 
reagents were purchased from Sigma Aldrich and used as received. Methyl p-toluenesulfonate 
(MeOTs) was purified by distillation over barium oxide and stored under argon. Dry solvents 
were obtained from a solvent purification system from J.C. Meyer, with aluminium oxide 
drying system and a nitrogen flow. MestOx
9
 was prepared according to literature procedures. 
 
Instrumentation 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker DMC300 (300 MHz 
for 
1
H) or a Bruker DMX 500 (500 MHz for 
1
H). 
Polymerisation reaction mixtures were prepared in a VIGOR Sci-Lab SG 1200/750 Glovebox 
system, with purity levels of less than 1 ppm for O2 and H2O.  
Polymerisations were carried out in a Biotage Initiator Microwave System with Robot Sixty 
utilizing capped reaction vials. These vials were heated to 120 °C overnight, allowed to cool 
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to room temperature and filled with nitrogen prior to use. All microwave polymerisations 
were performed with temperature control (IR sensor). 
Size-exclusion chromatography (SEC) was performed on an Agilent 1260-series HPLC 
system equipped with a 1260 online degasser, a 1260 ISO-pump, a 1260 automatic liquid 
sampler (ALS), a thermostatted column compartment (TCC) at 50°C equipped with two 
PLgel 5 µm mixed-D columns and a guard column in series, a 1260 diode array detector 
(DAD) and a 1260 refractive index detector (RID). The used eluent was DMA containing 
50mM of LiCl at a flow rate of 0.500 ml/min. The spectra were analysed using the Agilent 
Chemstation software with the GPC add on. Molar mass and PDI values were calculated 
against PMMA standards from PSS. 
Turbidity measurements were performed on an Avantium Crystal 16 platform. Solutions of 
the polymers were prepared in MilliQ water at 5 mg mL
-1
 and were stirred at room 
temperature until all polymer was dissolved. Three heating cycles were applied with a 
heating/cooling rate of 1 °C min
-1
, temperature ranges of 5-45, 20-60, 20-75, 60-105 or 70-
110 °C were used depending on the polymer, and with hold steps of 5 min at the extreme low 
temperatures, no hold time was applied when the samples were heated above 100 °C; all 
measurements were performed with a stirring rate of 700 rpm. The cloud points are given as 
the 50% transmittance point during the first heating run. GC vials with open caps and septa 
were used for these measurements allowing heating until 110 °C with minor pressure build up 
as noticed by slight expansion of the septum. 
Differential scanning calorimetry (DSC) traces were recorded under nitrogen with a Mettler-
Toledo DSC1 module. Glass transition temperatures were obtained from the second heating 
run with heating/cooling rates of 10 K min
-1
. Indium was used as a standard for temperature 
and enthalpy calibrations. 
Thermogravimetric analysis (TGA) was performed with a Mettler Toledo TGA/SDTA851e 
instrument under nitrogen atmosphere at a heating rate of 10 ° C min
-1 
between 25 °C and 800 
°C. 
 
Polymer Synthesis 
Polymers were prepared as described in chapter 3. 
 
Polymer modifications 
Methyl- and ethyl amine modified polymers 
100 mg of polymer was dissolved in 0.5 mL of methylamine (33 wt% solution in absolute 
ethanol) or ethylamine (70% solution in water). The reaction was stirred overnight at room 
temperature and the solvent was evaporated. The polymer was dissolved in methanol and 
precipitated in cold diethyl ether twice. The polymers were dissolved in water and freeze 
dried. 
 
Propyl- and butylamine modified polymers 
100 mg of polymer was dissolved in 0.5 mL of propylamine or butylamine. The reaction was 
stirred overnight at room temperature. 0.5 mL of DCM was added and the polymer was 
precipitated in cold diethyl ether twice. The precipitate was collected and dried under vacuum. 
 
DABAL-Me3 catalysed reaction 
The DABAL-Me3 amide reaction was performed as reported in literature.
47
 A polymer stock 
solution with a methyl ester concentration of 0.5 M in THF and a 0.4 M in THF DABAL-Me3 
stock solution were prepared. 0.5 mL of both solutions were mixed in a microwave tube and 1 
equivalent of the amine was added. The vail was capped and heated for 15 minutes under 
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microwave irradiation at 130 °C. The solvent was evaporated, the polymer was dissolved in 
DCM and precipitated in cold diethyl ether. 
 
Potassium tert-butoxide (KOt-Bu) reaction 
This reaction was performed according to literature.
48
 69.7 mg of KOt-Bu was dissolved in 
2.53 mL THF and stirred for 1 minute in air. 0.52 mL of this solution was added to a 0.255 
mL polymer stock solution with a methyl ester concentration of 0.25 M. One equivalent of 
amine was added and the reaction was stirred for 1 hour at room temperature. The reaction 
mixture was filtered and the solvent was evaporated. The polymer was dissolved in DCM and 
precipitated in cold diethyl ether. 
 
Sodium methoxide reaction 
This reaction was performed according to literature.
49
 PMestOx was dissolved in THF with a 
methyl ester concentration of 4.0 M. 1.3 equivalents of amine and 5 mol% of sodium 
methoxide were added. The reaction was stirred for one day at 50 °C. The reaction mixture 
was filtered and the solvent was evaporated. The polymer was dissolved in DCM and 
precipitated in cold diethyl ether. 
 
Pyrrolidine, piperidine, morpholine and 1-acetylpiperazine modified polymers 
100 mg of polymer was dissolved in 0.5 mL pyrrolidine, morpholine or 0.5 g 1-
acetylpiperazine. 100 µL of triethylamine was added and the reaction was stirred at 90 °C for 
6 days. 0.5 mL of DCM was added and the pyrrolidine and piperidine modified polymers 
were precipitated twice in cold diethyl ether. Morpholine and 1-acetylpiperazine polymers 
were precipitated three times in cold diethyl ether: acetone 3:1. The morpholine modified 
polymer was subsequently also precipitated in ethyl acetate. The precipitate was collected and 
dried under vacuum. 
 
1
H NMR data of the polymers synthesized  
 
PMestOx 1 
1
H NMR (CDCl3, 500 MHz): δ 3.64 (br, COOCH3, 297 H), 3.46 (br, NCH2CH2N, 396 H), 
3.14 (br, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.57 (br, COCH2CH2CO, 396 H), 
1.78 (s, CH2CH2CH2 piperidine, 6 H) 
FTIR: 2953 cm
-1
 (C-H alkane), 1729 cm
-1
 (C=O of methyl ester), 1637 cm
-1
 (C=O of amide), 
1436 cm
-1
 (C-N amide) 
SEC: Mn 19.4 kDa, Ð 1.10 
 
PMestOx 2 
1
H NMR (CDCl3, 500 MHz): δ 3.64 (br, COOCH3, 300 H), 3.46 (br, NCH2CH2N, 400 H), 
3.14 (br, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.57 (br, COCH2CH2CO, 400 H), 
1.78 (s, CH2CH2CH2 piperidine, 6 H) 
SEC: Mn 16.1 kDa, Ð 1.18 
 
PMestOx-NH-methyl 
1H NMR (MeOD, 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.14 (br, CH2NCH2 piperidine, 
4 H), 2.96 (s, NCH3, 3 H), 2.70 (br, CH3, 197 H), 2.57 (br, COCH2CH2CO, 396 H), 1.78 (s, 
CH2CH2CH2 piperidine, 6 H) 
FTIR: 3313 cm
-1
 (N-H), 2947 cm
-1
 (C-H alkane), 1636 cm
-1
 (C=O of amide), 1418 cm
-1
 (C-N 
amide) 
SEC: Mn 25.1 kDa, Ð 1.13 
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PMestOx-NH-ethyl 
1
H NMR (CDCl3, 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.19 (br, CH2NCH2 piperidine 
& NHCH2CH3, 202 H), 2.96 (s, NCH3, 3 H), 2.57 (br, COCH2CH2CO, 396 H), 1.78 (s, 
CH2CH2CH2 piperidine, 6 H), 1.09 (br, CH3, 197 H) 
FTIR: 3306 cm
-1
 (N-H), 2970 cm
-1
 (C-H alkane), 1636 cm
-1
 (C=O of amide), 1457 cm
-1
 (C-N 
amide) 
SEC: Mn 25.6 kDa, Ð 1.13 
 
PMestOx-NH-propyl 
1
H NMR (CDCl3, 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.19 (br, CH2NCH2 piperidine 
& NHCH2CH2, 202 H), 2.96 (s, NCH3, 3 H), 2.57 (br, COCH2CH2CO, 396 H), 1.78 (s, 
CH2CH2CH2 piperidine, 6 H), 1.49 (br, NHCH2CH2, 198 H), 0.90 (br, CH3, 197 H) 
FTIR: 3313 cm
-1
 (N-H), 2963 cm
-1
 (C-H alkane), 1628 cm
-1
 (C=O of amide), 1423 cm
-1
 (C-N 
amide) 
SEC: Mn 22.6 kDa, Ð 1.10 
 
PMestOx-NH-butyl 
1
H NMR (CDCl3, 300 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.19 (br, CH2NCH2 piperidine, 
4 H), 2.96 (s, NCH3, 3 H), 2.57 (br, COCH2CH2CO, CH3CHCH3, 495 H), 1.78 (s, 
CH2CH2CH2 piperidine, 6 H), 1.10 (br, CH3, 594 H) 
FTIR: 3296 cm
-1
 (N-H), 2957 cm
-1
 (C-H alkane), 1629 cm
-1
 (C=O of amide), 1433 cm
-1
 (C-N 
amide) 
SEC: Mn 22.8 kDa, Ð 1.09 
 
PMestOx-NH-isopropyl 
1
H NMR (CDCl3, 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.19 (br, CH2NCH2 piperidine 
& NHCH2CH2, 202 H), 2.96 (s, NCH3, 3 H), 2.57 (br, COCH2CH2CO, 396 H), 1.78 (s, 
CH2CH2CH2 piperidine, 6 H), 1.49 (br, NHCH2CH2, 198 H), 0.90 (br, CH3, 197 H) 
 
PMestOx-pyrrolidine 
1
H NMR (CDCl3, 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.34 (br, CH2NCH2 piperidine 
& CH2NCH2 pyrrolidine, 400 H), 2.96 (s, NCH3, 3 H), 2.57 (br, COCH2CH2CO, 396 H), 1.92 
(br, CH2 pyrrolidine, 196 H), 1.78 (s, CH2CH2CH2 piperidine & CH2 pyrrolidine, 204 H) 
FTIR: 2971 cm
-1
 (C-H alkane), 1630 cm
-1
 (C=O of amide), 1443 cm
-1
 (C-N amide) 
SEC: Mn 13.8 kDa, Ð 1.25 
 
PMestOx-piperidine 
1
H NMR (CDCl3, 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.41 (br, CH2NCH2 piperidine, 
400 H), 2.96 (s, NCH3, 3 H), 2.57 (br, COCH2CH2CO, 396 H), 1.56 (br, CH2CH2CH2, 600 H) 
FTIR: 2934 cm
-1
 (C-H alkane), 1636 cm
-1
 (C=O of amide), 1443 cm
-1
 (C-N amide) 
SEC: no peak visible, probably due to low concentration 
 
PMestOx-morpholine 
1
H NMR (CDCl3, 500 MHz): δ 3.67(br, CH2NCH2, 396H), 3.64 (br, CH2OCH2, 396 H), 3.46 
(br, NCH2CH2N, 396 H), 3.34 (br, CH2NCH2 piperidine, 6 H), 2.96 (s, NCH3, 3 H), 2.57 (br, 
COCH2CH2CO, 396 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H) 
FTIR: 2918 cm
-1
 (C-H alkane), 1634 cm
-1
 (C=O of amide), 1444 cm
-1
 (C-N amide), 1113 cm
-1
 
(C-O dialkyl ether) 
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SEC: Mn 19.1 kDa, Ð 1.23 
 
 
PMestOx-1-acetylpiperazine 
1
H NMR (CDCl3, 500 MHz): δ 3.93&3.80 (br, CONCH2, 198 H), 3.46 (br, NCH2CH2N, 396 
H), 3.19 (br, CH2NCH2 piperidine & CONCH2, 202 H), 2.96 (s, NCH3, 3 H), 2.57 (br, 
COCH2CH2CO, 396 H), 2012 (br, CH3, 197 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H) 
FTIR: 2919 cm
-1
 (C-H alkane), 1634 cm
-1
 (C=O of amide), 1435 cm
-1
 (C-N amide) 
SEC: Mn 18.4 kDa, Ð 1.32 
 
 
Figure S 17: Turbidity measurements for A) PMestOx-NHmethyl, B) PMestOx-NHethyl, C) 
PMestOx-morpholine and D) PMestOx-1-acetylpiperazine 
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Abstract 
Cell penetrating peptides (CPPs) and their synthetic mimics are used to transfer drugs across 
the biological membrane. Here we report a new polymeric mimic of CPPs based on the 
biocompatible polymer poly(2-oxazoline). This versatile class of polymers allows the 
introduction of functional groups in the side chain, such as methyl esters, which can be 
modified in an efficient three step procedure towards cellular uptake-facilitating guanidinium 
groups. We prepared a set of guanidine-functionalised polymers of DP 100 to study the effect 
of monomer distribution and degree of functionalisation on uptake efficiency. It was 
determined that only the block copolymers with 15 or 20% functionalisation were taken up by 
cells, clearly showing the influence of polymeric structure and degree of functionalisation. 
The cell penetrating efficiency was lower compared to the low molecular weight CPP octa-
arginine (R8), probably due to the large size of the polymeric construct. 
 
Introduction 
Drug molecules need to be balanced in hydrophobic and hydrophilic properties to be 
therapeutically active; they should be sufficiently water soluble to be transported through the 
body and be lipophilic enough to cross the lipid bilayer of the cell. Instead of increasing the 
lipophilicity of a molecule, cell uptake can also be improved by the employment of cell 
membrane transporter agents. A highly important class of molecular transporters (MoTrs) are 
the cell-penetrating peptides (CPPs), which often have a viral origin. The first CPP was 
derived from the HIV-1 protein TAT and consists of amino acids 49-57 of this protein, 
RKKRRQRRR (R: arginine, K: lysine and Q: glutamine).
1-3
 All charged amino acids, both 
arginine and lysine, were proven to be essential for cellular uptake. Over the years many 
different CPPs have been identified, of which a considerable number is rich in lysine (1) and 
arginine (2) residues, some examples can be found in Table 8. 
1, 2
 
 
Table 8: amino acid sequences of cell penetrating peptides 
Cell penetrating peptide Amino acid sequence 
TAT49-57 RKKRRQRRR (4) 
Penetratin RQIKIWFQNRRMKWKK 
Pep-1 KETWWETWWTEWSQPKKKRKV 
Transportan GWTLNSAGYLLGKINLKALAALAKKIL 
Nuclear localisation sequences FKKFRKF, SKKKKIKV, GRKRKKRT, 
VQRKRQKLMP, PKKKRKV, ERKKRRRE, 
KRPAATKKAGQAKKKL 
Oligo-arginines RRRRRRRR (R8), RRRRRRRRR (R9) 
Aminoacid abbreviations: A: Alanine, E: Glumatic acid, F: Phenylalanine, G: Glycine, I: Isoleucine, K: lysine, 
L: Leucine, M: methionine, N: Asparagine, P: Proline, Q: Glutamine, R: arginine, S: Serine, T: Threonine, V: 
Valine, W: Tryptophan, Y: Tryosine 
 
One of the most effective synthetic CPPs is oligo-arginine (3). The number of arginines 
needed for cell uptake is 5-20, with 7-9 being optimal with regard to performance and ease of 
synthesis.
3, 4
 The activity is furthermore not affected by stereochemistry. Although the exact 
mechanism of uptake is still not known, it has been demonstrated that the oligo-arginines only 
function well when these residues are in close proximity of each other, as is the case of course 
when they are part of a homo-oligopeptide. Another option to construct an active oligo-
arginine domain is by combining two peptides with 4 arginines by a disulfide bridge, which 
leads to similar uptake efficiency as regular octa-arginine. The reversibility of the disulfide 
bond allows the construction of activatable cell penetrating peptides.
5
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Figure 50: Structures of amino acids and cell penetrating peptides A) lysine and B) arginine, C) nona-
arginine and D) TAT peptide 
 
As the guanidine group of the arginine side chain seems to be the dominating functional 
element, many researchers have investigated the possibility to construct cell penetrating 
materials by installing this moiety on a wide range of carrier molecules, leading to so-called 
guanidinium-rich transporters (GRTs).
6, 7
 The first example was reported by Wender et al.
4
 
who prepared polypeptoids with amine groups which were subsequently converted into 
guanidines via a perguanidinylation reaction. These guanidinium polypeptoids (5) showed 
similar uptake as oligo-arginines. Also the length between the backbone and guanidinium 
functionality was varied, which showed that longer spacers lead to higher uptake efficiencies, 
suggesting molecular flexibility is important.
3, 4
 
 
Figure 51: Structure of A) guanidinium polypeptoids, B) β-oligo arginine and C) and D) oligoamides 
and oligocarbamates with guanidinium side chains, respectively. 
 
The introduction of extra methylene units in the backbone, for example in case of β-peptides 
(6) 
8, 9
 or an alternating peptide of arginine and aminocaproic acid (7) 
3, 10
 resulted in 
structures that outperformed or exhibited similar behaviour as the arginine homo-oligomers. 
In 2002 oligocarbamates bearing guanidinium side chains (8) were the first non-amide based 
MoTrs and the most efficient transporters published at that time.
11
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Nowadays, many examples of GRTs can be found in literature, based on aminoglycosides,
12
 
dendrimers,
13, 14
 sorbitol
15
 and inositol.
16
 Also a number of oligomeric and polymeric GRTs 
have been developed. These GRTs are of interest because of their stability, ability to 
introduce other functionalities, tuneable properties, structural diversity, and ease of production 
compared to regular CPP synthesis. 
 
Different oligomeric MoTrs have been reported which were either prepared by 
organocatalytic ring-opening polymerisation to yield biodegradable carbonate oligomers (9),
17
 
or by ring-opening metathesis polymerisation to create oligonorbornenes (10 and 11).
18-22
 In 
the former case the 8mer oligocarbonate showed an uptake comparable with R8, whereas the 
11mer was twice as effective. Although most polymerisation approaches aim to create 
oligomers of 7-12 repeating units with guanidine,
17-19
 some longer polymers have been 
reported containing 20-30, 50 or even 100 guanidinium units.
20-22
 Oligomers, random
22
 and 
block
20
 copolymers have all been shown to enter cells, although no quantification of the 
MoTrs or structure property relationship studies have been reported. A third class of 
polymeric MoTrs concerns a polydisulfide polymer (12) which can depolymerise in the cell 
yielding nontoxic degradation products. Uptake in HeLa cells was confirmed using flow 
cytometry experiments but the efficiency was not compared to existing CPPs.
23, 24
 A special 
oligomeric MoTr was created by positioning the guanidinium group in the main chain of the 
oligomer. This preorganised and non-hydrolysable chiral bicyclic structure (13) showed a two 
times better uptake than TAT.
25
 Uptake could also be improved by the incorporation of 
aromatic groups in norbonene MoTrs
21
 or the conjugation of fatty acids to CPPs.
26
 
 
 
Figure 52: Structures of polymeric MoTrs A) Carbonate oligomers, B)
20
 and C)
22
 examples of 
polymers prepared by ring opening metathesis, D) polydisulfide with guanidinium groups and E) 
oligomer with the guanidinium group in the main chain. 
 
The MoTrs investigated until now all have large backbone structures and in some cases the 
variation in monomeric units to fine tune the properties is somewhat limited. Furthermore, the 
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biocompatibility of the non-degradable oligomers is unknown. Poly(2-oxazoline)s might be 
an interesting alternative option for the synthesis of MoTrs. This class of polymers has a high 
side chain density, is versatile with respect to its use of monomers, which allows to tune the 
polymer properties; it is furthermore known to be biocompatible and non-ionic derivatives 
show stealth behaviour. Although this polymer is not biodegradable, it can be excreted by the 
kidneys.
27, 28
 The versatility of these polymers allows the introduction of reactive groups 
which can be used for post polymerisation functionalisation. Methyl esters are especially 
interesting, because they can undergo a direct amidation with a variety of amines to easily 
introduce other functional groups such as alcohols, hydrazide and amines, as described in 
chapter 4 and in literature.
29-34
 
 
In this chapter we describe the modification of copolymers consisting of 2-ethyl-2-oxazoline 
(EtOx) and 2-methoxycarbonylethyl-2-oxazoline (MestOx, 14) to obtain guanidinium 
functionalised poly(2-oxazoline)s. Series of random and block copolymers were synthesised 
to systematically study the effect of functional group distribution along the polymer chain on 
cellular uptake. Different percentages of MestOx were incorporated to study uptake and 
toxicity as function of composition. The cell viability was tested for these polymers because 
cellular uptake and toxicity go hand in hand, before starting uptake studies with confocal 
microscopy. Flow cytometry experiments were performed to quantify the uptake of the 
polymers. 
 
Results and discussion 
Polymer synthesis and modification 
A series of both random and block poly(2-oxazolines) was prepared, with 10, 15 and 20% 
MestOx. All polymers had low dispersities, Ð < 1.21(Table 9). They were terminated with an 
azide moiety (Scheme 12) to enable labelling of every polymer chain with a fluorescent dye to 
allow quantification of cellular uptake. These polymers (P(EtOx-MestOx)N3) were 
subsequently reacted with N-Boc-ethylene diamine to yield Boc-protected amine 
functionalised polymer. The Boc group was removed and the corresponding amine was 
guanidinylated. FITC functionalised with bicyclo[6.1.0]nonyne (BCN) was clicked to the 
azide to yield a dye-labelled guanidine-functionalised polymer (PAOx(Et-guanidine)FITC). 
The modifications were performed successfully yielding polymers with an average number of 
guanidine groups per polymer chain which is comparable to R8 and R9 for the 10% 
modification, up to the double amount for the 20% degree of guanidinylation. All polymers 
were purified by precipitation, except for the last two steps. These polymers were purified 
over Sephadex. All polymers were characterised by 
1
H NMR and IR spectroscopy. 
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Scheme 12: Synthesis of guanidine-functionalised block copolymers. For the synthesis of the random 
copolymers EtOx was copolymerized with MestOx in the desired ratio. 
 
Table 9: Overview of polymeric structures and properties 
Polymer Number 
of 
MestOx 
groups 
a
 
Number 
of EtOx 
groups 
a
 
Number of 
guanidine 
groups 
a
 
Structure Mn (kDa) 
MestOx 
polymer 
b
 
Ð MestOx 
polymer 
b
 
10B 12 94 12 Block  14.5 1.21 
10G 12 84 12 Random 16.3 1.16 
15B 15 84 15 Block 14.1 1.20 
15G 16 84 16 Random 18.0 1.13 
20B 23 89 23 Block 14.9 1.16 
20G 23 84 23 Random 18.0 1.17 
a. determined by 1H NMR spectroscopy 
b. determined by SEC against PMMA standards 
c. all characterisation was performed on the EtOx-MestOx copolymer (15), except for 
the number of guanidine groups. 
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Cell viability tests 
Cell viability was determined by incubation of HeLa cells with different concentrations (5, 10 
and 15 µM) of polymers containing amines 17 and guanidines 19. Incubations were 
performed for 90 minutes at 37 °C. After this incubation the cells were washed and incubated 
with Cell Counting Kit-8. This kit contains a compound that is transformed by living cells to 
an orange dye which was quantified by UV-Vis spectroscopy.
35
 The cell viability was 
calculated by comparing the absorbance of the treated cells with the absorbance of cells which 
were not incubated with polymers (Figure 53). The cells were viable with polymer 
concentrations of 5 and 10 µM, but toxicity slightly increased at 15 µM for the block 
copolymers whereas the cells were still viable at this concentration for the random 
copolymers. This lower cell viability in presence of the block copolymers might be due to a 
higher local concentration of charged groups. 
 
Figure 53: Cell viability of A) amine-functional polymers (17) and B) guanidine-functional polymers 
(19) at 5, 10 and 15 µM concentration after 90 minutes incubation, experiments were performed in 
threefold. 
 
Uptake studies with confocal microscopy 
As there were no signs of toxicity at the lower concentrations, HeLa cells were incubated with 
5 and 10 µM of polymer for 90 minutes. After washing, the cellular uptake was visualised 
using confocal fluorescence microscopy. The random copolymers (19-10G, 19-15G and 19-
20G) did not show any uptake at both 5 and 10 µM (Figure S 18 and Figure S 19). In this 
series only the block copolymers with 15 and 20 % guanidinium groups (19-15B and 19-20B) 
showed uptake at 10 µM (Figure 55), while at 5 µM (Figure 54) they merely bound to the cell 
membrane.  
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Figure 54: Confocal fluorescence (top) and transmission images (bottom) of a 5 µM uptake 
experiment of guanidine block copolymers, scale bar is 50 µm. 
 
 
Figure 55: Confocal fluorescence (top) and transmission images (bottom) of a 10 µM uptake 
experiment of guanidine block copolymers, scale bar is 50 µm. 
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Uptake studies with flow cytometry 
The uptake efficiency of the guanidinium polymers was further quantified by flow cytometry. 
For comparison R8 was also included in this study. HeLa cells were incubated with 10 µM 
polymer solutions, untreated cells were used as a negative control and R8 was used a positive 
control. Cells were treated with trypsin to remove membrane-bound peptides (R8) before 
measurement. The polymers will resist this treatment and therefore the fluorescence measured 
in these experiments may be an overestimation (Figure 56). The block copolymers 19-15B 
and 19-20B showed an uptake which was lower than R8; 19-20B had an uptake efficiency of 
50% compared to R8. The random copolymers 19-15G and 19-20G carried the same number 
of guanidinium groups as the block copolymers 19-15B and 19-20B but were not taken up, 
showing that the clustering of these functional groups, as in the block copolymer, is essential 
for uptake. The chances that a domain of 8 guanidinium groups is formed in the random 
polymers are really small; 6.0*10
-6 
% for 19-10G, 4.3*10
-5 
% for 19-15G and 4.6*10
-4 
% for 
19-20G, so the presence of large enough domains can be excluded. The introduction of more 
guanidinium groups led to an increase in cellular uptake. So both the monomer distribution as 
the degree of functionalisation is important for cellular uptake. 
 
Figure 56: Flow cytometry results of uptake studies of HeLa cells at 10 µM 90 minutes incubation. 
 
The lower uptake efficiency of the polymeric constructs might be due to the size of the 
polymeric chains, bigger constructs usually need longer incubation times. A similar effect is 
seen for nanoparticles covered with poly(ethylene glycol) (PEG) chains. The PEGylation 
suppresses the cellular uptake of these nanoparticles.
36, 37
 The MoTrs in literature with higher 
uptake compared to R8 or TAT are not polymeric but short oligomeric chains. Uptake 
efficiencies might be increased by testing longer incubation times, because larger objects 
require more time to cross the cell membrane. Moreover, the length of the spacer between the 
polymeric backbone and the guanidinium group can be extended by using C3MestOx instead 
of MestOx to introduce more flexibility which is important for uptake efficiency as reported 
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in literature.
3, 4
 In literature only one polymeric MoTrs has been quantified with flow 
cytometry, this preorganised non-hydrolysable chiral bicyclic structure (13) showed a two 
times better uptake than TAT.
25
 R8s uptake efficiency is also double compared to TAT,
4
 so 13 
should be comparable to R8 and its uptake is probably higher than 19-20B. 
 
Conclusions 
Poly(2-oxazoline)s with methyl ester groups were post-polymerisation modified to amines 
and subsequently to guanidinium copolymers. Both random and block methyl ester 
copolymers were prepared and modified. Both amine and guanidine functionalised polymers 
from these series did not show toxicity up to 10 µM, however at 15 µM for the block 
copolymers containing amines or guanidines some minor toxicity was observed. Uptake 
studies showed that only the block copolymers with 15 or 20% functionalisation were taken 
up by cells, clearly demonstrating the influence of monomer distribution and degree of 
functionalisation. The efficiency was lower compared to R8, probably due to the size of the 
polymeric construct. 
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Experimental 
Materials  
2-Chloroethylamine hydrochloride, methyl p-toluenesulfonate (MeOTs) and sodium 
carbonate were purchased from Acros Organics. FITC-BCN, officially BCN-POE3-NH-DY495 
conjugate (SX-A1030) was purchased from Synaffix BV (Oss, the Netherlands). N-Boc 
ethylene diamine was purchased from AK scientific. All other reagents were purchased from 
Sigma Aldrich and used as received, except 2-ethyl-2-oxazoline (EtOx) and methyl p-
toluenesulfonate (MeOTs). These were purified by distillation over barium oxide and stored 
under argon. Dry solvents were obtained from a solvent purification system from MBraun 
MB SPS800 system under nitrogen atmosphere. Triethylamine was distilled over CaH2 under 
argon atmosphere. MilliQ water was obtained from a Labconco Water Pro PS purification 
system (18.2 MΏ). Fetal calf serum (FCS) was obtained from Integro (Zaandam, The 
Netherlands), plain Dulbecco’s Modified Eagle Medium (DMEM), RPMI-1640 and 
trypsin/EDTA were from PAA Laboratories (Pasching, Austria). HeLa CCL-2 cells were 
obtained from American Type Culture Collection (ATCC, Manassas, U.S.A.). 
 
Instrumentation  
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker DMX 500 (500 MHz 
for 
1
H). 
Infrared (IR) spectra were obtained using a Bruker Tensor 27 spectrometer in ATR mode. 
Electro spray ionisation mass (ESI MS) spectra were recorded on a Thermo Finnigan LCQ 
Advantage Max. 
Polymerisations were carried out in a Biotage Initiator Microwave System with Robot Eight 
utilizing capped reaction vials. These vials were heated to 140 °C overnight, allowed to cool 
to room temperature and filled with argon prior to use. All microwave polymerizations were 
performed with temperature control (IR sensor). 
Size-exclusion chromatography (SEC) was performed on an Agilent 1260-series HPLC 
system equipped with a 1260 online degasser, a 1260 ISO-pump, a 1260 automatic liquid 
sampler (ALS), a thermostatted column compartment (TCC) at 50°C equipped with two 
PLgel 5 µm mixed-D columns and a guard column in series, a 1260 diode array detector 
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(DAD) and a 1260 refractive index detector (RID). The used eluent was DMA containing 
50mM of LiCl at a flow rate of 0.500 ml/min. The spectra were analysed using the Agilent 
Chemstation software with the GPC add on. Molar mass and PDI values were calculated 
against PMMA standards from PSS. 
 
Monomer synthesis 
Monomers were synthesized as described in chapter 2. 
 
Copolymer synthesis with azide terminus (P(EtOx-MestOx)N3) 
MestOx and EtOx were mixed under argon atmosphere in the right monomer ratio with 
methyl tosylate as initiator, a monomer:initiator ([M]/[I]) ratio of 100 and a final monomer 
concentration of 4 M in acetonitrile. This solution was heated for 20 minutes at 140 °C in the 
microwave. After cooling down, an excess sodium azide was added and the reaction was 
stirred overnight at 80 °C. The remaining solids were removed and the solvent was 
evaporated. The polymer was dissolved in DCM and precipitated twice in cold diethyl ether 
yielding a white foam. 
 
P(EtOx-MestOx 84-12)N3 (10G): 
1
H NMR (CDCl3. 500 MHz): δ 3.65 (br, OCH3, 36 H), 3.46 (br, NCH2CH2N, 384 H), 2.96 (s, 
NCH3, 3 H), 2.56 (br, COCH2CH2CO, 48 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 
252 H) 
SEC: Mn 16.3 kDa, Ð 1.16 
FTIR: 2100 cm
-1
 (azide), 1735 cm
-1
 (C=O of methyl ester) 
 
P(EtOx-MestOx 84-16)N3 (15G): 
1
H NMR (CDCl3. 500 MHz): δ 3.65 (br, OCH3, 48 H), 3.46 (br, NCH2CH2N, 400 H), 2.96 (s, 
NCH3, 3 H), 2.56 (br, COCH2CH2CO, 64 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 
252 H) 
SEC: Mn 18.0 kDa, Ð 1.13 
FTIR: 2100 cm
-1
 (azide), 1735 cm
-1
 (C=O of methyl ester) 
 
P(EtOx-MestOx 84-23)N3 (20G): 
1
H NMR (CDCl3. 500 MHz): δ 3.65 (br, OCH3, 69 H), 3.46 (br, NCH2CH2N, 421 H), 2.96 (s, 
CH3, 3 H), 2.56 (br, COCH2CH2CO, 92 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 252 
H) 
SEC: Mn 18.0 kDa, Ð 1.17 
FTIR: 2100 cm
-1
 (azide), 1735 cm
-1
 (C=O of methyl ester) 
 
Block-copolymer synthesis with azide terminus (P(MestOx-b-MestOx)N3) 
MestOx, methyl tosylate and acetonitrile were mixed under argon atmosphere in the right 
ratios. This solution was heated for 20 minutes at 140 °C in the microwave. After cooling 
down EtOx was added and the solution was again heated for 20 minutes at 140 °C in the 
microwave. The final [M]/[I] ratio of 100 and a final monomer concentration (if all monomers 
would have been added at the same time) of 4 M. Sodium azide was added and the reaction 
was stirred overnight at 80 °C. The remaining solids were removed and the solvent was 
evaporated. The polymer was dissolved in DCM and precipitated twice in cold diethyl ether 
yielding a white foam (95-99%). 
 
P(MestOx-b-EtOx 12-94)N3 (10B): 
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1
H NMR (CDCl3. 500 MHz): δ 3.65 (br, OCH3, 36 H), 3.46 (br, NCH2CH2N, 424 H), 2.96 (s, 
NCH3, 3 H), 2.56 (br, COCH2CH2CO, 48 H), 2.35 (b, COCH2, 188 H), 1.12 (br, CH2CH3, 
282 H) 
SEC: MestOx block Mn 4.05 kDa, Ð 1.11; block copolymer: Mn 14.5 kDa, Ð 1.21 
FTIR: 2100 cm
-1
 (azide), 1735 cm
-1
 (C=O of methyl ester) 
 
P(MestOx-b-EtOx 15-84)N3 (15B): 
1
H NMR (CDCl3. 500 MHz): δ 3.65 (br, OCH3, 45 H), 3.46 (br, NCH2CH2N, 396 H), 2.96 (s, 
NCH3, 3 H), 2.56 (br, COCH2CH2CO, 60 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 
252 H) 
SEC: MestOx block Mn 5.0 kDa, Ð 1.11; block copolymer: Mn 14.1 kDa, Ð 1.20 
FTIR: 2100 cm
-1
 (azide), 1735 cm
-1
 (C=O of methyl ester) 
 
P(MestOx-b-EtOx 23-89)N3 (20B): 
1
H NMR (CDCl3. 500 MHz): δ 3.65 (br, OCH3, 69 H), 3.46 (br, NCH2CH2N, 408 H), 2.96 (s, 
NCH3, 3 H), 2.56 (br, COCH2CH2CO, 69 H) 2.35 (b, COCH2, 178 H), 1.12 (br, CH2CH3, 267 
H) 
SEC: MestOx block Mn 6.1 kDa, Ð 1.10; block copolymer: Mn 14.9 kDa, Ð 1.16 
FTIR: 2100 cm
-1
 (azide), 1735 cm
-1
 (C=O of methyl ester) 
 
Synthesis of PAOx(Et-NHBoc)N3): amidation of methyl ester 
500 mg P(MestOx-b-EtOx)N3 or P(EtOx-MestOx)N3 polymer was dissolved in 3 drops of 
DCM and 5 mL N-Boc ethylene diamine was added. The solution was stirred for 3 days at 
room temperature. 5 mL DCM was added and the polymer was precipitated in cold diethyl 
ether twice. The precipitate was collected and dissolved in DCM. The solvent was evaporated 
yielding a white foam (95-99%). 
 
PAOx(Et-NHBoc 84-12)N3 (10G): 
1
H NMR (CDCl3. 500 MHz): δ 3.46 (br, NCH2CH2N, 384 H), 3.25 (br, 
CONHCH2CH2NHBoc, 24 H) 3.00 (br, CONHCH2CH2NHBoc &NCH3, 27 H), 2.60 (br, 
COCH2CH2CO, 48 H) 2.35 (b, COCH2, 168 H), 1.42 (br, C(CH3)3, 108 H), 1.12 (br, CH2CH3, 
252 H) 
FTIR: 2100 cm
-1
 (azide), 1703 cm
-1
 (C=O of t-butyl ester) 
 
PAOx(Et-NHBoc 84-16)N3 (15G): 
1
H NMR (CDCl3. 500 MHz): δ 3.46 (br, NCH2CH2N, 400 H), 3.25 (br, 
CONHCH2CH2NHBoc, 32 H) 3.00 (br, CONHCH2CH2NHBoc &NCH3, 35 H), 2.56 (br, 
COCH2CH2CO, 64 H) 2.35 (b, COCH2, 168 H), 1.42 (br, C(CH3)3, 144 H), 1.12 (br, CH2CH3, 
252 H) 
FTIR: 2100 cm
-1
 (azide), 1703 cm
-1
 (C=O of t-butyl ester) 
 
PAOx(Et-NHBoc 84-23)N3 (20G): 
1
H NMR (CDCl3. 500 MHz): δ 3.46 (br, NCH2CH2N, 421 H), 3.25 (br, 
CONHCH2CH2NHBoc, 46 H) 3.00 (br, CONHCH2CH2NHBoc &NCH3, 49 H), 2.56 (br, 
COCH2CH2CO, 92 H), 2.35 (b, COCH2, 168 H), 1.42 (br, C(CH3)3, 207 H),1.12 (br, CH2CH3, 
252 H) 
FTIR: 2100 cm
-1
 (azide), 1703 cm
-1
 (C=O of t-butyl ester) 
 
PAOx(NHBoc-b-Et 12-94)N3 (10B): 
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1
H NMR (CDCl3. 500 MHz): δ 3.46 (br, NCH2CH2N, 424 H), 3.25 (br, 
CONHCH2CH2NHBoc, 24 H) 3.00 (br, CONHCH2CH2NHBoc &NCH3, 27 H),  2.56 (br, 
COCH2CH2CO, 48 H), 2.35 (b, COCH2, 188 H), 1.42 (br, C(CH3)3, 108 H),1.12 (br, CH2CH3, 
282 H) 
FTIR: 2100 cm
-1
 (azide), 1703 cm
-1
 (C=O of t-butyl ester) 
 
 
 
PAOx(NHBoc-b-Et 15-84)N3 (15B): 
1
H NMR (CDCl3. 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.25 (br, 
CONHCH2CH2NHBoc, 30 H) 3.00 (br, CONHCH2CH2NHBoc &NCH3, 33 H), 2.56 (br, 
COCH2CH2CO, 60 H), 2.35 (b, COCH2, 168 H), 1.42 (br, C(CH3)3, 135 H),1.12 (br, CH2CH3, 
252 H) 
FTIR: 2100 cm
-1
 (azide), 1703 cm
-1
 (C=O of t-butyl ester) 
 
PAOx(NHBoc-b-Et 23-89)N3 (20B): 
1
H NMR (CDCl3. 500 MHz): δ 3.46 (br, NCH2CH2N, 408 H), 3.25 (br, 
CONHCH2CH2NHBoc, 46 H) 3.00 (br, CONHCH2CH2NHBoc &NCH3, 49 H), 2.56 (br, 
COCH2CH2CO, 69 H), 2.35 (b, COCH2, 178 H), 1.42 (br, C(CH3)3, 207 H), 1.12 (br, 
CH2CH3, 267 H) 
FTIR: 2100 cm
-1
 (azide), 1703 cm
-1
 (C=O of t-butyl ester) 
 
Synthesis of PAOx(Et-NH2)N3: removal of Boc protecting group 
500 mg PAOx (NHBoc-b-Et)N3 or PAOx(Et-NHBoc)N3 polymer was dissolved in 5 mL 
DCM and 5 mL TFA was added. The solution was stirred for 2 hours at room temperature and 
the solvent was evaporated. The polymer was dissolved in MeOH and precipitated twice in 
cold diethyl ether. The precipitated was collected and dissolved in MeOH. The solvent was 
evaporated yielding a colourless oil (95-99%).  
 
PAOx(Et-NH2 84-12)N3 (10G): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 384 H), 3.32&3.26 (br, 
CONHCH2CH2NH2, 24 H), 3.07 (br, CONHCH2CH2NH2 &NCH3, 27 H), 2.65 (br, 
COCH2CH2CO, 48 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 252 H) 
FTIR: 3465 cm
-1
 (NH2), 2100 cm
-1
 (azide) 
 
PAOx(Et-NH2 84-16)N3 (15G): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 400 H), 3.32&3.26 (br, 
CONHCH2CH2NH2, 32 H), 3.07 (br, CONHCH2CH2NH2 &NCH3, 35 H), 2.65 (br, 
COCH2CH2CO, 64 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 252 H) 
FTIR: 3465 cm
-1
 (NH2), 2100 cm
-1
 (azide) 
 
PAOx(Et-NH2 84-23)N3 (20G): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 421 H), 3.32&3.26 (br, 
CONHCH2CH2NH2, 46 H), 3.07 (br, CONHCH2CH2NH2 &NCH3, 49 H), 2.65 (br, 
COCH2CH2CO, 92 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 252 H) 
FTIR: 3465 cm
-1
 (NH2), 2100 cm
-1
 (azide) 
 
PAOx(NH2-b-Et 12-94)N3 (10B): 
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1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 424 H), 3.32&3.26 (br, 
CONHCH2CH2NH2, 24 H), 3.07 (br, CONHCH2CH2NH2 &NCH3, 27 H), 2.65 (br, 
COCH2CH2CO, 48 H), 2.35 (b, COCH2, 188 H), 1.12 (br, CH2CH3, 282 H) 
FTIR: 3465 cm
-1
 (NH2), 2100 cm
-1
 (azide) 
 
PAOx(NH2-b-Et 15-84)N3 (15B): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.32&3.26 (br, 
CONHCH2CH2NH2, 30 H), 3.07 (br, CONHCH2CH2NH2 &NCH3, 33 H), 2.65 (br, 
COCH2CH2CO, 60 H), 2.35 (b, COCH2, 168 H), 135 H),1.12 (br, CH2CH3, 252 H) 
FTIR: 3465 cm
-1
 (NH2), 2100 cm
-1
 (azide) 
 
 
PAOx(NH2-b-Et 23-89)N3 (20B): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 408 H), 3.32&3.26 (br, 
CONHCH2CH2NH2, 46 H), 3.07 (br, CONHCH2CH2NH2 &NCH3, 49 H), 2.6 (br, 
COCH2CH2CO, 69 H), 2.35 (b, COCH2, 178 H), 1.12 (br, CH2CH3, 267 H) 
FTIR: 3465 cm
-1
 (NH2), 2100 cm
-1
 (azide) 
 
Synthesis of PAOx(Et-guanidine)N3 or PAOx(Et-guanidine-FITC): Guanidinylation 
This reaction was performed according to a literature procedure.
38
 PAOx(NH2-b-Et)N3 or 
PAOx(Et-NH2)N3 polymer was dissolved in 2 mL 65 mM 1H-pyrazol-1-carboxaminidine 
hydrochloride. The pH was adjusted with 5% Na2CO3 solution to pH 9. The solution was 
stirred for 3 days at room temperature. The polymer was purified over Sephadex 25 and 
freeze dried, yielding a white fluffy powder (95-99%). 
 
PAOx(Et-guanidine 84-12)N3 (10G): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 384 H), 3.28 (br, 
CONHCH2CH2NH, 24 H), 3.07 (br, CONHCH2CH2NH &NCH3, 27 H), 2.65 (br, 
COCH2CH2CO, 48 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 252 H) 
FTIR: 2100 cm
-1
 (azide) 
 
PAOx(Et-guanidine 84-16)N3 (15G): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 400 H), 3.28 (br, 
CONHCH2CH2NH, 32 H), 3.07 (br, CONHCH2CH2NH &NCH3, 35 H), 2.65 (br, 
COCH2CH2CO, 64 H) 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 252 H) 
FTIR: 2100 cm
-1
 (azide) 
 
PAOx(Et-guanidine 84-23)N3 (20G): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 421 H), 3.28 (br, 
CONHCH2CH2NH, 46 H), 3.07 (br, CONHCH2CH2NH &NCH3, 49 H), 2.65 (br, 
COCH2CH2CO, 92 H), 2.35 (b, COCH2, 168 H), 1.12 (br, CH2CH3, 252 H) 
FTIR: 2100 cm
-1
 (azide) 
 
PAOx(guanidine-b-Et 12-94)N3 (10B): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 424 H), 3.28 (br, 
CONHCH2CH2NH, 24 H), 3.07 (br, CONHCH2CH2NH &NCH3, 27 H), 2.65 (br, 
COCH2CH2CO, 48 H) 2.35 (b, COCH2, 188 H), 1.12 (br, CH2CH3, 282 H) 
FTIR: 2100 cm
-1
 (azide) 
 
PAOx(guanidine-b-Et 15-84)N3 (15B): 
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1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 396 H), 3.28 (br, 
CONHCH2CH2NH, 30 H) 3.07 (br, CONHCH2CH2NH2 &NCH3, 33 H), 2.65 (br, 
COCH2CH2CO, 60 H) 2.35 (b, COCH2, 168 H), 135 H),1.12 (br, CH2CH3, 252 H) 
FTIR: 2100 cm
-1
 (azide) 
 
PAOx(guanidine-b-Et 23-89)N3 (20B): 
1
H NMR (MeOD-d4. 500 MHz): δ 3.46 (br, NCH2CH2N, 408 H), 3.28 (br, 
CONHCH2CH2NH, 46 H) 3.07 (br, CONHCH2CH2NH &NCH3, 49 H), 2.6 (br, 
COCH2CH2CO, 69 H) 2.35 (b, COCH2, 178 H), 1.12 (br, CH2CH3, 267 H) 
FTIR: 2100 cm
-1
 (azide) 
 
 
Synthesis of PAOx(Et-guanidine)FITC: FITC coupling by click chemistry 
0.33 g FITC-BCN was dissolved in 0.5 mL MeOH and added to PAOx(Et-guanidine)N3 or 
PAOx(guanidine-b-Et)N3 (0.95 eqv). The solution was stirred overnight. The solvent was 
evaporated and the polymer was dissolved in MilliQ. The polymer was purified over 
Sephadex 25 and freeze dried yielding a yellow fluffy powder (95-99%). FTIR measurements 
did not show a azide stretch anymore. 
 
Cell culture and cell viability assays 
Cell culture 
HeLa CCL-2 cells were maintained in sterile conditions in Dulbecco’s Modified Eagle’s 
medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS). Cells were 
maintained on tissue culture plastic and kept at 37 °C in a humidified atmosphere of 7.5% 
CO2. Cells were passaged every 2-3 days. Prior to cell viability assays or cellular uptake 
studies, cells within a confluent layer were detached using trypsin/EDTA. Cells were then 
resuspended in FCS-supplemented DMEM and the number of cells was counted using a 
standard inverted microscope and a cell counting chamber (Fuchs-Rosenthal). 
 
Cell viability assay 
Cell viability was evaluated using Cell Counting Kit-8 (CCK-8, Dojindo Molecular 
Technologies). HeLa cells were seeded in 96-well plates to obtain 40,000 cells/well the day of 
the experiment. On the day of the experiment, cells were incubated with a 100 μL solution of 
polymer FCS-supplemented DMEM for 90 minutes at 37 °C.  The polymer concentration was 
varied to study the optimal concentration for cellular uptake experiments, concentrations of 5, 
10 and 15 μM were used. After incubation, cells were washed 3 times with DMEM + 10% 
FCS and maintained in this solution after the last washing step. After 4 hours of incubation, 
the supernatant was removed and a solution of CCK-8 (10 % in DMEM + 10% FCS) was 
added. After 3 hours of incubation at 37 °C, the absorbance was measured at 490 nm using a 
microplate reader (Wallac Victor 1420 multilabel counter, Perkin Elmer). The experiments 
were performed in triplicate and repeated twice independently. Mean values +/- standard 
deviation are given in Figure 53. 
 
Confocal laser scanning microscopy 
HeLa cells were seeded in chambered coverslips (Nunc, Wiesbaden, Germany) at a density of 
40,000 cells (one day) or 20,000 cells per well (two days prior) to the experiment. Fluorescein 
was excited by an Argon laser at 488 nm and emission was collected between 500 and 550 
nm. Cells were incubated with the 5 µM or 10 µM polymer solutions for 90 min at 37 ºC.  
After incubation, cells were washed twice with DMEM + 10 % FCS and the living cells were 
analyzed immediately by confocal microscopy using a TCS SP5 confocal microscope (Leica 
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Microsystems, Mannheim, Germany) equipped with an HCX PL APO 63 x N.A. 1.2 water 
immersion lens. Fluorescein was excited by an argon laser at 488 nm and emission was 
collected between 500 and 550 nm. 
 
Flow cytometry 
HeLa cells were seeded in 24-well plates (Sarstedt, Numbrecht, Germany) one (80,000 
cells/well) or two (40,000 cells/well) days prior to the experiment. On the day of the 
experiment, cells were incubated with the polymer solutions (10 µM) for 90 min at 37 °C in 
RPMI (Roswell Park Memorial Institute medium) + 10% FCS. After washing the cells with 
HBS buffer pH 7.4 (10 mM HEPES, 135 mM NaCl, 5 mM KCl, 5 mM MgCl2, 1.8 mM 
CaCl2), cells were detached by trypsinisation for 5 minutes, spun down and resuspended in 
200 µL RPMI + 10% FCS. The fluorescence was measured using a FACS Calibur flow 
cytometer (BD Biosciences, Erembodegem, Belgium) and subsequently data was analysed 
with the Summit software (Fort Collins, U.S.A.). Results were based on 10,000 gated cells. 
 
Supplementary information 
 
Figure S 18: Confocal fluorescence (top) and transmission (bottom) images of a 5 µM uptake 
experiment of guanidine random copolymers, scale bar is 50 µm. 
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Figure S 19: Confocal fluorescence (top) and transmission images (bottom) of a 10 µM uptake 
experiment of guanidine random copolymers, scale bar is 50 µm. 
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Chapter 6 
 
Development of 
poly(2-oxazoline) 
based tissue tape 
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Abstract 
One of the main problems in abdominal surgery is the occurrence of leakages and related 
infections. A number of products are available to seal the wounds, but none of them has an 
excellent performance on all aspects. Here we present the development of a tissue tape based 
on poly(2-oxazoline)s, bearing N-hydroxysuccinimide (NHS) esters as tissue reactive groups. 
Two synthetic procedures were established for the preparation of NHS-ester functional 
poly(2-oxazoline)s. Also an amine functional polymer was made to provide crosslinking 
between the NHS-ester functionalised poly(2-oxazoline)s allowing to make self-standing 
crosslinked polymer films. Although these films provided tissue adhesion, a backing material 
was introduced to provide extra mechanical support and to avoid double-sided adhesion. In 
this way the strength of the films was significantly improved. Although we successfully 
demonstrated tissue adhesive properties, the reproducibility of the preliminary results was not 
optimal and the mechanical properties still need to be improved further. 
 
Introduction 
The efficient and reliable closure of internal and external surgical wounds is one of the 
greatest challenges in surgery. The traditional techniques using sutures and staples have 
improved in the last decades, but they still have limitations: the most common and serious one 
is leakage. Gastro-intestinal anastomoses, for example, have a 3-15% risk of leakage which 
can cause intra-abdominal abscesses, fistula, peritonitis and mortality.
1, 2
 A number of 
innovative materials are available and being developed to provide surgeons an alternative to 
the current wound closure procedures, although an optimal methodology has not been found 
yet. Wound-closure materials, which are normally described as haemostatic agents, sealants 
or adhesives, should meet a significant number of requirements; they must be safe, effective, 
easily usable, cheap, approved by the Food and Drug Administration (FDA) or labelled with a 
Conformité Européenne (European Community, CE) mark, biocompatible and biodegradable. 
From a mechanical point of view they should match the properties of the underlying tissue, 
they should have an acceptable swelling index and be shelf stable. Most available sealants are 
lacking in one or more of these requirements.
3-5
 
 
DuraSeal
TM
 Dural Sealant is a poly(ethylene glycol) (PEG)-based sealant used in combination 
with sutures to close the dural membrane after cranial surgery to prevent leakage of 
cerebrospinal fluid. This two-component system crosslinks spontaneously when the 
compounds are mixed. A four-armed star-PEG endcapped with N-hydroxysuccinimide (NHS) 
esters reacts with trilysine, a tetra-amine crosslinker, yielding a watertight crosslinked 
network within seconds.
3-9
 The NHS ester is an activated ester which can react with the 
amines present in the crosslinker and amines present in the tissue, allowing covalent binding 
of the tissue adhesive and the underlying tissue. The adhesion of the DuraSeal product is 
excellent, but the cohesion is weak. This is due to the poor mechanical properties of PEG, it 
has a low glass transition temperature (Tg< -40 °C) and a tendency to crystallize into a brittle 
material.
3, 10
 Also important is that the functional groups on the PEG polymer are only present 
at the termini, so a maximum of 2, 4 or 8 groups for linear, 4-arm star or 8-arm star PEG 
respectively, can be introduced. 
 
In order to significantly improve on the existing Duraseal
TM
 technology, we aimed to develop 
a tissue adhesive material with increased crosslink density, based on poly(2-alkyl/aryl-2-
oxazoline)s (PAOx), a biocompatible polymer
11-13
 containing side chain NHS esters (Figure 
57). By crosslinking the PAOx-NHS polymers with trilysine or by a poly(2-oxazoline) with 
side chain amine functionality, it was expected that a mechanically robust self-standing 
polymeric tape could be formed. The material properties of this film could furthermore be 
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adjusted by controlling the content of NHS, the overall monomer composition of the polymers 
and by adding different ratios of amine-based crosslinker. The adhesion properties of the tape 
would originate from the remaining activated esters on its surface that can react with amines 
found on the lysine residues of any protein in tissue, providing covalent conjugation. In this 
chapter the synthetic procedures toward NHS- functional PAOx are described as well as their 
application in preliminary tissue tape preparations. 
 
 
Figure 57: Design of a poly(2-alkyl/aryl-2-oxazoline) based tissue tape consisting of side chain 
functionalised polymers containing NHS or amine groups. 
 
Results and discussion 
In order to prepare a PAOx tissue tape, both an NHS-ester functional and amine-functional 
PAOx had to be synthesised. Two approaches were followed (Scheme 13). The first route 
started with commercially available poly(2-ethyl-oxazoline) (PEtOx, Aquazol 50), which was 
first partially hydrolysed to the corresponding secondary amine backbone,
14-16
 and 
subsequently modified via an amidation reaction to the desired PAOx.
17
 In the second 
approach, the functionalities were directly introduced during the polymerisation of PAOx.
13, 
18-23
 
 
Partial hydrolysis route 
PEtOx was partially hydrolysed using acidic conditions,
15-17, 24
 yielding a copolymer of PEtOx 
and poly(ethylene imine) (PEtOx-PEI, 1). The secondary amines of the PEtOx-PEI backbone 
were used for further functionalisation, by a coupling reaction with methyl succinyl chloride 
to yield a methyl ester-functionalised polymer, (PEtOx-COOMe, 2). Subsequently, the methyl 
esters were removed by hydrolysis with lithium hydroxide, yielding an acid-functionalised 
polymer, PEtOx-COOH (3). These carboxylic acids were finally functionalised with NHS 
using carbodiimide chemistry, yielding PAOx-NHS (4). 
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Scheme 13: PAOx-NHS synthesis via partial hydrolysis of poly(2-ethyl-2-oxazoline) 
 
Hydrolysis of PEtOx has been extensively studied,
16, 24
 and it was demonstrated that this 
process is independent of chain length, but highly dependent on temperature. The hydrolysis 
conversion after 120 minutes is 97% at an internal reaction temperature of 100 °C, 54% at 90 
°C, 14% at 73 °C and only 4% at 57 °C.
24
 By choosing reaction time and temperature, the 
degree of hydrolysis can thus be tuned. Because we aimed for a hydrolysis degree of 
maximum 20% to have a reasonable amount of crosslinkable groups, but avoiding high 
crosslink densities leading to very stiff materials, we selected 73 °C to have a controlled 
hydrolysis. We first determined the hydrolysis kinetics of Aquazol® 50, a commercially 
available PEtOx with a weight average molecular weight of 50 kDa and a dispersity of 3-4. 
(Figure 58). Kinetics reported in literature
24
 were performed with 2.38 g of Aquazol; as we 
performed the hydrolysis at a large scale using 25 g of Aquazol, more time was needed to heat 
up the entire reaction mixture to 73 °C, which led to a slower rate of hydrolysis at the start of 
the reaction. 
 
Figure 58: Hydrolysis kinetics of Aquazol® 50 at 73 °C for 25 g of polymer in 526 mL of 5.8 M HCl 
solution (amide concentration of 0.48 M) 
 
The degree of hydrolysis was not perfectly controllable with this method, and it was also 
affected by temperature fluctuations of the oil bath. To minimize these fluctuations, the 
temperature was controlled with a temperature probe in the oil bath and regularly checking 
the internal temperature and adjusting the probe temperature if necessary. For example, when 
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aiming at 5% hydrolysis, the final degree of hydrolysis was between 4 and 7.5%, when 
aiming for 10% hydrolysis, the final degree of hydrolysis was 9-12% and when aiming for 
20% hydrolysis 16-24% hydrolysis was observed. 
 
The resulting amine of the PEI was reacted with methyl succinyl chloride in the presence of 
triethyl amine to obtain the methyl ester functionalised polymer PEtOx-COOMe. 
Subsequently, the methyl ester was hydrolysed with LiOH to the corresponding carboxylic 
acid PEtOx-COOH. Both polymers were obtained with quantitative conversions according to 
1
H NMR spectroscopy. 
 
The NHS ester was first installed using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC), which was removed by washing with water. The purification procedure however also 
resulted in some loss of NHS from the polymer. Therefore, EDC was replaced by diisopropyl 
carbodiimide (DIC), which could efficiently be removed by precipitation of the polymer in 
diethyl ether. The NHS-ester content was subsequently determined by 
1
H NMR and UV-Vis 
spectroscopy.
25
 
 
In Table 10 an overview is given of the aimed degree of hydrolysis, the obtained degree of 
hydrolysis (PEI peaks in 
1
H NMR at δ 2.8 ppm), and the methyl ester (1H NMR peaks at δ 
3.65 and 2.6 ppm), carboxylic acid (
1
H NMR peak at δ 2.6 ppm) and NHS content (1H NMR 
peaks at δ 2.9 ppm) obtained after purification. All modifications were determined by 1H 
NMR spectroscopy, except for the NHS content, which was determined both by UV-Vis 
spectroscopy and 
1
H NMR spectroscopy. Because the NMR results were more variable, and 
the UV measurements showed better reproducibility, the UV-values were used for further 
experiments. The table clearly shows the NHS polymers still contained some free carboxylic 
acid. Figure 59 depicts the 
1
H NMR spectra of the different modification stages. 
 
Table 10: Degree of hydrolysis of  poly(2-ethyl-2-oxazoline): aimed vs obtained percentages and 
functionalisation with NHS. PEI: poly(ethylene imine) 
 
Aimed PEI 
content (%) 
PEI content 
obtained (%) 
Methyl ester content 
(%) 
COOH content (%) NHS content obtained 
(UV/NMR %) 
5 5.6 5.6 5.6 5.3 / 4.2 
5 7.2 7.2 7.2 4.4 / 6.1 
5 7.4 7.4 7.4 6.6 / 5.7 
10 11.0 11 11 8.5 / 7.5 
10 12.0 12 12 11.9 / 6.5 
20 24.0 24 24 23.0 / 26.5 
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Figure 59: 
1
H NMR spectra from top to bottom of PEtOx, PEtOx-PEI, PEtOx-COOMe, PEtOx-COOH 
and PEtOx-NHS 
 
 
Figure 60: Amidation of PEtOx-COOMe with ethylene diamine to yield PEtOx-NH2 
 
PEtOx, side chain-functionalised with amines was easily prepared by reacting PEtOx-
COOMe with ethylene diamine to yield PAOx-NH2 (Figure 60). This reaction was performed 
in bulk, and 30 equivalents of ethylene diamine vs methyl ester were added to avoid coupling 
of polymer chains. A kinetic study revealed that the methyl ester was not fully converted after 
6 hours, but it was after 17 hours, based on the disappearance of the methyl ester resonance in 
1
H NMR (δ = 3.65 ppm) . This reaction proceeded faster than literature reports indicated.26 
Despite the large excess of ethylene diamine, polymers containing more than 20% methyl 
esters were partially crosslinked using this procedure, indicated by the presence of gel parts 
after redissolution of the polymer. 
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Figure 61: 
1
H NMR spectrum of PAOx-NH2 
 
Monomer route 
The second developed synthesis route entailed the copolymerisation of a 2-alkyl-2-oxazoline 
and a methyl ester-functional 2-oxazoline monomer, namely 2-methoxycarbonylethyl-2-
oxazoline (MestOx). As both the acid and NHS ester functionalities were incompatible with 
cationic ring opening polymerisation (CROP) the methyl ester functional polymer was used as 
starting point for further modification. Although the partial hydrolysis route, described above, 
is faster, its lack of reproducibility is a big problem for biomedical applications. Furthermore, 
with the CROP method the ratios of functional and alkyl monomers can be controlled more 
precisely by addition of the right amounts of those monomers in the polymerisation mixture 
and the length of the polymer can be controlled by the monomer to initiator [M]/[I] ratio. The 
polymers obtained by this route are more defined than Aquazol and do not contain a molar 
mass fraction (Mn>40 kDa) that cannot be excreted by the kidneys. Here we used a MestOx 
content of 10 mol% for 2-n-propyl-2-oxazoline (nPropOx) copolymers, and 25, 50 or 75 
mol% for 2-methyl-2oxaozline (MeOx) and EtOx copolymers; in all cases an [M]/[I] ratio of 
100:1 was used. 
MestOx homo- and copolymerisations were performed as described in chapter 3.  
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Figure 62: Copolymerisation of MestOx with MeOx (R = CH3), EtOx ((R = CH2CH3) or nPropOx (R 
= CH2CH2CH3) and subsequent functionalisation towards PAOx-NHS 
 
Subsequently, the methyl esters of the copolymers were hydrolysed to the corresponding 
carboxylic acid and NHS was coupled (Figure 62). Unfortunately the NHS coupling to MeOx 
copolymers did not succeed, probably due to the presence of water in the very hygroscopic 
polymer; research was therefore continued with the nPropOx copolymers of which all 
MestOx groups were successfully converted into NHS esters (Table 11). 
 
As alternative strategy, the methyl esters of PMestOx homopolymers were partially 
hydrolysed to the carboxylic acid by the addition of stoichiometric amounts of LiOH to the 
percentage to be hydrolysed (Figure 63). The degree of hydrolysis was determined by 
1
H 
NMR spectroscopy and is listed in Table 11. Subsequently NHS was coupled to these 
polymers, yielding P(MestOx-NHS) copolymers. 
PAOx-NH2 based on the monomer route was prepared in the same way as described before. 
The P(EtOx77-MestOx11) copolymer (Ð=1.35) was dissolved in an excess of ethylene diamine 
and stirred overnight to get PEtOx-NH2. 
 
Table 11: Methyl ester hydrolysis of PMestOx homo and copolymers, DP 100, to carboxylic acid, 
followed by NHS modification 
# NHS content was only determined by 
1
H NMR spectroscopy. 
* Reaction to NHS was not performed. 
a. monomer ratios were determined by 
1
H NMR spectroscopy 
Polymer 
a
 Ð Added equivalents 
of LiOH 
Obtained degree 
of hydrolysis (%) 
NHS content obtained 
(NMR / UV, %) 
P(MeOx70-MestOx23) 117 20 24 0 
P(MeOx50-MestOx49) 1.16 20 49 0 
P(MeOx21-MestOx57) 1.15 20 73 0 
P(EtOx73-MestOx23) 1.15 20 25 * 
P(EtOx42-MestOx36) 1.16 20 46 * 
P(EtOx25-MestOx76) 1.15 20 76 75# 
P(nPropOx87-MestOx10) 1.40 2 10 10 / 10 
PMestOx95 1.15 0.252 23.7 25# 
PMestOx95 1.15 0.498 48.0 49# 
PMestOx95 1.15 0.753 74.0 74# 
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Figure 63: Partial hydrolysis of the methyl esters of PMestOx 
 
After preparing the NHS- and amine-functional poly(2-oxazoline)s the next steps in the 
procedure toward a tissue tape material were solvent casting of the polymers on a backing 
material and a crosslinking step between the amine- and NHS-functional polymers. In order to 
determine the stability of PAOx-NHS polymers under casting conditions from methanol 
(alcohols are the preferred casting solvents), PAOx (nProp-NHS 11%) was dissolved in 
deuterated methanol and NHS loss in time was determined by 
1
H NMR spectroscopy by 
quantifying the residual bound NHS (Figure 64). After 90 minutes only 2% of the NHS 
groups was lost, which increased to 55% after 5 days. As film formation is a fast process, this 
was considered not to be a problem. 
 
Figure 64: Stability of PAOx (nProp-NHS 11%) in methanol-d4 after 90 minutes (A) and 5 days (B) 
 
The measurement was repeated in deuterated water at 23 °C, in order to avoid precipitation of 
the polymer as a result of its LCST behavior. In 93 minutes 12.4% of the NHS groups was 
hydrolysed (Figure 65), indicating water should be avoided during the casting step. 
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Figure 65: Stability of PAOx (nProp-NHS 11%) in deuterated water 
 
Crosslinking tests 
To test the reactivity of the NHS-ester functionalised polymers, PAOx-NHS 12.0% was 
dissolved in absolute ethanol (EtOH) and mixed with a solution containing PAOx-NH2 
11.9%. Both polymers were prepared by the partial hydrolysis route. The crosslinking 
reaction was tested using stock solutions of both polymers (28.3 mg/mL for the PAOx-NH2-
polymer and 30.2 mg/mL for the PAOx-NHS polymer) to ensure that every reaction had the 
same NHS:NH2 ratio of 1:1. In order to investigate the pH dependence of the reaction 
different amounts of triethylamine (Et3N) were added to vary the pH from 7 to 11. The 
formation of amide bonds only takes place under basic conditions as part of the amines need 
to be present as free base,
27
 on the other hand the NHS esters do not allow high pH values; the 
half-life of hydrolysis in water is 4-5 hours at pH 7.0 and 0 °C, while at pH 8.6 and 4 °C the 
half-life drastically decreases to 10 minutes.
28
 The crosslink times were determined by a tube 
inversion test to check when the material formed a gel. Crosslinking proceeded faster when 
the pH was increased (Figure 66), from pH 9 or higher the crosslink times did not change 
anymore. As pH values get higher and are coming closer to the pKa of amines, between 10 
and 11, more of the amines become available as free base amines, increasing their reactivity. 
Although the values tested here are probably still below this pKa, still more than half of the 
amines is present as –NH2 group. For higher pH values, the increased percentage of free 
amines might be counterbalanced by the loss of NHS esters, because these become more 
unstable at higher pH values; although absolute ethanol was used, the presence of water 
during processing could not be completely excluded due to the hygroscopic properties of the 
solvent and the polymers. Solutions within the pH range of 7.5-8.5 proved to be optimal for 
the crosslinking reactions as the crosslinking was fast and hydrolysis was minimal. 
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Figure 66: pH dependence of crosslinking of PAOx-NHS 12.0% with PAOx-NH2 11.9% with an 
NHS:NH2 ratio of 1:1 at a polymer concentration of 30 mg/mL. 
 
Tape formation and adhesion tests  
Similar to the crosslink tests, PAOx-NHS and PAOx-NH2 were dissolved separately with a 
concentration of 100 mg/mL and mixed together. Next, the solution was cast into a mold and 
the solvent was allowed to evaporate overnight. The NHS:NH2 ratios were varied to obtain 
tapes with excess of NHS groups to introduce tissue adhesiveness. The adhesive strength of 
these tapes was tested on a home-made adhesion test set up (Figure 67). A piece of 
peritoneum tissue containing a small incision was mounted on top of an Erlenmeyer flask 
which was connected to a burette. After pressing the tape onto the bovine peritoneum tissue, 
pressure was increased by the addition of water to the burette until leakage occurred at the 
tissue, which could be either the result of burst or adhesion failure; the height of the water 
column at this point was noted as burst pressure. 
 
Figure 67: Adhesion test set up with 1) burette, 2) Erlenmeyer flask and 3) tissue or collagen sheet 
with a 3 mm incision 
 
Tape formation with polymers prepared by the partial hydrolysis route 
A range of different tapes was produced, in which the type of crosslinker, the crosslink 
density and the amount of free NHS groups was varied (Table 12). A number of control 
experiments were performed and these confirmed that the adhesion was due to the presence of 
NHS esters and crosslinks in the polymer film. A tape consisting only of PAOx-NHS (entry 
2) also adhered well, but dissolved as soon as pressure was built up, while a fully crosslinked 
tape without any residual NHS groups did not adhere at all (entry 3). Also a tape consisting of 
only Aquazol 50 (entry 1) dissolved upon the addition of water. All determined burst 
pressures can be found in Table 12. These results show that the concept of the PAOx based 
tissue tape works. The use of PAOx-NH2 resulted in a higher burst pressure than with trilysine 
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as crosslinker, so therefore the polymeric crosslinker is preferred, which may be expected 
based on the higher obtainable cross-link density. 
 
Table 12: Burst pressures of PAOx tapes prepared by partial hydrolysis route 
Entry Ratio PAOx-
NHS 
(%) 
PAOx-
NH2 
(%) 
Height water 
column (cm) 
Leakage by Adhesion Remarks 
NHS NH2 
1 1 0 0 - 4 Adhesion Bad Film dissolved very fast 
2 1 0 4.4 - 5 Burst Good Film dissolved very fast 
3 1 1 4.4 K3* 5 Adhesion Bad, 
slippery 
 
4 5 1 4.4 K3* 15 Adhesion Good  
5 5 1 4.4 12 31.5# Burst Good  
6 2 1 23 6 N.D. Adhesion Bad, 
slippery 
 
7 5 1 23 6 22.5# Burst Good  
8 10 1 23 6 15 Adhesion Good  
9 3 1 11.9 12 N.D. Adhesion Bad, 
slippery 
 
10 5 1 11.9 12 24 Adhesion Good  
# Tape contained an air bubble and this caused the burst 
- Some burst pressures were not determined because of a lack of adhesion 
* K3: trilysine 
 
The disadvantage of all these investigated PAOx tapes was their high degree of swelling upon 
contact with water and their double sided adhesion which makes them not applicable in the 
body because of the risk of nerve and blood vessel compression and unwanted adhesions of 
tissues. To avoid these problems, a backing material was introduced to the design to give both 
mechanical support and prevent undesired adhesion. As backing material the biodegradable 
polymer poly(lactic-co-glycolic acid) (PLGA) was chosen. 
 
To cast PLGA films, first PLGA 69:31 and PLGA 50:50 were dissolved in either EtOH or 
DCM. The polymers did not dissolve well in EtOH, but excellently dissolved in DCM. After 
casting, the films were dried overnight. Casting PLGA 50:50 resulted in non-flat films, while 
PLGA 69:31 yielded flat transparent films. The adhesive layer consisting of PAOx-NHS 8.5% 
and PAOx-NH2 7.4%was cast directly onto the PLGA films from EtOH. These tapes (5.0x6.3 
cm) were cut into four equal pieces for adhesive testing. The thickness of the backing was 
also varied (entry 1 and 2, Table 13). The tapes with the PLGA backing yielded adhesive 
tapes with higher burst pressures than the pure PAOx tapes (Table 13), showing the 
mechanical support of the backing material. The reproducibility of these materials however 
proved troublesome (entry 3 and 4). When the thickness of the adhesive layer was decreased 
(entry 5+6), worse results were obtained. When the backing material was made thinner, this 
increased the strength of the tapes. This can be explained by the fact that this led to less stiff 
tapes which showed better adhesion. After the burst pressure was reached, a gel was observed 
on the tissue and the backing, which could be easily removed from this backing, caused by 
delamination of the adhesive layer and the backing. Although still some work has to be done, 
the introduction of a backing was found to improve the burst pressure. 
 
  
133 
 
Table 13: burst pressures of PLGA backing tapes using PAOx-NHS 8.5% and PAOx-NH2 7.4% 
polymers prepared by the partial hydrolysis route, with an NHS:NH2 ratio of 5:1 
Entry Amount 
PLGA 
(g) 
Amount 
PAOx 
(mg) 
Average water 
column (cm) 
Number of 
experiments 
1 0.5 285 45 ± 10 2 # 
2 1 285 >39.1 ± 12.4 4 * 
3 0.5 285 16.3 ± 8.4 3 § 
4 1 285 18.5 ± 10.8 4 
5 0.5 143 10.5 ± 2.3 3 §  
6 1 143 9.7 ± 1.3 4 
7 0.2 ¥ 285 24 ± 3 2 
# Adhesive layer partially delaminated from backing, so only 2 tapes could be tested 
* 61.5 cm is the maximum height of the column, reached in one of the measurements 
§ One of the four tapes was not used because of the presence of an air bubble 
¥ tape of 5.0x5.0 cm 
 
Tape formation with polymers prepared with the copolymerisation route 
Because the previously described backing materials are stiff, a more flexible polymer was 
mixed into the films together with PAOx-NH2 to provide covalent attachment of the adhesive 
layer to the backing material, avoiding delamination or detachment during the adhesion test. 
Therefore commercially available PLGA 75:25 and poly(L-lactide-co-caprolactone) 70:30 
(PLC) were mixed, starting with 50:50 mass ratios and to this mixture different amounts of 
PAOx-NH2 were added. The films with a low percentage (5 or 10 wt% of PAOx-NH2 10%) of 
this latter polymer had good mechanical properties, while the rest appeared brittle. All films 
were tested for the presence of amines on the surface with nynhydrin and turned blue 
confirming the presence of amines. Films consisting of only PLGA or PLGA and PLC did not 
colour by nynhydrin staining. 
 
The adhesive layer can be applied to the backing using different techniques. Solvent casting 
on top of the backing material is described above. The second method involved the use of 
coating bars which allowed to spread a thin and even layer over the backing. This method, 
however, was not successful, because the backing partially dissolved in the used DCM or the 
coating was uneven due to a not completely flat backing. Another possibility is to spray a 
polymeric solution onto the backing using a paint brush. When spraying a polymer solution in 
DCM on the backing, the backing stayed intact, but it was hard to control the amount of 
polymer which was sprayed onto it. The adhesion strength to collagen sheets of as-such 
prepared tapes was also not good. A final casting procedure that was investigated was to 
prepare the backing and the adhesive layer separately, after which they were bonded by hot-
pressing both parts together. PAOx(MestOx-NHS 75-25) and PAOx(Et-NH2 10%) with an 
NHS:NH2 ratio of 5:1 were used for the preparation of the adhesive layers. The advantage of 
this method is that it allows more freedom in the choice of solvents to make the separate parts. 
Unfortunately, these tapes did not stick onto the collagen sheets used for the adhesion test. So 
therefore the casting on top of the backing method was used for the further preparation of 
tapes. 
 
Tapes containing PAOx(nProp-NHS) adhered very well to collagen, so for these the influence 
of casting solvent and drying time was investigated. Tapes with an NHS:NH2 ratio of 5:1 
were cast from methanol (MeOH), ethanol (EtOH), 1-propanol (1PrOH) or 2-propanol 
(2PrOH) and ratios of 3:1 and 7:1 were cast from methanol, all onto a backing consisting of 
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PLGA:PLC 50:50 plus 10 wt% PAOx(Et-NH2 10%). Each film was made in triplicate, cut 
into 4 pieces which were tested in the adhesion test after one, two, three and six nights of 
drying at 40 °C. The burst pressures can be found in Table 14. 2-Propanol and 1-propanol 
gave the highest burst pressures. Propanol is less hydrophilic than ethanol and methanol, and 
is therefore better compatible with the slightly hydrophobic NHS groups. When dissolved in 
propanol the polymer is probably better solvated than in ethanol or methanol and therefore the 
NHS groups are more available for the amidation reaction by the amines in the tissue. The 7:1 
NHS:NH2 ratio was an improvement compared to 5:1, also here more NHS groups are 
available for reaction with tissue, but more ratios need to be studied in future work to find the 
optimum conditions. The drying time also seem to influence the burst pressure, but this effect 
was not reproducible. 
 
Table 14: burst pressures of tapes prepared of PAOx(nProp-NHS 10%) and PAOx(Et-NH2 12%) on 
PLGA:PLC 50:50 + 10 wt% PAOx(Et-NH2 12%) backings. PAOx polymers prepared by 
copolymerisation route 
NHS:   cm H2O after x days of drying Averages 
NH2 Solvent 1 day 2 days 3 days 6 days 1 day 2 days 3 days 6 days Per film Per type 
5:1 MeOH 23.5 41.0 59.0 53.0         44.1±11.9   
5:1 MeOH 29.0 24.0 60.0 23.0 21.2 34.5 46.0 36 34.0±13.0 34.4±13.2 
5:1 MeOH 11.0 38.5 19.0 32.0  ± 6.8  ± 7.0  ±18.0  ± 11.3 25.1±10.1   
                        
5:1 EtOH 25.0 15.0 13.0 23.0         19.0±5.0   
5:1 EtOH 30.0 15.0 23.0 35.0 27.8 23.7 19.3 28.0 25.8±6.8 24.7±6.2 
5:1 EtOH 28.5 41.0 22.0 26.0  ± 1.9  ± 11.6  ± 4.2  ± 4.7 29.4±5.8   
                        
5:1 1PrOH 60.0 23.0 45.0 23.0         37.8±14.8   
5:1 1PrOH 60.0 45.0 59.0 60.0 60.5 34.0 55.2 46.3 56.0±5.5 49.0±12.5 
5:1 1PrOH 61.5 34.0 61.5 56.0  ± 0.7  ± 7.3  ± 6.8  ±15.6 53.3±9.6   
                        
5:1 2PrOH 28.0 46.0 41.5 45.0         40.1±6.1   
5:1 2PrOH 40.0 61.5 61.5 61.5 39.3 51.5 54.8 53.7 56.1±8.1 49.8±8.6 
5:1 2PrOH 50.0 47.0 61.5 54.5  ± 7.6  ± 6.7  ± 8.9  ± 5.8 53.3±4.8   
                        
3:1 MeOH 57.0 56.0 30.0 48.5         47.9±8.9   
3:1 MeOH 15.0# 29.0 27.0 39.0 45.5 47.3 26.0 36.2 31.7±4.9 38.1±12.1 
3:1 MeOH 34.0 57.0 21.0 21.0  ± 11.5  ± 12.2  ± 3.3  ±10.1 33.3±12.3   
                        
7:1 MeOH 60.0 52.0 40.0 32.0         46.0±10.0   
7:1 MeOH 61.5 55.0 61.5 60.5 50.8 46.0 48.8 40.2 59.6±2.3 46.5±12.0 
7:1 MeOH 31.0 31.0 45.0 28.0  ± 13.2  ± 10.0  ± 8.4  ±13.6 33.8±5.6   
# tape dropped into water before testing, and was excluded from averages 
 
Because an NHS:NH2 ratio of 7:1 gave high burst pressures, new tapes were prepared with a 
7:1 and 5:1 ratio, cast from 2-propanol and dried for 2 days. Again, each film was cut into 
four pieces and tested (Table 15). This time the 5:1 ratio had a higher burst pressure (41.6 cm 
H2O) than the 7:1 (35.2 cm H2O) and the values were lower than for the previous test, 
although the variability is large, showing the limited reproducibility of the adhesive strength 
of these films. A possible explanation can be that the conditions in the lab were a little bit 
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different, e.g. temperature and humidity. Furthermore, the preparation procedure is not well 
standardized.  
 
Table 15: Burst pressures of tapes consisting of PAOx(nProp-NHS 10%) and PAOx(Et-NH2 10%) cast 
from 2-PrOH with different NHS:NH2 ratios 
Film NHS:NH2 
ratio 
Average burst 
pressure of 4 
film (cm H2O) 
1 7:1 33.9 ± 13.8 
2 7:1 31.5 ± 2.5 
3 7:1 40.1 ± 12.6 
4 5:1 36.0 ± 11.0 
5 5:1 46.1 ± 10.6 
6 5:1 42.3 ± 6.3 
 
In a final set of experiments tapes were prepared with a polymer with a higher NHS content, 
namely PAOx(nProp-NHS 30%). Because the solubility of this polymer in 2-propanol was 
lower, DCM (5 v/v%) was added. The burst pressures can be found in Table 16. In this 
experiment the 7:1 ratios adhered better (average of 30.6 cm H2O) than the 5:1 sample 
(average of 22.0 cm H2O) of which 3 of the 8 pieces did not stick at all, also here variability is 
large. This result cannot be explained by the usage of DCM, as an incubation experiment of 
the backing material with DCM-propanol showed that up to 20% of DCM in the solution was 
well tolerated. Higher percentages of DCM resulted in the dissolution of the backing material. 
The variation in burst pressure is due to the hard to reproduce preparation conditions. 
 
Table 16: Burst pressures of films consisting of PAOx(nProp-NHS 30%) and PAOx(Et-NH2 10%) cast 
from 2-PrOH:DCM 95:5 with different NHS:NH2 ratios 
Film NHS:NH2 
ratio 
Average Burst 
pressures (cm H2O) 
Number of experiments 
1 5:1 20 ± 8.0 2 # 
2 5:1 25.0 ± 8.7 3 # 
3 7:1 29.3± 15.4 4 
4 7:1 32.0±13.5 4 
#: Other films out of four did not stick and were excluded for calculating the average 
 
Conclusions and outlook 
Synthetic routes for N-hydroxysuccinimide-ester functionalised poly(2-oxazoline)s and amine 
functionalised poly(2-oxazoline)s were established. The rate of crosslinking of these two 
polymers is pH dependent with an optimum of pH 7.5-8.5 for fast crosslinking, with a 
minimum loss of NHS esters due to high pH values. Polymeric tapes required crosslinking to 
avoid fast dissolution at contact with fluids, however complete crosslinking yielded non-
sticking tapes. An NHS:NH2 ratio of 5:1 to 7:1 seemed to be optimal, but higher contents of 
NHS need to be tested. Addition of polyester backing materials, containing some PAOx-NH2 
to covalently link it to the adhesive layer, significantly improved the mechanical properties of 
the adhesive films, although the ratios of PLGA and PLC and NH2 content have to be 
optimised. The solvent used for casting the adhesive layer on top of the backing greatly 
influenced the burst pressure, with 1-propanol and 2-propanol proving the best solvents. 
Unfortunately, the standard deviation of the adhesion of the films was high, obstructing in 
depth evaluation of the effect of varying the tape composition. Detailed studies have to be 
performed to find causes and solutions for this problem.  
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Experimental 
 
Materials  
Aquazol® 50 was kindly donated by Polymer Chemistry Innovations. PLGA 69:31 and 
PLGA 50:50 were kindly donated by Encapson. PLGA 75-25 (PDLG 7507) and PLC 70-30 
(7015) were purchased from Purac. 2-Chloroethylamine hydrochloride, methyl p-
toluenesulfonate (MeOTs) and sodium tetraborate were purchased from Acros Organics. 
EDC.HCl was purchased from Fluka. DIC was purchased from Biosolve and sodium 
carbonate was purchased from Fischer Chemical. All other reagents were purchased from 
Sigma Aldrich and used as received, except 2-methyl-2-oxazoline (MeOx), 2-ethyl-2-
oxazoline (EtOx) and methyl p-toluenesulfonate (MeOTs). These were purified by distillation 
over barium oxide and stored under argon. Dry solvents were obtained from a solvent 
purification system from MBraun MB SPS800 system under nitrogen atmosphere. 
Triethylamine was distilled over CaH2 under argon atmosphere. 
 
Instrumentation 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker DMC300 (300 MHz 
for 
1
H, 75 MHz for 
13
C) or a Bruker DMX 500 (500 MHz for 
1
H, 125 MHz for 
13
C). 
 
Electro spray ionisation mass (ESI MS) spectra were recorded on a Thermo Finnigan LCQ 
Advantage Max. 
 
Polymerisations were carried out in a Biotage Initiator Microwave System with Robot Eight 
utilizing capped reaction vials. These vials were heated to 140 °C overnight, allowed to cool 
to room temperature and filled with argon prior to use. All microwave polymerizations were 
performed with temperature control (IR sensor). 
 
Size exclusion chromatography (SEC) was performed on an Agilent 1260 - series HPLC 
system equipped with a 1260 online degasser, a 1260 ISO-pump, a 1260 automatic liquid 
sampler, a thermostatted column compartment, a 1260 diode array detector (DAD) and a 1260 
refractive index detector (RID). Analyses were performed on a PSS Gram30 column in series 
with a PSS Gram1000 column at 50 °C. N,N-dimethylacetamide (DMA), containing 50 mM 
of LiCl, was used as an eluent, at a flow rate of 0.593 ml min
-1
. The SEC traces were analysed 
using the Agilent Chemstation software with the GPC add on. Number average molecular 
weights (Mn) and dispersity (Ð) values were calculated against poly(methyl methacrylate) 
PMMA standards. 
 
Partial hydrolysis route 
Hydrolysis kinetics 
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Aquazol 50 (25 g) was allowed to dissolve in 263 mL water at 60 °C for 1 hour. 263 mL 
concentrated HCl was added and the oil bath was put at 90 °C and the internal temperature 
was monitored and kept constant at 73 °C. This temperature was reached in 10 minutes. 
Samples of the reaction were taken regularly and neutralised to pH 7-9. The solvent was 
evaporated and the residue was dissolved in deuterated methanol. The degree of hydrolysis 
was determined by 
1
H NMR spectroscopy using the signals of the backbone of the 
polyoxazoline (at δ=3.5 ppm), PEI signals (δ=2.8 ppm) and the remaining CH2 group in the 
PEtOx side chain (δ=2.4 ppm); both values were averaged. 
 
PAOx-PEI synthesis 
Aquazol 50 (25 g) was allowed to dissolve in 263 mL water at 60 °C for 1 hour. 263 mL 
concentrated HCl was added and the oil bath was put at 90 °C and the internal temperature 
was monitored and kept constant at 73 °C. This temperature was reached in 10 minutes. The 
temperature was kept for the required amount of time. After this, the reaction mixture was 
concentrated until a viscous solution was obtained. This was neutralised with 4 M NaOH till 
pH 10-11. Water was evaporated until saturation was almost reached. The work up procedure 
depends on the degree of hydrolysis. Up to 10%, DCM was added and the polymer was 
extracted into the organic phase. The aqueous layer was washed a second time with DCM. 
From 10 to 20% hydrolysis, DCM and 5 % aqueous Na2CO3 solution were added and the 
polymer was extracted. The water layer was washed a second time with DCM. Above 20-25% 
hydrolysis, the polymer was first collected by freeze drying. DCM was added to dissolve the 
polymer. The remaining salts were filtered off and the organic phase was washed with 5% 
Na2CO3 solution twice. 
The combined organic layers were dried over Na2SO4 and the solvent was evaporated, 
yielding a white foam. 
1
H NMR (500 MHz, CD3OD): δ 3.45 (N(COCH2)CH2CH2), 2.80 (NHCH2CH2), 2.40 
(COCH2), 1.11 (CH3). 
 
PAOx-COOMe synthesis 
PAOx-PEI was dissolved in DCM (minimum 6.3 mL/ g polymer) and cooled on an ice bath. 
Triethylamine (2.5 eq) was added and methyl succinyl chloride (2 eq) was added dropwise in 
20 minutes. The reaction was stirred overnight. The brown reaction mixture was washed with 
twice 5% Na2CO3 solution and the organic phase was dried over Na2SO4. The solution was 
concentrated and the polymer was precipitated twice in cold diethyl ether, yielding a brown 
polymer. 
1
H NMR (500 MHz, CDCl3): δ 3.63 (COOCH3), 3.44 (NCH2CH2), 2.62 
(COCH2CH2COCH3), 2.33 (COCH2CH3), 1.11 (CH2CH3) 
 
PAOx-COOH synthesis 
PAOx-COOMe was dissolved in MeOH (10 mL/ g polymer) and water (10 mL/g polymer). 
20 equivalents (to methyl ester) of LiOH were added and the reaction mixture was stirred for 
3 hours at room temperature. The solution was filtered and acidified with HCl to pH 4. 
Methanol was evaporated and the water was removed by freeze drying. The polymer was 
dissolved in MeOH and precipitated in cold acetone twice, yielding a yellow-brown polymer. 
1
H NMR (500 MHz, CD3OD): δ 3.45 (NCH2CH2), 2.62 (COCH2CH2COOH), 2.33 
(COCH2CH3), 1.11 (CH2CH3) 
 
PAOx-NHS synthesis 
PAOx-COOH was dissolved in DMA (12.5 mL/ g polymer). Two equivalents of NHS and 2 
equivalents of EDC.HCl or DIC were added with a syringe. The solution was stirred 
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overnight at room temperature. The solvent was evaporated and the polymer was dissolved in 
DCM and washed with water and brine once. The organic phase was dried over Na2SO4 and 
the solvent was reduced. The polymer was precipitated twice in cold diethyl ether yielding a 
yellow-brown polymer. The NHS content was determined with UV-Vis spectroscopy; the 
polymer was dissolved in 0.1 M NH4OH (1 mg/mL) and this was diluted 10 times to measure 
absorbance at 260 nm. NHS absorbs temporarily (maximum 20 minutes) at 260 nm when 
deprotonated.
25
 
1
H NMR (500 MHz, CDCl3): δ 3.45 (NCH2CH2), 2.82 (CH2CH2. NHS), 2.33 (COCH2CH2CO 
& COCH2CH3), 1.11 (CH2CH3) 
 
PAOx-NH2 synthesis 
Ethylene diamine (30 eqv vs COOMe) was added to PAOx-COOMe. The polymer dissolved 
in a few minutes and the solution was stirred overnight. The excess of ethylene diamine was 
evaporated. The polymer was dissolved in MeOH and precipitated in cold diethyl ether twice. 
1
H NMR (500 MHz, CD3OD): δ 3.45 (NCH2CH2), 2.76 (NHCH2CH2NH2), 2.69 
(COCH2CH2COOH), 2.33 (COCH2CH3), 1.11 (CH2CH3) 
 
Monomer synthesis 
Monomers were synthesized as described in chapter 2. 
 
Copolymerisation yielding P(MeOx-MestOx). P(EtOx-MestOx) or P(nPropOx-MestOx) 
MestOx and MeOx/EtOx/nPropOx were mixed under argon atmosphere in the right monomer 
ratio with methyl tosylate and acetonitrile. This solution was heated for 20 minutes at 140 °C 
in the microwave. After cooling down, piperidine was added and the reaction was stirred for 1 
hour. The solvent was evaporated, the polymer was dissolved in DCM and precipitated twice 
in cold diethyl ether. 
 
P(EtOx-MestOx) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3), 3.46 (br, NCH2CH2N), 3.14 (b, 
CH2NCH2 piperidine), 2.96 (s, NCH3), 2.63 (b, COCH2CH2CO), 2.27 (b, COCH2), 1.78 (s, 
CH2CH2CH2 piperidine), 1.12 (br, CH2CH3) 
 
P(nPropOx-MestOx) 
1
H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3), 3.46 (br, NCH2CH2N), 3.14 (b, 
CH2NCH2 piperidine), 2.96 (s, NCH3), 2.63 (b, COCH2CH2CO), 2.27 (b, COCH2), 1.78 (s, 
CH2CH2CH2 piperidine), 1.63 (b, COCH2CH2), 0.95 (br, CH2CH3) 
 
PAOx-COOH synthesis 2 
Copolymer was dissolved in methanol (13 mL/g) and water (1.3 mL/g). 2 equivalents of 
lithium hydroxide were added and the reaction was stirred overnight. The solvent was 
evaporated and the polymer was dissolved in MeOH and precipitated in acetone. The 
precipitate was collected, dissolved in MeOH and acidified to pH 2 with 2 M HCl. The 
solvent was evaporated, polymer was dissolved in MeOH and precipitated in acetone. 
 
Partial hydrolysis methyl esters 
PMestOx (4.5 g) was dissolved in 60 mL MeOH and 6 mL water. This solution was split into 
three equal portions. To the first 102.84 mg of LiOH.H2O was added. To the second 203.17 
mg and to the third 306.95 mg. The solutions were stirred overnight. The solvent was 
evaporated and the polymer was dissolved in MeOH and precipitated in acetone. The 
precipitate was collected, dissolved in MeOH and acidified to pH 2 with 1 M HCl. The 
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solvent was evaporated, polymer was dissolved in MeOH and precipitated in acetone : diethyl 
ether 1:1. 
 
Stability measurements with 
1
H NMR 
The NMR signal was locked with only solvent and then the sample was inserted. A 
continuous experiment was performed where 45 runs of 4 scans were taken with a relaxation 
time of 2 seconds and waiting time in between runs of 116 seconds. The obtained spectra 
were integrated for the bound NHS signal and the percentage of the left over bound NHS was 
calculated and plotted against time. 
 
Crosslink tests 
Crosslink tests were performed with a final polymer concentration of 30 mg/mL. 3.40 mg 
PAOx-NH2 12% was dissolved in 120 µL EtOH:Et3N 99:1 and 3.62 mg PAOx-NHS 11.9% 
was dissolved in 120 µL EtOH. The PAOx-NHS solution was added to the PAOx-NH2 
solution and quickly mixed by vortexing.  
 
pH dependence of crosslinking 
42.42 mg of PAOx-NH2 12% was dissolved in 1.5 mL of absolute EtOH and PAOx-NHS 
11.9% was dissolved in 1.5 mL of absolute EtOH. To 100 µL of the PAOx-NH2 solution 0. 
0.5. 0.7. 1.0. 1.5. 1.75 or 2 µL of Et3N were added and some additional EtOH was added to 
have equal volumes. To each of the PAOx-NH2 solutions 100 µL of PAOx-NHS solutions 
was added and mixed by vortexing. A drop was taken to determine the final pH on pH paper. 
 
Film formation 
Cups of anti-adhesive paper of minimal 2.5x2.5 cm were prepared. Sharp fold lines were 
made and the cups were stapled at the top to avoid leakage and allow easy removal of the 
staples and thus the tape from the cup. PAOx-NHS and PAOx-NH2 were dissolved separately 
in EtOH, at least 10 µL of solvent per mg of polymer, and the dissolution of PAOx-NH2 could 
be helped by gently heating or via the addition of 1 v/v% of Et3N if necessary. Both solutions 
were mixed and cast into the paper cup and allowed to dry overnight at room temperature or 
40 °C. 
 
Adhesion test 
The set up as depicted in Figure 67 was prepared and the tissue with a 3 mm circular incision 
was levelled with the 50 mL mark of the column. All air bubbles were removed from the 
system and the tissue was secured to the set up. Borate buffer pH 8.5 (prepared by dissolving 
38.137 g of disodium tetraborate in 450 mL, and adjusting the pH to pH 8.5 using 1 M HCl 
solution)was dripped on top of the tissue and removed again with some paper towel. A piece 
of tape was pushed onto the tissue for 1 minute. The tape was lightly pushed to check if 
adhesion had occurred. The pressure was increased gradually by the addition of demi water to 
the column until failure by either adhesion or burst occurred. This value was noted as burst 
pressure.  
 
PLGA backing 
The required amount of PLGA was dissolved in 5 mL DCM and cast in the paper cup. The 
solvent was allowed to evaporate overnight. 
 
Amine containing backings 
The required amounts of PLGA, PLC and PAOx-NH2 were dissolved in 5 mL DCM and 0.5 
mL MeOH and cast in the paper cup. The solvents were allowed to evaporate overnight. 
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Adhesive layer formation 
PAOx-NHS and PAOx(Et-NH2), total weight polymers 100 mg, were dissolved separately in 
total 5 mL of DCM. The solutions were mixed and cast in a paper cup and dried overnight at 
room temperature. 
 
 
 
Hotpress 
The backing was removed from its paper cup and put on top of the adhesive layer, which 
stayed in its cup where the staples were removed. A piece of anti-adhesive paper was put on 
top and this was placed between two Teflon covered metal sheets (cut from a baking tray). 
This was placed in the hotpress of which the temperature of the bottom plate was manually 
controlled at 30-40 °C. The films were put on a pressure of 10000 for 5 minutes and allowed 
to cool down before testing. 
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Summary 
 
Sutures and staples are widely used for closure of incisions, but it has certain drawbacks, 
especially for vulnerable and delicate tissues. When wounds have to closed, sutures and 
staples do not provide a tight seal preventing leakage of gas and fluids. Tissue adhesive 
materials are developed to provide, in combination with sutures, a watertight seal. Many 
(polymeric) products are available, but they have several drawbacks. Cyanoacrylates are used 
for skin closure, but due to their toxic degradation products (formaldehyde) other applications 
are difficult to realize. Poly(ethylene glycol) gels are biocompatible, but do lack mechanical 
strength, which limits their applicability. The general challenge regarding synthetic adhesives 
is to find polymers which are non-toxic and which display good gel strength. The variety of 
polymers used at the moment is therefore small and most adhesives are based on either PEG, 
polyurethanes or PLGA. Clearly there is a need for new synthetic polymers which satisfy 
better the criteria for an optimal tissue adhesive. Biomimetic adhesives are a rapidly 
expanding research field. Especially the introduction of the dihydroxyphenyl moiety (DOPA), 
responsible for the adhesive behavior of mussel adhesive proteins, into synthetic polymers, 
such as polystyrene or PEG, is being explored. This research area shows a lot of perspective 
in adhesion strength, but long degradation times and the use of toxic oxidizing agents are 
major concerns. A list of requirements for ideal tissue adhesive materials is included in 
chapter 1. A class of polymers that is regarded to be potentially very interesting for 
biomedical applications are the poly(2-oxazoline)s which are described in the second part of 
chapter 1. Poly(2-alkyl/aryl-2-oxazoline)s (PAOx) are an interesting class of polymers 
because of their tuneable properties, biocompatibility, stealth behavior and thermosensitivity. 
The polymers are made by the living cationic ring opening polymerisation (CROP) of 2-
oxazoline monomers, allowing easy access to well-defined polymers with controlled end 
group functionalities. Different strategies for monomer synthesis, the polymerisation 
mechanism, functional monomers are described. A list of polymer properties is given, 
consisting of the aqueous solution behaviour, thermal properties and biocompatibility and 
stealth behaviour. 
 
In chapter 2 the synthesis of the methyl ester functional oxazoline monomers MestOx and 
C3MestOx is described. Homopolymerisation studies revealed a faster propagation of MestOx 
and C3MestOx compared to the alkyl monomers, 2-methyl-2-oxazoline (MeOx), 2-ethyl-2-
oxazoline (EtOx) and 2-n-propyl-2-oxazoline (nPropOx). Activation energies for MestOx and 
C3MestOx were lower than for MeOx and EtOx. The copolymerisation, however, revealed a 
reversed order of incorporation. The EtOx and nPropOx copolymerisations led to a minor 
deviation from ideal random monomer distribution, whereas the MeOx copolymerisation with 
MestOx or C3MestOx led to gradient copolymers. Both the polymerisation temperature and 
the type of monomer influenced the gradient formation, MestOx and 80 °C resulted in a more 
pronounced gradient than a temperature of 140 °C and with C3MestOx monomer. The large 
difference in reaction rates between homo- and copolymerisation of MeOx with the ester-
containing oxazolines was further corroborated by the determination of the activation energy 
of MeOx during copolymerisation, which was comparable to homopolymerisation, while the 
activation energy of MestOx was increased. 
 
The synthesis of series of homo- and copolymers of MestOx and C3MestOx with EtOx and 
nPropOx is described in chapter 3. All polymers, except P(EtOx49-MestOx51), showed 
cloudpoint temperatures (TCPs) between 24 °C and 108 °C depending on the composition, at a 
concentration of 5 mg/mL in water. All these polymers were amorphous with glass transition 
temperatures between -2 °C and 54 °C. The P(EtOx-MestOx), P(EtOx-C3MestOx) and 
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P(nPropOx-C3MestOx) copolymers have glass transition temperatures that can be tuned in 
between the Tgs of the homopolymers. However, for P(nPropOx-MestOx) copolymers, the 
Tgs of all copolymers are lower than the ones of both homopolymers, indicating suppression 
of interchain interactions. All homo- and copolymers are thermally stable up to at least 250 
°C, whereby copolymers with more (C3)MestOx were found to be less stable. Nonetheless, 
the stabilities will allow thermal processing, e.g. hot-melt extrusion, at temperatures well 
above room temperature. Also MeOx-C3MestOx polymers, both gradient and block-
copolymers, were prepared with a 25-75 mol% ratio. Both polymers showed 
thermoresponsive behavior:  
the gradient copolymer showed a similar transition as EtOx and nPropOx copolymers, while 
the block copolymer showed a different transmittance curve indicating particle formation. 
 
In chapter 4 the modification of the methyl esters was described. The methyl ester was reacted 
with a series of primary and secondary amines resulting in their corresponding amides. The 
linear primary and cyclic secondary amines used are methylamine, ethylamine, n-
propylamine, n-butylamine, pyrrolidine, piperidine, morpholine and 1-acetylpiperazine 
respectively. The linear primary amines could be used for direct amidations reactions, 
however the cyclic secondary amines did not react under these conditions. The addition of 
triethylamine was needed to perform this reaction. The starting polymer PMestOx had a 
cloudpoint temperature of 101 °C at 5 mg/mL which was modified by these reactions. The 
introduction of n-propylamine, pyrrolidine and piperidine lowered the TCP, while n-
butylamine resulted in a non watersoluble polymer. The other amines lead to an increase of 
TCP. So the LCST behaviour of one polymer can be varied over a broad range of temperatures 
by reacting it with different amines. At the same time glass transition temperatures were 
raised from 39 °C to a range from 53-89 °C. The relationship between the number of carbons 
in the primary amines and the resulting Tgs is linear and similar to the reported trend for 
poly(2-alkyl-2-oxazoline)s. All amidated polymers were found to be thermally stable up to at 
least 250 °C. The amidation of PMestOx polymers enables a wide variety of properties from 
the same scaffold. More amines and combinations of amines need to be tested to achieve fine 
tuning of solution and bulk properties. 
 
Chapter 5 describes the three step post-polymerisation modification of EtOx-MestOx 
copolymers to yield amine and subsequently guanidinium functionalised poly(2-oxazoline)s. 
Both random and block methyl ester containing copolymers were prepared and modified. 
Both amine and guanidinium functionalised copolymers did not show toxicity up to 10 µM, 
however at 15 µM for the block copolymers containing amines or guanidines some minor 
toxicity was observed. Uptake studies showed that only the block copolymers with 15 or 20% 
functionalisation were taken up by HeLa cells, clearly demonstrating the influence of 
monomer distribution and degree of functionalisation. The efficiency was lower compared to 
R8, probably due to the size of the polymeric construct, this might be improved by longer 
incubation times. Also the impact of spacer length between the polymeric backbone and the 
guanidinium group need to be tested by using C3MestOx instead of MestOx. 
 
One of the main problems in abdominal surgery is the occurrence of leakages and related 
infections. A number of products are available to seal the wounds, but none of them has an 
excellent performance on all aspects. In chapter 6 the development of a tissue adhesive 
material based on poly(2-oxazoline)s, bearing N-hydroxysuccinimide (NHS) esters as tissue 
reactive groups is described. Two synthetic routes were developed for the preparation of 
NHS-ester functional poly(2-oxazoline)s. The first route started with commercially available 
poly(2-ethyl-2-oxazoline) (PEtOx) which was partially hydrolysed to yield a copolymer of 
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poly(ethylene imine) (PEI) and PEtOx. The resulting amine was reacted an acid chloride to 
yielding a methyl ester functional polymer. Similar methyl ester functionalised polymers were 
prepared in the second route by the copolymerisation of MeOx, EtOx or nPropOx with 
MestOx. From this point the preparations of NHS functional PAOx were similar. The methyl 
ester was subsequently hydrolysed to its corresponding carboxylic acid which was reacted 
with NHS to obtain the NHS functional polymers. Also an amine functional polymer was 
made to provide crosslinking between the PAOx-NHS polymers allowing to make self-
standing crosslinked polymer films. The rate of crosslinking of these two polymers is pH 
dependent with an optimum of pH 7.5-8.5 for fast crosslinking with a minimum loss of NHS 
esters due to high pH values. Polymeric tapes required crosslinking to avoid fast dissolution at 
contact with fluids, however complete crosslinking yielded non-sticking tapes. An NHS:NH2 
ratio of 5:1 to 7:1 seemed to be optimal, but higher contents of NHS need to be tested. 
Addition of polyester backing materials, containing some PAOx-NH2 to covalently link it to 
the adhesive layer, significantly improved the mechanical properties of the adhesive films, 
although the ratio of PLGA and PLC and NH2 content have to be optimised. The solvent used 
for casting the adhesive layer on top of the backing greatly influenced the burst pressure, with 
1-propanol and 2-propanol proving the best solvents. Unfortunately, the standard deviation of 
the adhesion of the films was high, obstructing in depth evaluation of the effect of varying the 
tape composition. Detailed studies have to be performed to find causes and solutions for this 
problem.  
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Samenvatting 
 
Hechtingen en nietjes worden veel gebruikt voor het sluiten van chirurgische snijwonden, 
maar dit heeft veel nadelen vooral voor kwetsbaar en teer weefsel. Als wonden gesloten 
worden zorgen hechtingen en nietjes niet voor een water- en luchtdichte afsluiting. 
Weefselplakkende materialen werden ontwikkelend om, eventueel in combinatie met 
hechtingen, voor een waterdichte afsluiting te zorgen. Veel (plastic) materialen zijn 
beschikbaar, maar deze hebben verschillende bezwaren. Cyanoacrylaten (secondelijm) wordt 
gebruikt voor het sluiten van huidwondjes, maar omdat er bij afbraak giftige 
degradatieproducten (formaldehyde) ontstaan zijn andere toepassingen moeilijk te realiseren. 
Poly(ethyleen glycol) (PEG) gelen zijn biocompatibel, maar deze materialen zijn niet sterk, 
wat de toepasbaarheid beperkt. De algemene uitdaging voor synthetische plakkende 
materialen is om een polymeer te vinden dat niet giftig is en een goede mechanische 
eigenschappen heeft. De verscheidenheid van polymeren die op dit moment gebruikt worden 
is daardoor klein en de meeste plakkende materialen zijn gebaseerd op PEG, polyurethaan of 
PLGA. Er is duidelijk behoefte aan een nieuw synthetisch polymeer dat de wensen voor een 
optimaal weefsel plakkend materiaal vervuld. Plakkende materialen die de natuur nabootsen 
zijn een snel uitbreidende onderzoeksveld, vooral sinds het introduceren van de 
dihydroxyfenyl eenheid (DOPA), die verantwoordelijk is voor de plakeigenschappen van het 
mossellijm eiwitten, in synthetische polymeren, zoals polystyreen of PEG, wordt onderzocht. 
Dit onderzoeksgebied is veel belovend wat betreft plakkracht, maar de lange degradatietijden 
en het gebruik van giftige oxiderende stoffen zijn verontrustend. Een lijst van eisen voor een 
ideaal weefsel plakkend materiaal is te vinden in hoofdstuk 1. Een type van polymeren dat 
potentieel zeer interessant is voor biomedische toepassingen zijn poly(2-oxazoline)s. Deze 
polymeren worden beschreven in het tweede deel van hoofdstuk 1. Poly(2-alkyl/aryl-2-
oxazoline)s (PAOx) zijn interessante materialen vanwege hun afstembare eigenschappen, 
biocompatibiliteit, stealth gedrag en thermoresponsief gedrag. De polymeren worden gemaakt 
met behulp van levende kationische ringopening polymerisatie (CROP) van 2-oxazoline 
monomeren, hiermee kunnen goed gedefinieerde polymeren met gecontroleerde eindgroepen 
gemaakt worden. Verschillende monomeersynthese routes, het polymerisatiemechanisme en 
functionele monomeren worden beschreven. Een lijst van polymeereigenschappen, met 
daarbij gedrag in waterige oplossing, thermische eigenschappen, biocompatibiliteit en stealth 
gedragen, is gegeven. 
 
In hoofdstuk 2 wordt de synthese van methyl ester gefunctionaliseerde oxazoline monomeren 
MestOx en C3MestOx beschreven. Homopolymerisatie studies laten zien dat MestOx en 
C3MestOx een snellere propagatiereactie ondergaan dan de alkyl monomeren, 2-methyl-2-
oxazoline (MeOx), 2-ethyl-2-oxazoline (EtOx) en 2-n-propyl-2-oxazoline (nPropOx). De 
activeringsenergieën voor MestOx en C3MestOx zijn lager dan die voor MeOx en EtOx. De 
copolymerisatie laat een omgekeerde volgorde van inbouw van de monomeren zien ten 
opzichte van de homopolymerisatie. De EtOx en nPropOx copolymerisaties leiden tot een 
kleine afwijking van de ideale willekeurige monomeerverdeling, terwijl MeOx 
copolymerisatie met MestOx of C3MestOx leidt tot de vorming van gradiënt copolymeren. 
Zowel het type monomeer als de polymerisatietemperatuur hebben invloed op de vorming van 
het gradiënt, MestOx en 80 °C leiden tot de vorming van een sterker gradiënt dan C3MestOx 
en een temperatuur van 140 °C. Het grote verschil in reactiesnelheid tussen MeOx en 
monomeren met methyl esters werd bevestigd door de bepaling van de activeringsenergie van 
MeOx en MestOx in de copolymerisatie. De activeringsenergie van MeOx was vergelijkbaar 
met de homopolymerisatie, terwijl die van MestOx steeg. 
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De synthese van series homo- en copolymeren van MestOx en C3MestOx met EtOx en 
nPropOx wordt beschreven in hoofdstuk 3. Alle polymeren, behalve P(EtOx49-MestOx51), 
hebben een troebelingspunt (TCP) tussen de 24 en 108 °C afhankelijk van de samenstelling bij 
een concentratie van 5 mg/mL in water. Al deze polymeren waren amorf met een 
glasovergangstemperatuur (Tg) tussen -2 en 54 °C. De P(EtOx-MestOx), P(EtOx-C3MestOx) 
en P(nPropOx-C3MestOx) copolymeren hebben glasovergangstemperaturen die ingesteld 
kunnen worden tussen de Tgs van de homopolymeren. Echter voor P(nPropOx-MestOx) 
copolymeren, de Tgs van alle copolymeren zijn lager dan die van beide homopolymeren, dit 
wijst op de onderdrukking van de interacties tussen ketens. Alle homo- en copolymeren zijn 
stabiel bij verhitting tot 250 °C, waarbij polymeren die meer (C3)MestOx bevatten minder 
stabiel waren. Niettemin laten deze stabiliteit thermische verwerking boven het smeltpunt toe, 
zoals bijvoorbeeld extrusie. Ook werden MeOx-C3MestOx polymeren bereid, zowel gradiënt 
als blok copolymeren met een 25-75 mol% verhouding. Beide polymeren zijn 
thermoresponsief: het gradiënt copolymeer heeft een vergelijkbare overgang als de EtOx en 
nPropOx polymeren, terwijl het blok copolymeer een andere transmissiecurve laat zien die 
wijst op de vorming van deeltjes.  
 
In hoofdstuk 4 wordt de modificatie van de methyl esters beschreven. De methyl ester 
onderging een reactie met primaire en secundaire amines wat resulteerde in de 
overeenkomstige amides. De lineaire primaire en cyclische secundaire amines die gebruikt 
werden, zijn respectievelijk methylamine, ethylamine, n-propylamine, n-butylamine, 
pyrrolidine, piperidine, morpholine en 1-acetylpiperazine. De lineaire primaire amines werden 
gebruikt in een direct amidatie reactie, maar de cyclische secundaire amines reageerde niet 
onder deze omstandigheden, toevoeging van triethylamine was nodig om deze reactie te laten 
verlopen. Het uitgangsmateriaal, PMestOx, had een troebelingspunt van 101 °C bij een 
concentratie van 5 mg/mL. Deze troebelingstemperatuur veranderde door de reacties: de 
introductie van n-propylamine, pyrrolidine en piperidine verlaagden de TCP, terwijl de reactie 
met n-butylamine resulteerde in een polymeer dat niet meer wateroplosbaar was. De andere 
amines resulteerden in een toename van de TCP. Het LCST (onderste kritische 
oplossingstemperatuur) gedrag van een polymeer kan over een groot temperatuursgebied 
gevarieerd worden door het te laten reageren met verschillende amines. Tegelijkertijd werden 
de glasovergangstemperaturen naar van 39 °C naar 53-89 °C verhoogd. Het verband tussen 
het aantal koolstofatomen in de primaire amines en de bijbehorende Tgs is lineair en 
vergelijkbaar met trend die waargenomen is voor poly(2-alkyl-2-oxazoline)s. Alle 
geamideerde polymeren zijn stabiel tot 250 °C. De amidatie van PMestOx geeft toegang tot 
een grote verscheidenheid aan eigenschappen uitgaande van hetzelfde materiaal. Meer amines 
en combinaties van amines moeten worden getest om fijne afstemming van de eigenschappen 
in bulk en oplossing te bereiken. 
 
Hoofdstuk 5 beschrijft de post-polymerisatie modificatie in drie stappen van EtOx-MestOx 
copolymeren naar amine en vervolgens guanidine gefunctionaliseerde poly(2-oxazoline)s. 
Statistische als blok copolymeren met methyl esters zijn gemaakt en gemodificeerd. Zowel de 
amine als de guanidine gefunctionaliseerde copolymeren lieten geen toxiciteit zien tot 10 µM, 
maar bij 15 µM lieten de blok copolymeren met amines of guanidines een kleine toxiciteit 
zien. Opnamestudies lieten zien dat alleen de blok copolymeren met 15 of 20% 
functionalisering werden opgenomen door HeLa cellen. De opname van de polymeren is dus 
afhankelijk van de monomeer distributie en het aantal functionele groepen. De opname-
efficiency is lager dan die van R8, waarschijnlijk komt dit door de grootte van het polymeer. 
De opname kan mogelijk verbeterd worden door de cellen langer de tijd te geven om het 
materiaal op te nemen. De invloed van de lengte van de spacer tussen de polymeerhoofdketen 
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en de guanidine groep moet getest worden door C3MestOx in plaats van MestOx te 
gebruiken. 
Een van de belangrijkste problemen in buikchirurgie is het optreden van lekkages en 
bijbehorende infecties. Er zijn een aantal producten beschikbaar die wonden waterdicht 
maken, maar geen een voldoet aan alle eisen. In hoofdstuk 6 wordt de ontwikkeling van 
weefsel plakkende materialen op basis van poly(2-oxazoline)s beschreven. Deze polymeren 
hebben N-hydroxysuccinimide (NHS) esters als weefselplakkende groep. Twee synthese 
routes voor de bereiding van NHS-ester functionele poly(2-oxazoline)s worden beschreven. 
De eerste methode start vanuit een commercieel verkrijgbaar poly(2-ethyl-2-oxazoline) 
(PEtOx) die gedeeltelijk wordt gehydrolyseerd. Dit resulteert in een copolymeer van 
poly(ethyleen imine) (PEI) en PEtOx. Het ontstane amine wordt met behulp van methyl 
succinyl chloride omgezet in een methyl ester functioneel polymeer. Vergelijkbare methyl 
ester gefunctionaliseerde polymeren worden in de tweede route gemaakt door de 
copolymerisatie van MeOx, EtOx of nPropOx met MestOx. Vanaf de methyl ester is de 
bereiding van NHS gefunctionaliseerde PAOx hetzelfde. The methyl ester wordt 
gehydrolyseerd naar het overeenkomstig carbonzuur wat reageert met NHS om NHS 
gefunctionaliseerde polymeren te verkrijgen. Ook werden er amine gefunctionaliseerde 
polymeren gemaakt, deze zorgen voor het crosslinken van de PAOx-NHS polymeren zodat 
een op zichzelf staande gecrosslinkte polymerenfilm gemaakt kan worden. De snelheid van 
crosslinken tussen de twee polymeren is pH afhankelijk met een optimum tussen pH 7.5 en 
8.5. Deze pH waarde zorgt voor snelle crosslinking met een minimum verlies aan NHS esters 
vanwege hoge pH waarden. De polymeren plakbanden hebben crosslinks nodig om te 
vermijden dat ze snel oplossen op het moment ze in contact komen met vloeistoffen, echter 
compleet gecrosslinkte film zorgt voor niet plakkende tapes. Een NHS:NH2 ratio van 5:1 tot 
7:1 lijkt optimaal, maar hogere NHS waarden moeten nog getest worden. Door de toevoeging 
van een ondersteunende laag, die ook wat PAOx-NH2 bevat om de lagen covalent aan elkaar 
te verbinden, verbeterde de mechanische eigenschappen van de films significant. Alhoewel de 
verhouding van PLGA en PLC en NH2 hoeveelheid nog geoptimaliseerd moeten worden. Het 
oplosmiddel wat gebruikt wordt voor het gieten van de plakkende laag boven op de 
ondersteunende laag heeft grote invloed op de barst-druk; 1-propanol en 2-propanol bleken de 
beste oplosmiddelen. Helaas is de standaard deviatie van de plakkende films erg hoog, 
waardoor het effect van variërende samenstelling lastig is te evalueren. Gedetailleerde studies 
zullen moeten worden uitgevoerd om een oplossing voor dit probleem te vinden. 
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Dankwoord 
 
Na een heel boekje geschreven te hebben, is het nu tijd voor het laatste en meest gelezen 
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niet gelukt om dit werk te doen. 
 
Als eerste wil ik mijn promotor Jan bedanken voor de goede begeleiding gedurende 4,5 jaar. 
Je probeerde altijd met oplossingen te komen voor de kleine, op papier simpele stappen in het 
GATT project die soms tot grote problemen leidden. Ondanks de langzame vooruitgang van 
dit project wist je me altijd te motiveren om weer verder te gaan. Achteraf ben ik erg blij dat 
jullie de beslissing hebben genomen om mij naar Gent te sturen om dit proefschrift te vullen 
en dit heeft goed uitgepakt. Ik kon altijd met vragen bij je terecht, maar vaak werd ik dan 
doorverwezen naar Gent omdat daar meer kennis aanwezig is. 
 
Met Gent bedoel ik natuurlijk mijn andere promotor Richard. Ook jou wil ik bedanken voor 
de goede begeleiding de afgelopen jaren. Ik heb erg veel geleerd van jouw gigantische 
ervaring met poly(2-oxazoline)s. Ik vond het erg fijn om op twee plekken te kunnen werken, 
het labo in Gent was een welkome afwisseling met het lab in Nijmegen. Tijdens de 
groepsactiviteiten of het nu sport of spel was, was je altijd erg fanatiek. Je spoorde iedereen 
aan om mee te doen, ook met het vakgroep schaatsen deed je dat erg fanatiek. Helaas eindigde 
deze voor jou op de spoed, ik hoop dat ik mijn taak als EHBO’er toen goed vervuld heb. 
 
I would also like to thank the members of the committee, Alan Rowan, Roeland Nolte, 
Dennis Löwik, Bruno de Geest, Sandra Van Vlierberghe, Hans Heuts, Gisèle Volet and 
Bryn Monnery for their contribution in the defense and the critical reading of the manuscript. 
Dennis wil ik ook bedanken voor het meedenken over welke polymeren gemaakt moesten 
worden voor hoofdstuk 5. 
 
Zonder de vaste medewerkers van de afdeling organische chemie was het niet gelukt om dit 
boekje te schrijven en deze moeten natuurlijk ook bedankt worden. Marieke voor alle 
administratieve ondersteuning en het gezellige babbeltje iedere keer als ik langs kwam. Het 
plannen van overleggen was niet het makkelijkste in dit project gezien de vele en drukke 
agenda’s. Peter van Dijk voor de bestellingen, ik zal je gezicht niet vergeten toen je kwam 
zeggen dat er een pakketje voor mij was en dat ik deze zelf maar moest komen halen omdat 
de 160 gram materiaal geen pakketje was maar een vat verpakkingsmateriaal van minimaal 20 
liter. Paul voor de hulp bij de NMR metingen op de 500 MHz, de belangstelling voor wat ik 
nu allemaal aan het meten en natuurlijk de naar jou genoemde Paul Schlebos Vette Hap borrel 
waar je altijd bamischijven aanbid. Peter v G voor de hulp bij de LCQ, Theo bij de IR, 
Helene voor GPC, Ad voor NMR, Jan D, René en Hans voor hulp op het lab, Desiree, Paula 
en Jacky voor administratieve ondersteuning. Astrid en Leny van P&O wil graag bedanken 
voor de administratie en het geregel van het contract rondom het gezamenlijk doctoraat. 
 
Ook in de vakgroep Organische en Macromoleculaire Chemie heb ik veel ondersteuning 
gehad van verschillende mensen en ik wil hen graag bedanken daarvoor. Tom, voor de vele 
en geduldige administratie rondom het gezamenlijk doctoraat (al kon u dat woord op den duur 
niet meer horen), het ritje naar het UFO voor de inschrijving en de computerzaken tijdens 
mijn eerste twee bezoeken aan Gent. Jos voor zijn winkeltje en om mij te voorzien in mijn 
behoefte in naalden en spuiten, Tim voor de NMR, Pieter voor de ICT ondersteuning tijdens 
mijn derde en lange bezoek, Bernhard voor GPC en TGA metingen en Claudia voor de SEC 
metingen. 
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Het grootste gedeelte van mijn promotietijd heb ik besteed aan het GATT project. Dit begon 
met een heel klein groepje en is uiteindelijk een grote groep van mensen geworden. Johan, de 
man die het project bedacht heeft; je had vaak gekke ideeën en je wist uit allerlei potjes aan te 
spreken om mensen aan te nemen die het project kwamen versterken. Als eerste kwam Huub 
me helpen. We hadden elkaar een paar maanden eerder in Gent leren kennen waar we de eer 
van de Nederland, eigenlijk meer Eindhoven, hoog hielden. Je hebt mij toen samen met Victor 
de kneepjes van de (poly)oxazoline synthese geleerd. Je hulp resulteerde in het op poten 
zetten van de hydrolyse route voor de synthese van de NHS polymeren. Jij was degene die als 
eerste een NHS polymeer maakte en per ongeluk een druppel DCM oplossing op je hand liet 
vallen. Onze, toen nog bruine, polymeren leverde een mooie vlek op je hand op die je er niet 
af gewassen kreeg. Samen maakte we het eerste gelletje waarmee we lieten zien dat de 
methode werkte. Na een half jaar verliet je Nijmegen om terug te keren op de TU/e voor een 
promotieonderzoek daar. Ik weet niet hoe wel het voor elkaar krijgen, maar we hebben 
dezelfde promotiedatum gepland. Vlak nadat Huub begon, werd ook Encapson bij het project 
betrokken, bij Joost, Dennis en Bram kon ik altijd aankloppen voor advies. Bram, toen je bij 
later bij GATT ging werken, werd onze samenwerking intensiever en wisselden we 
ervaringen met de synthese en materialen uit om zo prototypes te kunnen maken en testen. 
Toen Marcel begon met zijn promotieonderzoek had ik weer een labmaatje die ongeveer 
hetzelfde werk deed. Ondanks onze krappe start, met zijn drieën in een zuurkast, is de 
samenwerking goed verlopen. We namen materiaal van elkaar over om de synthese verder te 
zetten. We irriteerden onze labgenoten met het gezoem van de Turrax en bezetten we met zijn 
tweeën alle rotorvaps in ons lab. Ook de andere mensen in het GATT team die ik ontmoette 
tijdens onze grote overleggen. Harry het was erg prettig om de medische kant van het verhaal 
van jou te horen, ik heb erg veel geleerd over de heelkunde, ook heb je bijdrage geleverd aan 
ons review artikel door hier samen met Simon de medische kant van het verhaal correct op 
papier te zetten. Verder wil ik Etienne en Mark bedanken. Maria and Alexandra you made 
the team quite Spanish. 
 
Rosa, you joint the GATT team shortly after Marcel, although you are not trained in 
chemistry, I hope I learnt you a lot of chemistry, that must be the case after all the questions 
you asked me. You learnt me a lot about biomaterials and enjoyed our collaboration. I loved a 
the chats we had which made the PhD life a lot easier. I really appreciate it that you want to 
be my paranimf. 
 
Mijn andere paranimf, Maarten (aka Big Jim), je hebt een mooie bijdrage geleverd aan mijn 
doctoraat, terug te lezen in hoofdstuk 2. Het was onderdeel uw masterthesis om de 
polymerisatiekinetiek van MestOx te onderzoeken, wat uiteindelijk resulteert heeft in twee 
mooie papers. Ik heb u pas echt leren kennen toen ik voor langere tijd naar Gent kwam en 
toen was je net begonnen aan uw doctoraat. In die tijd heb ik veel van u geleerd over de 
praktische kanten van polymerisatiekinetiek. 
 
The first month of my PhD I spent in Nijmegen reading loads of literature. The second month 
I went to Ghent to learn the labwork of PAOx. I joint, at that time, a very small research 
group of 8 in total who was having their group meetings in Richards office, hard to 
understand right now. Victor, the Spanish guy, later on responsible for the introduction of the 
concept ‘Spanish time.’ After my first polymerisation in the microwave you did a little dance 
together with Huub, to show me how the polymerisation mixture should show waves. I 
enjoyed our trip to San Diego to visit the ACS national meeting, we had a lot of fun over 
there. Lenny¸ jij begon tegelijkertijd met mij in Gent, dit bracht het aantal Nederlanders in de 
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groep op 4. Het was altijd gezellig met jou wat resulteerde in lange praatjes waarbij we soms 
de tijd uit het oog verloren. Veel succes met je postdoc in Auckland. Gertjan, in eerste 
instantie de enige Belg in de groep, maar je wist je goed staande te houden tegen al dat 
Nederlandse geweld. Tijdens mijn lange verblijf vond ik de babbels die we, vooral in het 
bureau, hadden erg prettig. 
During my second visit in Ghent, I was working on the methyl ester monomer synthesis. 
Bryn, although I have mentioned you already before, I would like to thank you for the help 
with this. You taught me a lot about distillations and could not stop talking about high 
vacuum. Tijdens dit bezoek maakte ik kennis met een aantal nieuwe collega’s. Bart, het was 
prettig samenwerken met u, alhoewel het soms lastig was om een trekkast met zijn drieën te 
delen. Je aanwezigheid op het labo was niet te missen, ik denk dat ik misschien wel een dag 
slechter gehoord heb nadat je in uw mail las dat je de IWT beurs toegewezen had gekregen. 
Kathleen¸ onze eerste kennismaking was in Houffalize, toen ik een paar maanden later naar 
Gent kwam voelde het alsof we elkaar al lang kende. Het was een fijne tijd met u op het labo. 
Ik heb u wel veel metingen laten doen, wat resulteerde in een publicatie die ook terug te 
vinden is in hoofdstuk 3. Tijdens de ACS in San Francisco deelde we een kamer met een knus 
1.40 m bed en gingen we gezellig samen shoppen. Als een van de eerste collega’s wist ik van 
uw zwangerschap en ik wens je veel geluk met Wouter en Kasper in de toekomst. 
 
I would also like to thank my other labmates and colleagues Samarendra¸ mostly called by 
your family name Maji, you were always interested in my work and thanks for helping me out 
with the turbidity measurements. Bahar, I met your husband Martin (eindelijk een oxazoline 
poster op de DPD) first, you were the first to stand next to me when I created a fireball in the 
lab. Joachim, eerst student, later collega, altijd in voor een grapje. Een deel van de groep zat 
uiteindelijk op het vierde: Maarten M (Jim), bedankt voor de rit naar de spoed van het UZ. 
Glenn, voor het kijken van een WK wedstrijd op de Oude Markt in Leuven en de 
overnachting in jullie nieuwe appartement met nauwelijks meubels na Kathleens bruiloft, 
Mathias, giving nice and funny presentations at the group meeting. The Asian corner at the 
fourth floor, Qilu, the first PhD to graduate from the SC group, Kanykei, Dingying and 
Zhanyou. I also enjoyed talking with the (exchange) students Silke, Jin, Özlem, Sibel and 
Belgin. 
 
De relaxroom op het eerste werd gedeeld met de mensen van de Madder groep, ook hen wil 
graag bedanken voor de hulp en gezelligheid: Matthias, Vicky, Duchan, Yara, Lieselot, 
Nathalie, Bram, Ellen, Kurt, Willem, Vincent en Abhishek. 
 
Tijdens mijn promotieonderzoek heb ik verschillende studenten mogen begeleiden. Lia, you 
came as an exchange student from the USA and you were the first student I had to supervise. 
Although the project was not always working along, you worked hard trying to find solutions 
for the problems we were facing. Only a little part of your work, the pH dependent 
crosslinking tests, ended up in my thesis. Good luck with finishing Med School and hopefully 
you or any of your colleagues will be able to use the GATT product. Harry¸ officieel stond je 
onder begeleiding van Marcel, maar ik vond het erg leuk om je te helpen met je masterstage. 
Je bent begonnen met het maken van polymeren zodat ik daar weer tapes van kon maken. Het 
was altijd gezellig met jou op het lab. Ik wens je heel veel succes met je eigen 
promotieonderzoek in de VS. Tijdens mijn lange verblijf in Gent heb ik samen met Maarten 
M het bachelorproject mogen begeleiden, de drie bachies waren Willem¸ Wouter en Yentl. 
Jullie hebben vier weken hard gewerkt aan het maken van polymerendeeltjes op basis van 
MeOx en C3MestOx. Alhoewel het einddoel van het project niet gehaald is, zijn jullie 
kinetiekresultaten terug te vinden in hoofdstuk 2 en een set van de drie copolymeren die jullie 
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gemaakt hebben in hoofdstuk 3. Het schrijven van mijn review heb ik niet alleen gedaan, 
Marleen was op zoek naar een onderwerp voor haar literatuurscriptie en heeft een mooi stuk 
werk afgeleverd wat een vermelding op het review opleverde. 
 
Ook in Nijmegen had ik vele collega’s die het werken daar leuk maakte. Britta, ik kon altijd 
bij je terecht om mijn hart te luchten en je was bereid om naar me te luisteren en een kop thee 
te gaan drinken. Chemie bleek een erg kleine wereld toen bleek dat jouw vader en mijn 
moeder in hun studententijd samen stage hadden gelopen. Anika, ik mis de LUNCH! om 
12.30 precies  en ook het napraten over Wie is de mol of Boer zoekt vrouw. Toen ik begon 
met mijn promotie was het van Hest-lab nog in vleugel 4, een aantal mensen bedanken om mij 
wegwijs te maken op het lab. René, mijn zuurkastbuurman waar ik altijd met vragen terecht 
kon met de verhuizing naar vleugel 1 bleef je achter om daarna toch ook de overstap te maken 
en mijn bureaubuurman te worden. Ik vind het erg leuk dat jij de PAOx heb geïntroduceerd in 
de projecten bij de HAN en hoop dat dit boekje je nog wat inspiratie bied. Silvie, bedankt dat 
ik gebruik mocht maken van je zuurkast als ik vacuümdestillaties moest doen. Matthijs, jij 
was verantwoordelijk voor mijn eerste labwerk van mijn PhD, ik was nog niet op het lab 
geweest of jij had het van boven tot onder roze gekleurd. Saskia, jij kwam in mijn rijtje 
bureaus te zitten. Het contact is altijd goed geweest, op een dag was je aan het vloeken op een 
naam genoot van mij en toen geinde we dat onze projecten zo ver uit elkaar lagen dat we 
nooit iets samen zouden doen, niet wetende dat het anders zou uitpakken. In de laatste 
maanden van mijn onderzoek ben ik polymeren CPP mimics gaan maken die we samen 
hebben getest op cellen, eigenlijk fungeerde is als aangever van de epjes en noemde ik de 
volumes op dit gepipetteerd moesten worden. Helaas is dit werk nog niet voltooid omdat mijn 
tijd er opzat. Nanda, mijn EHBO-maatje, het was leuk om elkaar in te pakken met verband 
om te oefenen met zwachtelen, wat verbaasde en geschrokken blikken van de collega’s 
opleverde. I would also like to thank the other member so the van Hest group (Ruud, 
Morten, Sanne, Marlies, David, Joep, Annika, Fei, Ilmar, Yingfeng, Loai, Jan, Roger, 
Lise, Jorgen, Marjoke, Emilia, Melek, Dave, Iria, Daniela, Damei, Henk, Mariëlle, 
Mark, Selma, Lianne, Zhipeng, Anhe and all students) for their help and making it a nice 
time.  
 
Ook wil ik graag mijn labgenoten uit vleugel 1 bedanken, ik was een verstekeling van de van 
Hestgroep op het Rutjes lab. Thomas, Angelique, Rinske, Thorben, Rens en alle studenten 
bedankt voor de leuke tijd. Roel en Maike waren twee andere collega’s waarmee Nanda en ik 
samen de EHBO cursus hebben gevolgd, zeer leerzaam en gezellig. Verder wil de rest van de 
Rutjes groep ook bedanken voor de gezamenlijke lunches en borrels. 
 
In koffiepauzes bracht in ook veel tijd door met de mensen van de Rowan/Elemans/practicum 
groep waar ik mijn master gedaan heb, ook na werktijd was het erg gezellig tijdens de Vette 
hap & Wisky borrels, etentjes en verjaardagsfeestjes. Hans, Femke, Onno, Niels, Zaskia, 
Jialiang, Daniël, Arjen, Dennis, Maarten, Kathleen, Duncan, Stijn, Johan, Luuk, Tom, 
Bart (moeilijke bril), Tim, Roel, Maurice, Pascale, Toine en Inès. Joris en zijn familie 
bedankt voor alle steun en veel succes met het afronden van jouw proefschrift. 
 
Vroeger pakten we bus 2 om naar elkaar toe te gaan, tegenwoordig wonen we iets verder uit 
elkaar en zien we elkaar minder, maar de gezelligheid is er niet minder om. Jasper&Aimée 
(en Sophie en Isa), Jurjen&Sabrina, Moniek&Michel, Renee&Marcel, Koos&Elleke de 
etentjes, uitstapjes, verjaardagen, klus- en verhuispartijen hebben voor de broodnodige 
ontspanning en afleiding gezorgd. Ik hoop dat we deze gezelligheid nog vele jaren kunnen 
doorzetten. Bram, jou zag ik wat minder, dank je wel voor de gezelligheid en het uitwisselen 
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van promotie-ervaringen. Je begon op dezelfde dag als ik en hebt een half jaar eerder kunnen 
verdedigen. Willemijn, ik ken je al vanuit de tijd dat we beide in Nijmegen studeerden. Toen 
je naar Utrecht verhuisde zijn we elkaar even uit het oog verloren, maar toen ik de eerste keer 
in Gent was en foto’s postte bleek jij net aangenomen te zijn als doctoraatsstudent in de S8, 
twee gebouwen verderop op de Sterre. Dit heeft het contact hersteld en ik wil je graag 
bedanken voor het logeeradres wat je me bood als ik tijdens een kort verblijf een extra nachtje 
wilde blijven en alle gezellige en eindeloze kletspartijen. Ook delen we een aantal dezelfde 
hobby’s, namelijk handwerken en schaatsen. Je wilde graag gaan schaatsen maar durfde/wilde 
niet de eerste keer alleen richting Kristallijn fietsen. Ik heb je meegenomen en geïntroduceerd 
bij LBSG, waar ik het erg naar mijn zin heb gehad daarom wil ik mijn oud-clubgenoten voor 
bedanken. Ik hoop dat we er een jaarlijkse traditie van kunnen maken dat ik jullie coach 
tijdens het BK afstanden in Eindhoven.  
 
Het familieweekend in Arcen vlak voordat ik voor een aantal maanden naar Gent vertrok was 
een leuke afwisseling en goed om mijn hoofd leeg te maken en alle promotie-perikelen even 
te vergeten. Ik wil oma hiervoor bedanken en ook alle ooms en tantes, die daarbuiten ook veel 
belangstelling toonden in mijn onderzoek, neefjes, nichtjes, hun aanhang en achternichtjes en 
neefje, alle 45 namen opschrijven wordt me iets te gek 
 
In het diepe zuiden van het land vond ik ook vaak afleiding bij opa en oma. Ook waren de 
neefjes, die ondertussen niet meer klein zijn, Felix, Wim jr., Henk en Sjaak een goede 
manier om de stress even te vergeten en natuurlijk de rest van de familie ook. 
 
Thijs en Simone, mijn broertje dat vroeger niets met scheikunde te maken wilde hebben en 
ondertussen de grootste pyromaan van de familie is als verbrandingstechnoloog. Tijdens het 
over en weer klussen en verhuizen was er, naast het harden werken, ook altijd tijd voor een 
geintje en goede babbel. Natuurlijk zal ik onze skivakantie naar Serfaus niet vergeten. Ik wens 
jullie heel veel geluk toe in jullie nieuwe huisje in Amersfoort. 
 
En als laatste wil ik papa en mama bedanken voor alle steun. Jullie zorgden voor afleiding en 
ontspanning. Terwijl ik aan het werk was, heeft papa alle binnendeuren van mijn appartement 
geverfd, iets wat ik enorm waardeer. Jullie bezoekjes aan Gent waren erg leuk, ook al hebben 
jullie twee keer met veel spullen moeten sjouwen, dit maakte het leven in mijn studioke daar 
wel een stuk aangenamer. 
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